#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Difference in the functional connectivity of the dorsolateral prefrontal cortex between smokers with nicotine dependence and individuals with internet gaming disorder
#Text=Background
#Text=It has been reported that internet gaming disorder (IGD) and smokers with nicotine dependence (SND) share clinical characteristics, such as over-engagement despite negative consequences and cravings.
1-1	0-10	Difference	_
1-2	11-13	in	_
1-3	14-17	the	_
1-4	18-28	functional	_
1-5	29-41	connectivity	_
1-6	42-44	of	_
1-7	45-48	the	_
1-8	49-61	dorsolateral	_
1-9	62-72	prefrontal	_
1-10	73-79	cortex	_
1-11	80-87	between	_
1-12	88-95	smokers	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[1]
1-13	96-100	with	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[1]
1-14	101-109	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[1]
1-15	110-120	dependence	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[1]
1-16	121-124	and	_
1-17	125-136	individuals	_
1-18	137-141	with	_
1-19	142-150	internet	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[2]
1-20	151-157	gaming	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[2]
1-21	158-166	disorder	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[2]
1-22	167-177	Background	_
1-23	178-180	It	_
1-24	181-184	has	_
1-25	185-189	been	_
1-26	190-198	reported	_
1-27	199-203	that	_
1-28	204-212	internet	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[3]
1-29	213-219	gaming	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[3]
1-30	220-228	disorder	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[3]
1-31	229-230	(	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[3]
1-32	230-233	IGD	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[3]
1-33	233-234	)	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[3]
1-34	235-238	and	_
1-35	239-246	smokers	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[4]
1-36	247-251	with	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[4]
1-37	252-260	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[4]
1-38	261-271	dependence	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[4]
1-39	272-273	(	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[4]
1-40	273-276	SND	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[4]
1-41	276-277	)	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[4]
1-42	278-283	share	_
1-43	284-292	clinical	_
1-44	293-308	characteristics	_
1-45	308-309	,	_
1-46	310-314	such	_
1-47	315-317	as	_
1-48	318-333	over-engagement	_
1-49	334-341	despite	_
1-50	342-350	negative	_
1-51	351-363	consequences	_
1-52	364-367	and	_
1-53	368-376	cravings	_
1-54	376-377	.	_

#Text=This study is to investigate the alterations in the resting-state functional connectivity (rsFC) of the dorsolateral prefrontal cortex (DLPFC) observed in SND and IGD.
2-1	378-382	This	_
2-2	383-388	study	_
2-3	389-391	is	_
2-4	392-394	to	_
2-5	395-406	investigate	_
2-6	407-410	the	_
2-7	411-422	alterations	_
2-8	423-425	in	_
2-9	426-429	the	_
2-10	430-443	resting-state	_
2-11	444-454	functional	_
2-12	455-467	connectivity	_
2-13	468-469	(	_
2-14	469-473	rsFC	_
2-15	473-474	)	_
2-16	475-477	of	_
2-17	478-481	the	_
2-18	482-494	dorsolateral	_
2-19	495-505	prefrontal	_
2-20	506-512	cortex	_
2-21	513-514	(	_
2-22	514-519	DLPFC	_
2-23	519-520	)	_
2-24	521-529	observed	_
2-25	530-532	in	_
2-26	533-536	SND	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
2-27	537-540	and	_
2-28	541-544	IGD	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder
2-29	544-545	.	_

#Text=In this study, 27 IGD, 29 SND, and 33 healthy controls (HC) underwent a resting-state functional magnetic resonance imaging (rs-fMRI) scan.
3-1	546-548	In	_
3-2	549-553	this	_
3-3	554-559	study	_
3-4	559-560	,	_
3-5	561-563	27	_
3-6	564-567	IGD	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder
3-7	567-568	,	_
3-8	569-571	29	_
3-9	572-575	SND	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
3-10	575-576	,	_
3-11	577-580	and	_
3-12	581-583	33	_
3-13	584-591	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]
3-14	592-600	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]
3-15	601-602	(	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]
3-16	602-604	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]
3-17	604-605	)	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]
3-18	606-615	underwent	_
3-19	616-617	a	_
3-20	618-631	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[6]
3-21	632-642	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[6]
3-22	643-651	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[6]
3-23	652-661	resonance	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[6]
3-24	662-669	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[6]
3-25	670-671	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[6]
3-26	671-678	rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[6]
3-27	678-679	)	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[6]
3-28	680-684	scan	_
3-29	684-685	.	_

#Text=DLPFC connectivity was determined in all participates by investigating the synchronized low-frequency fMRI signal fluctuations using a temporal seed-based correlation method.
4-1	686-691	DLPFC	_
4-2	692-704	connectivity	_
4-3	705-708	was	_
4-4	709-719	determined	_
4-5	720-722	in	_
4-6	723-726	all	_
4-7	727-739	participates	_
4-8	740-742	by	_
4-9	743-756	investigating	_
4-10	757-760	the	_
4-11	761-773	synchronized	_
4-12	774-787	low-frequency	_
4-13	788-792	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-14	793-799	signal	_
4-15	800-812	fluctuations	_
4-16	813-818	using	_
4-17	819-820	a	_
4-18	821-829	temporal	_
4-19	830-840	seed-based	_
4-20	841-852	correlation	_
4-21	853-859	method	_
4-22	859-860	.	_

#Text=Results
#Text=Compared with the HC group, the IGD and SND groups showed decreased rsFC with DLPFC in the right insula and left inferior frontal gyrus with DLPFC.
5-1	861-868	Results	_
5-2	869-877	Compared	_
5-3	878-882	with	_
5-4	883-886	the	_
5-5	887-889	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-6	890-895	group	_
5-7	895-896	,	_
5-8	897-900	the	_
5-9	901-904	IGD	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder
5-10	905-908	and	_
5-11	909-912	SND	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
5-12	913-919	groups	_
5-13	920-926	showed	_
5-14	927-936	decreased	_
5-15	937-941	rsFC	_
5-16	942-946	with	_
5-17	947-952	DLPFC	_
5-18	953-955	in	_
5-19	956-959	the	_
5-20	960-965	right	_
5-21	966-972	insula	_
5-22	973-976	and	_
5-23	977-981	left	_
5-24	982-990	inferior	_
5-25	991-998	frontal	_
5-26	999-1004	gyrus	_
5-27	1005-1009	with	_
5-28	1010-1015	DLPFC	_
5-29	1015-1016	.	_

#Text=Compared with SND group, the IGD subjects exhibited increased rsFC in the left inferior temporal gyrus and right inferior orbital frontal gyrus and decreased rsFC in the right middle occipital gyrus, supramarginal gyrus, and cuneus with DLPFC.
6-1	1017-1025	Compared	_
6-2	1026-1030	with	_
6-3	1031-1034	SND	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
6-4	1035-1040	group	_
6-5	1040-1041	,	_
6-6	1042-1045	the	_
6-7	1046-1049	IGD	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder
6-8	1050-1058	subjects	_
6-9	1059-1068	exhibited	_
6-10	1069-1078	increased	_
6-11	1079-1083	rsFC	_
6-12	1084-1086	in	_
6-13	1087-1090	the	_
6-14	1091-1095	left	_
6-15	1096-1104	inferior	_
6-16	1105-1113	temporal	_
6-17	1114-1119	gyrus	_
6-18	1120-1123	and	_
6-19	1124-1129	right	_
6-20	1130-1138	inferior	_
6-21	1139-1146	orbital	_
6-22	1147-1154	frontal	_
6-23	1155-1160	gyrus	_
6-24	1161-1164	and	_
6-25	1165-1174	decreased	_
6-26	1175-1179	rsFC	_
6-27	1180-1182	in	_
6-28	1183-1186	the	_
6-29	1187-1192	right	_
6-30	1193-1199	middle	_
6-31	1200-1209	occipital	_
6-32	1210-1215	gyrus	_
6-33	1215-1216	,	_
6-34	1217-1230	supramarginal	_
6-35	1231-1236	gyrus	_
6-36	1236-1237	,	_
6-37	1238-1241	and	_
6-38	1242-1248	cuneus	_
6-39	1249-1253	with	_
6-40	1254-1259	DLPFC	_
6-41	1259-1260	.	_

#Text=Conclusion
#Text=Our results confirmed that SND and IGD share similar neural mechanisms related to craving and impulsive inhibitions.
7-1	1261-1271	Conclusion	_
7-2	1272-1275	Our	_
7-3	1276-1283	results	_
7-4	1284-1293	confirmed	_
7-5	1294-1298	that	_
7-6	1299-1302	SND	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
7-7	1303-1306	and	_
7-8	1307-1310	IGD	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder
7-9	1311-1316	share	_
7-10	1317-1324	similar	_
7-11	1325-1331	neural	_
7-12	1332-1342	mechanisms	_
7-13	1343-1350	related	_
7-14	1351-1353	to	_
7-15	1354-1361	craving	_
7-16	1362-1365	and	_
7-17	1366-1375	impulsive	_
7-18	1376-1387	inhibitions	_
7-19	1387-1388	.	_

#Text=The significant difference in rsFC with DLPFC between the IGD and SND subjects may be attributed to the visual and auditory stimulation generated by long-term internet gaming.
8-1	1389-1392	The	_
8-2	1393-1404	significant	_
8-3	1405-1415	difference	_
8-4	1416-1418	in	_
8-5	1419-1423	rsFC	_
8-6	1424-1428	with	_
8-7	1429-1434	DLPFC	_
8-8	1435-1442	between	_
8-9	1443-1446	the	_
8-10	1447-1450	IGD	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder
8-11	1451-1454	and	_
8-12	1455-1458	SND	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
8-13	1459-1467	subjects	_
8-14	1468-1471	may	_
8-15	1472-1474	be	_
8-16	1475-1485	attributed	_
8-17	1486-1488	to	_
8-18	1489-1492	the	_
8-19	1493-1499	visual	_
8-20	1500-1503	and	_
8-21	1504-1512	auditory	_
8-22	1513-1524	stimulation	_
8-23	1525-1534	generated	_
8-24	1535-1537	by	_
8-25	1538-1547	long-term	_
8-26	1548-1556	internet	_
8-27	1557-1563	gaming	_
8-28	1563-1564	.	_

#Text=Background
#Text=Internet gaming disorder (IGD), also known as problematic internet use, is the excessive and recurrent use of online internet games.
9-1	1565-1575	Background	_
9-2	1576-1584	Internet	_
9-3	1585-1591	gaming	_
9-4	1592-1600	disorder	_
9-5	1601-1602	(	_
9-6	1602-1605	IGD	_
9-7	1605-1606	)	_
9-8	1606-1607	,	_
9-9	1608-1612	also	_
9-10	1613-1618	known	_
9-11	1619-1621	as	_
9-12	1622-1633	problematic	_
9-13	1634-1642	internet	_
9-14	1643-1646	use	_
9-15	1646-1647	,	_
9-16	1648-1650	is	_
9-17	1651-1654	the	_
9-18	1655-1664	excessive	_
9-19	1665-1668	and	_
9-20	1669-1678	recurrent	_
9-21	1679-1682	use	_
9-22	1683-1685	of	_
9-23	1686-1692	online	_
9-24	1693-1701	internet	_
9-25	1702-1707	games	_
9-26	1707-1708	.	_

#Text=IGD is different from substance abuse or drug addiction such that no substance or chemical intake is involved; however, excessive internet use may lead to physical dependence similar to that observed in other addictions.
10-1	1709-1712	IGD	_
10-2	1713-1715	is	_
10-3	1716-1725	different	_
10-4	1726-1730	from	_
10-5	1731-1740	substance	_
10-6	1741-1746	abuse	_
10-7	1747-1749	or	_
10-8	1750-1754	drug	_
10-9	1755-1764	addiction	_
10-10	1765-1769	such	_
10-11	1770-1774	that	_
10-12	1775-1777	no	_
10-13	1778-1787	substance	_
10-14	1788-1790	or	_
10-15	1791-1799	chemical	_
10-16	1800-1806	intake	_
10-17	1807-1809	is	_
10-18	1810-1818	involved	_
10-19	1818-1819	;	_
10-20	1820-1827	however	_
10-21	1827-1828	,	_
10-22	1829-1838	excessive	_
10-23	1839-1847	internet	_
10-24	1848-1851	use	_
10-25	1852-1855	may	_
10-26	1856-1860	lead	_
10-27	1861-1863	to	_
10-28	1864-1872	physical	_
10-29	1873-1883	dependence	_
10-30	1884-1891	similar	_
10-31	1892-1894	to	_
10-32	1895-1899	that	_
10-33	1900-1908	observed	_
10-34	1909-1911	in	_
10-35	1912-1917	other	_
10-36	1918-1928	addictions	_
10-37	1928-1929	.	_

#Text=Currently, IGD has become a serious mental health issue around the world, thereby requiring additional investigation, as exemplified by its inclusion as a condition for further study in Section 3 of the Diagnostic and Statistical Manual of Mental Disorders (5th Edition, DSM-5).
11-1	1930-1939	Currently	_
11-2	1939-1940	,	_
11-3	1941-1944	IGD	_
11-4	1945-1948	has	_
11-5	1949-1955	become	_
11-6	1956-1957	a	_
11-7	1958-1965	serious	_
11-8	1966-1972	mental	_
11-9	1973-1979	health	_
11-10	1980-1985	issue	_
11-11	1986-1992	around	_
11-12	1993-1996	the	_
11-13	1997-2002	world	_
11-14	2002-2003	,	_
11-15	2004-2011	thereby	_
11-16	2012-2021	requiring	_
11-17	2022-2032	additional	_
11-18	2033-2046	investigation	_
11-19	2046-2047	,	_
11-20	2048-2050	as	_
11-21	2051-2062	exemplified	_
11-22	2063-2065	by	_
11-23	2066-2069	its	_
11-24	2070-2079	inclusion	_
11-25	2080-2082	as	_
11-26	2083-2084	a	_
11-27	2085-2094	condition	_
11-28	2095-2098	for	_
11-29	2099-2106	further	_
11-30	2107-2112	study	_
11-31	2113-2115	in	_
11-32	2116-2123	Section	_
11-33	2123-2124	 	_
11-34	2124-2125	3	_
11-35	2126-2128	of	_
11-36	2129-2132	the	_
11-37	2133-2143	Diagnostic	_
11-38	2144-2147	and	_
11-39	2148-2159	Statistical	_
11-40	2160-2166	Manual	_
11-41	2167-2169	of	_
11-42	2170-2176	Mental	_
11-43	2177-2186	Disorders	_
11-44	2187-2188	(	_
11-45	2188-2191	5th	_
11-46	2192-2199	Edition	_
11-47	2199-2200	,	_
11-48	2201-2204	DSM	_
11-49	2204-2205	-	_
11-50	2205-2206	5	_
11-51	2206-2207	)	_
11-52	2207-2208	.	_

#Text=The following diagnostic criteria for IGD were suggested: time distortion, time spent longer than initially intended and planned time, use of internet activity to cope with or escape problems, compulsive behavior, deception about the extent of use, failure to stop or control use, and preoccupation with internet use when offline.
12-1	2209-2212	The	_
12-2	2213-2222	following	_
12-3	2223-2233	diagnostic	_
12-4	2234-2242	criteria	_
12-5	2243-2246	for	_
12-6	2247-2250	IGD	_
12-7	2251-2255	were	_
12-8	2256-2265	suggested	_
12-9	2265-2266	:	_
12-10	2267-2271	time	_
12-11	2272-2282	distortion	_
12-12	2282-2283	,	_
12-13	2284-2288	time	_
12-14	2289-2294	spent	_
12-15	2295-2301	longer	_
12-16	2302-2306	than	_
12-17	2307-2316	initially	_
12-18	2317-2325	intended	_
12-19	2326-2329	and	_
12-20	2330-2337	planned	_
12-21	2338-2342	time	_
12-22	2342-2343	,	_
12-23	2344-2347	use	_
12-24	2348-2350	of	_
12-25	2351-2359	internet	_
12-26	2360-2368	activity	_
12-27	2369-2371	to	_
12-28	2372-2376	cope	_
12-29	2377-2381	with	_
12-30	2382-2384	or	_
12-31	2385-2391	escape	_
12-32	2392-2400	problems	_
12-33	2400-2401	,	_
12-34	2402-2412	compulsive	_
12-35	2413-2421	behavior	_
12-36	2421-2422	,	_
12-37	2423-2432	deception	_
12-38	2433-2438	about	_
12-39	2439-2442	the	_
12-40	2443-2449	extent	_
12-41	2450-2452	of	_
12-42	2453-2456	use	_
12-43	2456-2457	,	_
12-44	2458-2465	failure	_
12-45	2466-2468	to	_
12-46	2469-2473	stop	_
12-47	2474-2476	or	_
12-48	2477-2484	control	_
12-49	2485-2488	use	_
12-50	2488-2489	,	_
12-51	2490-2493	and	_
12-52	2494-2507	preoccupation	_
12-53	2508-2512	with	_
12-54	2513-2521	internet	_
12-55	2522-2525	use	_
12-56	2526-2530	when	_
12-57	2531-2538	offline	_
12-58	2538-2539	.	_

#Text=Notably, many of these behavioral symptoms resemble substance-related disorders.
13-1	2540-2547	Notably	_
13-2	2547-2548	,	_
13-3	2549-2553	many	_
13-4	2554-2556	of	_
13-5	2557-2562	these	_
13-6	2563-2573	behavioral	_
13-7	2574-2582	symptoms	_
13-8	2583-2591	resemble	_
13-9	2592-2609	substance-related	_
13-10	2610-2619	disorders	_
13-11	2619-2620	.	_

#Text=Currently the precise pathogenesis of IGD remains unclear.
14-1	2621-2630	Currently	_
14-2	2631-2634	the	_
14-3	2635-2642	precise	_
14-4	2643-2655	pathogenesis	_
14-5	2656-2658	of	_
14-6	2659-2662	IGD	_
14-7	2663-2670	remains	_
14-8	2671-2678	unclear	_
14-9	2678-2679	.	_

#Text=A few studies suggested that the risk factor of IGD is related to the increased prevalence of substance dependence.
15-1	2680-2681	A	_
15-2	2682-2685	few	_
15-3	2686-2693	studies	_
15-4	2694-2703	suggested	_
15-5	2704-2708	that	_
15-6	2709-2712	the	_
15-7	2713-2717	risk	_
15-8	2718-2724	factor	_
15-9	2725-2727	of	_
15-10	2728-2731	IGD	_
15-11	2732-2734	is	_
15-12	2735-2742	related	_
15-13	2743-2745	to	_
15-14	2746-2749	the	_
15-15	2750-2759	increased	_
15-16	2760-2770	prevalence	_
15-17	2771-2773	of	_
15-18	2774-2783	substance	_
15-19	2784-2794	dependence	_
15-20	2794-2795	.	_

#Text=Numerous studies found that IGD and substance dependence shared similar neural mechanisms, such as nicotine dependence.
16-1	2796-2804	Numerous	_
16-2	2805-2812	studies	_
16-3	2813-2818	found	_
16-4	2819-2823	that	_
16-5	2824-2827	IGD	_
16-6	2828-2831	and	_
16-7	2832-2841	substance	_
16-8	2842-2852	dependence	_
16-9	2853-2859	shared	_
16-10	2860-2867	similar	_
16-11	2868-2874	neural	_
16-12	2875-2885	mechanisms	_
16-13	2885-2886	,	_
16-14	2887-2891	such	_
16-15	2892-2894	as	_
16-16	2895-2903	nicotine	_
16-17	2904-2914	dependence	_
16-18	2914-2915	.	_

#Text=On the basis of behavioral addiction, researchers have been attempting to associate IGD with other behavioral problems that can lead to addiction, such as drug abuse, alcohol abuse, and nicotine dependence.
17-1	2916-2918	On	_
17-2	2919-2922	the	_
17-3	2923-2928	basis	_
17-4	2929-2931	of	_
17-5	2932-2942	behavioral	_
17-6	2943-2952	addiction	_
17-7	2952-2953	,	_
17-8	2954-2965	researchers	_
17-9	2966-2970	have	_
17-10	2971-2975	been	_
17-11	2976-2986	attempting	_
17-12	2987-2989	to	_
17-13	2990-2999	associate	_
17-14	3000-3003	IGD	_
17-15	3004-3008	with	_
17-16	3009-3014	other	_
17-17	3015-3025	behavioral	_
17-18	3026-3034	problems	_
17-19	3035-3039	that	_
17-20	3040-3043	can	_
17-21	3044-3048	lead	_
17-22	3049-3051	to	_
17-23	3052-3061	addiction	_
17-24	3061-3062	,	_
17-25	3063-3067	such	_
17-26	3068-3070	as	_
17-27	3071-3075	drug	_
17-28	3076-3081	abuse	_
17-29	3081-3082	,	_
17-30	3083-3090	alcohol	_
17-31	3091-3096	abuse	_
17-32	3096-3097	,	_
17-33	3098-3101	and	_
17-34	3102-3110	nicotine	_
17-35	3111-3121	dependence	_
17-36	3121-3122	.	_

#Text=Our previous study revealed that smokers with IGD exhibited decreased resting-state functional connectivity (rsFC) in the right rectus gyrus and increased rsFC in the left middle frontal gyrus with post cingulate cortex (PCC), compared with nonsmokers with IGD.
18-1	3123-3126	Our	_
18-2	3127-3135	previous	_
18-3	3136-3141	study	_
18-4	3142-3150	revealed	_
18-5	3151-3155	that	_
18-6	3156-3163	smokers	_
18-7	3164-3168	with	_
18-8	3169-3172	IGD	_
18-9	3173-3182	exhibited	_
18-10	3183-3192	decreased	_
18-11	3193-3206	resting-state	_
18-12	3207-3217	functional	_
18-13	3218-3230	connectivity	_
18-14	3231-3232	(	_
18-15	3232-3236	rsFC	_
18-16	3236-3237	)	_
18-17	3238-3240	in	_
18-18	3241-3244	the	_
18-19	3245-3250	right	_
18-20	3251-3257	rectus	_
18-21	3258-3263	gyrus	_
18-22	3264-3267	and	_
18-23	3268-3277	increased	_
18-24	3278-3282	rsFC	_
18-25	3283-3285	in	_
18-26	3286-3289	the	_
18-27	3290-3294	left	_
18-28	3295-3301	middle	_
18-29	3302-3309	frontal	_
18-30	3310-3315	gyrus	_
18-31	3316-3320	with	_
18-32	3321-3325	post	_
18-33	3326-3335	cingulate	_
18-34	3336-3342	cortex	_
18-35	3343-3344	(	_
18-36	3344-3347	PCC	_
18-37	3347-3348	)	_
18-38	3348-3349	,	_
18-39	3350-3358	compared	_
18-40	3359-3363	with	_
18-41	3364-3374	nonsmokers	_
18-42	3375-3379	with	_
18-43	3380-3383	IGD	_
18-44	3383-3384	.	_

#Text=Furthermore, negatively correlation was found in the PCC connectivity with the right rectus gyrus with Chen’s internet addiction score (CIAS) of smokers with IGD before correction.
19-1	3385-3396	Furthermore	_
19-2	3396-3397	,	_
19-3	3398-3408	negatively	_
19-4	3409-3420	correlation	_
19-5	3421-3424	was	_
19-6	3425-3430	found	_
19-7	3431-3433	in	_
19-8	3434-3437	the	_
19-9	3438-3441	PCC	_
19-10	3442-3454	connectivity	_
19-11	3455-3459	with	_
19-12	3460-3463	the	_
19-13	3464-3469	right	_
19-14	3470-3476	rectus	_
19-15	3477-3482	gyrus	_
19-16	3483-3487	with	_
19-17	3488-3492	Chen	_
19-18	3492-3493	’	_
19-19	3493-3494	s	_
19-20	3495-3503	internet	_
19-21	3504-3513	addiction	_
19-22	3514-3519	score	_
19-23	3520-3521	(	_
19-24	3521-3525	CIAS	_
19-25	3525-3526	)	_
19-26	3527-3529	of	_
19-27	3530-3537	smokers	_
19-28	3538-3542	with	_
19-29	3543-3546	IGD	_
19-30	3547-3553	before	_
19-31	3554-3564	correction	_
19-32	3564-3565	.	_

#Text=The results suggested that, compared with the nonsmokers with IGD, smokers with IGD had alterations of function in brain regions related to executive motivation and function.
20-1	3566-3569	The	_
20-2	3570-3577	results	_
20-3	3578-3587	suggested	_
20-4	3588-3592	that	_
20-5	3592-3593	,	_
20-6	3594-3602	compared	_
20-7	3603-3607	with	_
20-8	3608-3611	the	_
20-9	3612-3622	nonsmokers	_
20-10	3623-3627	with	_
20-11	3628-3631	IGD	_
20-12	3631-3632	,	_
20-13	3633-3640	smokers	_
20-14	3641-3645	with	_
20-15	3646-3649	IGD	_
20-16	3650-3653	had	_
20-17	3654-3665	alterations	_
20-18	3666-3668	of	_
20-19	3669-3677	function	_
20-20	3678-3680	in	_
20-21	3681-3686	brain	_
20-22	3687-3694	regions	_
20-23	3695-3702	related	_
20-24	3703-3705	to	_
20-25	3706-3715	executive	_
20-26	3716-3726	motivation	_
20-27	3727-3730	and	_
20-28	3731-3739	function	_
20-29	3739-3740	.	_

#Text=However, Vergara et al. delineated a general pattern of hypoconnectivity in the precuneus, insula, postcentral gyrus, and visual cortex of substance consumers.
21-1	3741-3748	However	_
21-2	3748-3749	,	_
21-3	3750-3757	Vergara	_
21-4	3758-3760	et	_
21-5	3761-3763	al	_
21-6	3763-3764	.	_
21-7	3765-3775	delineated	_
21-8	3776-3777	a	_
21-9	3778-3785	general	_
21-10	3786-3793	pattern	_
21-11	3794-3796	of	_
21-12	3797-3813	hypoconnectivity	_
21-13	3814-3816	in	_
21-14	3817-3820	the	_
21-15	3821-3830	precuneus	_
21-16	3830-3831	,	_
21-17	3832-3838	insula	_
21-18	3838-3839	,	_
21-19	3840-3851	postcentral	_
21-20	3852-3857	gyrus	_
21-21	3857-3858	,	_
21-22	3859-3862	and	_
21-23	3863-3869	visual	_
21-24	3870-3876	cortex	_
21-25	3877-3879	of	_
21-26	3880-3889	substance	_
21-27	3890-3899	consumers	_
21-28	3899-3900	.	_

#Text=In addition, connectivity reduction between postcentral and one resting state networks covering right fusiform and lingual gyri showed their significant association with severity of hazardous drinking.
22-1	3901-3903	In	_
22-2	3904-3912	addition	_
22-3	3912-3913	,	_
22-4	3914-3926	connectivity	_
22-5	3927-3936	reduction	_
22-6	3937-3944	between	_
22-7	3945-3956	postcentral	_
22-8	3957-3960	and	_
22-9	3961-3964	one	_
22-10	3965-3972	resting	_
22-11	3973-3978	state	_
22-12	3979-3987	networks	_
22-13	3988-3996	covering	_
22-14	3997-4002	right	_
22-15	4003-4011	fusiform	_
22-16	4012-4015	and	_
22-17	4016-4023	lingual	_
22-18	4024-4028	gyri	_
22-19	4029-4035	showed	_
22-20	4036-4041	their	_
22-21	4042-4053	significant	_
22-22	4054-4065	association	_
22-23	4066-4070	with	_
22-24	4071-4079	severity	_
22-25	4080-4082	of	_
22-26	4083-4092	hazardous	_
22-27	4093-4101	drinking	_
22-28	4101-4102	.	_

#Text=In smokers, hypoconnectivity between the thalamus and putamen was observed.
23-1	4103-4105	In	_
23-2	4106-4113	smokers	_
23-3	4113-4114	,	_
23-4	4115-4131	hypoconnectivity	_
23-5	4132-4139	between	_
23-6	4140-4143	the	_
23-7	4144-4152	thalamus	_
23-8	4153-4156	and	_
23-9	4157-4164	putamen	_
23-10	4165-4168	was	_
23-11	4169-4177	observed	_
23-12	4177-4178	.	_

#Text=By contrast, the angular gyrus showed hyper-connectivity with the precuneus linked to smoking and significantly correlated with the severity of nicotine dependence.
24-1	4179-4181	By	_
24-2	4182-4190	contrast	_
24-3	4190-4191	,	_
24-4	4192-4195	the	_
24-5	4196-4203	angular	_
24-6	4204-4209	gyrus	_
24-7	4210-4216	showed	_
24-8	4217-4235	hyper-connectivity	_
24-9	4236-4240	with	_
24-10	4241-4244	the	_
24-11	4245-4254	precuneus	_
24-12	4255-4261	linked	_
24-13	4262-4264	to	_
24-14	4265-4272	smoking	_
24-15	4273-4276	and	_
24-16	4277-4290	significantly	_
24-17	4291-4301	correlated	_
24-18	4302-4306	with	_
24-19	4307-4310	the	_
24-20	4311-4319	severity	_
24-21	4320-4322	of	_
24-22	4323-4331	nicotine	_
24-23	4332-4342	dependence	_
24-24	4342-4343	.	_

#Text=These results suggested that particular effects of alcohol and nicotine can be separated and identified.
25-1	4344-4349	These	_
25-2	4350-4357	results	_
25-3	4358-4367	suggested	_
25-4	4368-4372	that	_
25-5	4373-4383	particular	_
25-6	4384-4391	effects	_
25-7	4392-4394	of	_
25-8	4395-4402	alcohol	_
25-9	4403-4406	and	_
25-10	4407-4415	nicotine	_
25-11	4416-4419	can	_
25-12	4420-4422	be	_
25-13	4423-4432	separated	_
25-14	4433-4436	and	_
25-15	4437-4447	identified	_
25-16	4447-4448	.	_

#Text=Han et al. found IGD subjects and alcohol dependence (AD) have positive rsFC values in the dorsolateral prefrontal cortex (DLPFC) and cingulate, cerebellum, as well as negative rsFC values between the DLPFC and orbitofrontal cortex.
26-1	4449-4452	Han	_
26-2	4453-4455	et	_
26-3	4456-4458	al	_
26-4	4458-4459	.	_
26-5	4460-4465	found	_
26-6	4466-4469	IGD	_
26-7	4470-4478	subjects	_
26-8	4479-4482	and	_
26-9	4483-4490	alcohol	_
26-10	4491-4501	dependence	_
26-11	4502-4503	(	_
26-12	4503-4505	AD	_
26-13	4505-4506	)	_
26-14	4507-4511	have	_
26-15	4512-4520	positive	_
26-16	4521-4525	rsFC	_
26-17	4526-4532	values	_
26-18	4533-4535	in	_
26-19	4536-4539	the	_
26-20	4540-4552	dorsolateral	_
26-21	4553-4563	prefrontal	_
26-22	4564-4570	cortex	_
26-23	4571-4572	(	_
26-24	4572-4577	DLPFC	_
26-25	4577-4578	)	_
26-26	4579-4582	and	_
26-27	4583-4592	cingulate	_
26-28	4592-4593	,	_
26-29	4594-4604	cerebellum	_
26-30	4604-4605	,	_
26-31	4606-4608	as	_
26-32	4609-4613	well	_
26-33	4614-4616	as	_
26-34	4617-4625	negative	_
26-35	4626-4630	rsFC	_
26-36	4631-4637	values	_
26-37	4638-4645	between	_
26-38	4646-4649	the	_
26-39	4650-4655	DLPFC	_
26-40	4656-4659	and	_
26-41	4660-4673	orbitofrontal	_
26-42	4674-4680	cortex	_
26-43	4680-4681	.	_

#Text=The AD group was found to have positive rsFC values between the DLPFC, striatal areas, and temporal lobe, whereas the IGD group shows negative rsFC values among these areas.
27-1	4682-4685	The	_
27-2	4686-4688	AD	_
27-3	4689-4694	group	_
27-4	4695-4698	was	_
27-5	4699-4704	found	_
27-6	4705-4707	to	_
27-7	4708-4712	have	_
27-8	4713-4721	positive	_
27-9	4722-4726	rsFC	_
27-10	4727-4733	values	_
27-11	4734-4741	between	_
27-12	4742-4745	the	_
27-13	4746-4751	DLPFC	_
27-14	4751-4752	,	_
27-15	4753-4761	striatal	_
27-16	4762-4767	areas	_
27-17	4767-4768	,	_
27-18	4769-4772	and	_
27-19	4773-4781	temporal	_
27-20	4782-4786	lobe	_
27-21	4786-4787	,	_
27-22	4788-4795	whereas	_
27-23	4796-4799	the	_
27-24	4800-4803	IGD	_
27-25	4804-4809	group	_
27-26	4810-4815	shows	_
27-27	4816-4824	negative	_
27-28	4825-4829	rsFC	_
27-29	4830-4836	values	_
27-30	4837-4842	among	_
27-31	4843-4848	these	_
27-32	4849-4854	areas	_
27-33	4854-4855	.	_

#Text=They concluded that the both groups may have deficits in executive function.
28-1	4856-4860	They	_
28-2	4861-4870	concluded	_
28-3	4871-4875	that	_
28-4	4876-4879	the	_
28-5	4880-4884	both	_
28-6	4885-4891	groups	_
28-7	4892-4895	may	_
28-8	4896-4900	have	_
28-9	4901-4909	deficits	_
28-10	4910-4912	in	_
28-11	4913-4922	executive	_
28-12	4923-4931	function	_
28-13	4931-4932	.	_

#Text=In this study, we attempted to detect the difference between the rsFC of individuals with IGD and those of smokers with nicotine dependence (SND), and explore the mechanism of this difference.
29-1	4933-4935	In	_
29-2	4936-4940	this	_
29-3	4941-4946	study	_
29-4	4946-4947	,	_
29-5	4948-4950	we	_
29-6	4951-4960	attempted	_
29-7	4961-4963	to	_
29-8	4964-4970	detect	_
29-9	4971-4974	the	_
29-10	4975-4985	difference	_
29-11	4986-4993	between	_
29-12	4994-4997	the	_
29-13	4998-5002	rsFC	_
29-14	5003-5005	of	_
29-15	5006-5017	individuals	_
29-16	5018-5022	with	_
29-17	5023-5026	IGD	_
29-18	5027-5030	and	_
29-19	5031-5036	those	_
29-20	5037-5039	of	_
29-21	5040-5047	smokers	_
29-22	5048-5052	with	_
29-23	5053-5061	nicotine	_
29-24	5062-5072	dependence	_
29-25	5073-5074	(	_
29-26	5074-5077	SND	_
29-27	5077-5078	)	_
29-28	5078-5079	,	_
29-29	5080-5083	and	_
29-30	5084-5091	explore	_
29-31	5092-5095	the	_
29-32	5096-5105	mechanism	_
29-33	5106-5108	of	_
29-34	5109-5113	this	_
29-35	5114-5124	difference	_
29-36	5124-5125	.	_

#Text=According to Han et al., cravings induced by particular substances such as alcohol are closely associated with DLPFC activity.
30-1	5126-5135	According	_
30-2	5136-5138	to	_
30-3	5139-5142	Han	_
30-4	5143-5145	et	_
30-5	5146-5148	al	_
30-6	5148-5149	.	_
30-7	5149-5150	,	_
30-8	5151-5159	cravings	_
30-9	5160-5167	induced	_
30-10	5168-5170	by	_
30-11	5171-5181	particular	_
30-12	5182-5192	substances	_
30-13	5193-5197	such	_
30-14	5198-5200	as	_
30-15	5201-5208	alcohol	_
30-16	5209-5212	are	_
30-17	5213-5220	closely	_
30-18	5221-5231	associated	_
30-19	5232-5236	with	_
30-20	5237-5242	DLPFC	_
30-21	5243-5251	activity	_
30-22	5251-5252	.	_

#Text=Furthermore, DLPFC is thought to play key roles in mediating clinical symptoms of executive dysfunction, alcohol dependence, including impulsivity, and aggravation of abuse potential.
31-1	5253-5264	Furthermore	_
31-2	5264-5265	,	_
31-3	5266-5271	DLPFC	_
31-4	5272-5274	is	_
31-5	5275-5282	thought	_
31-6	5283-5285	to	_
31-7	5286-5290	play	_
31-8	5291-5294	key	_
31-9	5295-5300	roles	_
31-10	5301-5303	in	_
31-11	5304-5313	mediating	_
31-12	5314-5322	clinical	_
31-13	5323-5331	symptoms	_
31-14	5332-5334	of	_
31-15	5335-5344	executive	_
31-16	5345-5356	dysfunction	_
31-17	5356-5357	,	_
31-18	5358-5365	alcohol	_
31-19	5366-5376	dependence	_
31-20	5376-5377	,	_
31-21	5378-5387	including	_
31-22	5388-5399	impulsivity	_
31-23	5399-5400	,	_
31-24	5401-5404	and	_
31-25	5405-5416	aggravation	_
31-26	5417-5419	of	_
31-27	5420-5425	abuse	_
31-28	5426-5435	potential	_
31-29	5435-5436	.	_

#Text=The present study aims to assess DLPFC-seeded rsFC in IGD and SND.
32-1	5437-5440	The	_
32-2	5441-5448	present	_
32-3	5449-5454	study	_
32-4	5455-5459	aims	_
32-5	5460-5462	to	_
32-6	5463-5469	assess	_
32-7	5470-5482	DLPFC-seeded	_
32-8	5483-5487	rsFC	_
32-9	5488-5490	in	_
32-10	5491-5494	IGD	_
32-11	5495-5498	and	_
32-12	5499-5502	SND	_
32-13	5502-5503	.	_

#Text=Methods
#Text=Participants
#Text=The current study was approved by the Research Ethics Committee of Ren Ji Hospital and School of Medicine, Shanghai Jiao Tong University, China No.[2016]079k(2) with written informed consent from all subjects.
33-1	5504-5511	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod
33-2	5512-5524	Participants	_
33-3	5525-5528	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-4	5529-5536	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-5	5537-5542	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-6	5543-5546	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-7	5547-5555	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-8	5556-5558	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-9	5559-5562	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-10	5563-5571	Research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-11	5572-5578	Ethics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-12	5579-5588	Committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-13	5589-5591	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-14	5592-5595	Ren	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-15	5596-5598	Ji	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-16	5599-5607	Hospital	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-17	5608-5611	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-18	5612-5618	School	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-19	5619-5621	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-20	5622-5630	Medicine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-21	5630-5631	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-22	5632-5640	Shanghai	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-23	5641-5645	Jiao	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-24	5646-5650	Tong	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-25	5651-5661	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-26	5661-5662	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-27	5663-5668	China	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-28	5669-5671	No	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-29	5671-5672	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-30	5672-5673	[	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-31	5673-5677	2016	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-32	5677-5678	]	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-33	5678-5682	079k	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-34	5682-5683	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-35	5683-5684	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-36	5684-5685	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-37	5686-5690	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-38	5691-5698	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-39	5699-5707	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-40	5708-5715	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-41	5716-5720	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-42	5721-5724	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-43	5725-5733	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]
33-44	5733-5734	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]

#Text=All participants were informed of the aims of our study before MRI examination.
34-1	5735-5738	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-2	5739-5751	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-3	5752-5756	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-4	5757-5765	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-5	5766-5768	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-6	5769-5772	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-7	5773-5777	aims	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-8	5778-5780	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-9	5781-5784	our	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-10	5785-5790	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-11	5791-5797	before	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-12	5798-5801	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[9]
34-13	5802-5813	examination	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]
34-14	5813-5814	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]

#Text=Of the 86 participants included in the study and were evaluated by brain MRI from Jan 2016 to Dec 2016, 27 had IGD, 29 SND, and 30 healthy controls (HC).
35-1	5815-5817	Of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-2	5818-5821	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-3	5822-5824	86	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-4	5825-5837	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-5	5838-5846	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-6	5847-5849	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-7	5850-5853	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-8	5854-5859	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-9	5860-5863	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-10	5864-5868	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-11	5869-5878	evaluated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-12	5879-5881	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-13	5882-5887	brain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-14	5888-5891	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[11]
35-15	5892-5896	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-16	5897-5900	Jan	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-17	5901-5905	2016	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-18	5906-5908	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-19	5909-5912	Dec	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-20	5913-5917	2016	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-21	5917-5918	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-22	5919-5921	27	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-23	5922-5925	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-24	5926-5929	IGD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[12]
35-25	5929-5930	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-26	5931-5933	29	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-27	5934-5937	SND	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[13]
35-28	5937-5938	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-29	5939-5942	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-30	5943-5945	30	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
35-31	5946-5953	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[14]
35-32	5954-5962	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[14]
35-33	5963-5964	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[14]
35-34	5964-5966	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[14]
35-35	5966-5967	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[14]
35-36	5967-5968	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]

#Text=As described in our previously study, the IGD subjects who met the diagnostic questionnaire for internet addiction (i.e., YDQ) test modified by Beard and Wolf were recruited from the psychological outpatient clinic at the Shanghai Mental Health Center.
36-1	5969-5971	As	_
36-2	5972-5981	described	_
36-3	5982-5984	in	_
36-4	5985-5988	our	_
36-5	5989-5999	previously	_
36-6	6000-6005	study	_
36-7	6005-6006	,	_
36-8	6007-6010	the	_
36-9	6011-6014	IGD	http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder
36-10	6015-6023	subjects	_
36-11	6024-6027	who	_
36-12	6028-6031	met	_
36-13	6032-6035	the	_
36-14	6036-6046	diagnostic	_
36-15	6047-6060	questionnaire	_
36-16	6061-6064	for	_
36-17	6065-6073	internet	_
36-18	6074-6083	addiction	_
36-19	6084-6085	(	_
36-20	6085-6088	i.e	_
36-21	6088-6089	.	_
36-22	6089-6090	,	_
36-23	6091-6094	YDQ	_
36-24	6094-6095	)	_
36-25	6096-6100	test	_
36-26	6101-6109	modified	_
36-27	6110-6112	by	_
36-28	6113-6118	Beard	_
36-29	6119-6122	and	_
36-30	6123-6127	Wolf	_
36-31	6128-6132	were	_
36-32	6133-6142	recruited	_
36-33	6143-6147	from	_
36-34	6148-6151	the	_
36-35	6152-6165	psychological	_
36-36	6166-6176	outpatient	_
36-37	6177-6183	clinic	_
36-38	6184-6186	at	_
36-39	6187-6190	the	_
36-40	6191-6199	Shanghai	_
36-41	6200-6206	Mental	_
36-42	6207-6213	Health	_
36-43	6214-6220	Center	_
36-44	6220-6221	.	_

#Text=While, the SND and HC groups were recruited through advertisements.
37-1	6222-6227	While	_
37-2	6227-6228	,	_
37-3	6229-6232	the	_
37-4	6233-6236	SND	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
37-5	6237-6240	and	_
37-6	6241-6243	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
37-7	6244-6250	groups	_
37-8	6251-6255	were	_
37-9	6256-6265	recruited	_
37-10	6266-6273	through	_
37-11	6274-6288	advertisements	_
37-12	6288-6289	.	_

#Text=The IGD group played internet game approximately 42–70 h (mean ± SD: 44.31 ± 10.27) per week.
38-1	6290-6293	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-2	6294-6297	IGD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]|http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[16]
38-3	6298-6303	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-4	6304-6310	played	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-5	6311-6319	internet	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-6	6320-6324	game	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-7	6325-6338	approximately	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-8	6339-6341	42	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-9	6341-6342	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-10	6342-6344	70	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-11	6344-6345	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-12	6345-6346	h	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-13	6347-6348	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-14	6348-6352	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-15	6352-6353	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-16	6353-6354	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-17	6354-6355	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-18	6355-6357	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-19	6357-6358	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-20	6359-6364	44.31	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-21	6364-6365	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-22	6365-6366	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-23	6366-6367	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-24	6367-6372	10.27	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-25	6372-6373	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-26	6374-6377	per	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-27	6378-6382	week	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
38-28	6382-6383	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]

#Text=The appropriate questions from the Structured Clinical Interview for DSM-IV was used to assess nicotine dependence.
39-1	6384-6387	The	_
39-2	6388-6399	appropriate	_
39-3	6400-6409	questions	_
39-4	6410-6414	from	_
39-5	6415-6418	the	_
39-6	6419-6429	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[17]
39-7	6430-6438	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[17]
39-8	6439-6448	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[17]
39-9	6449-6452	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[17]
39-10	6453-6459	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[17]
39-11	6460-6463	was	_
39-12	6464-6468	used	_
39-13	6469-6471	to	_
39-14	6472-6478	assess	_
39-15	6479-6487	nicotine	_
39-16	6488-6498	dependence	_
39-17	6498-6499	.	_

#Text=The participant from the IGD and HC groups had never smoked, and no participant self-reported daily alcohol consumption or other substance use disorder (SUD).
40-1	6500-6503	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-2	6504-6515	participant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-3	6516-6520	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-4	6521-6524	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-5	6525-6528	IGD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#GamingDisorder[19]
40-6	6529-6532	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-7	6533-6535	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[20]
40-8	6536-6542	groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-9	6543-6546	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-10	6547-6552	never	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-11	6553-6559	smoked	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-12	6559-6560	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-13	6561-6564	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-14	6565-6567	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-15	6568-6579	participant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-16	6580-6593	self-reported	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-17	6594-6599	daily	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-18	6600-6607	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-19	6608-6619	consumption	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-20	6620-6622	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-21	6623-6628	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-22	6629-6638	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-23	6639-6642	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-24	6643-6651	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-25	6652-6653	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-26	6653-6656	SUD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-27	6656-6657	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]
40-28	6657-6658	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]

#Text=All the SND subjects began smoking 2–10 years before the current study onset.
41-1	6659-6662	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-2	6663-6666	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-3	6667-6670	SND	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]|http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[22]
41-4	6671-6679	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-5	6680-6685	began	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-6	6686-6693	smoking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-7	6694-6695	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-8	6695-6696	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-9	6696-6698	10	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-10	6698-6699	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-11	6699-6704	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-12	6705-6711	before	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-13	6712-6715	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-14	6716-6723	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-15	6724-6729	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-16	6730-6735	onset	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
41-17	6735-6736	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]

#Text=They are all daily smokers, and they smoke approximately 10–45 cigarettes (mean ± SD: 21 ± 1.76) per day.
42-1	6737-6741	They	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-2	6742-6745	are	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-3	6746-6749	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-4	6750-6755	daily	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-5	6756-6763	smokers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-6	6763-6764	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-7	6765-6768	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-8	6769-6773	they	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-9	6774-6779	smoke	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-10	6780-6793	approximately	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-11	6794-6796	10	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-12	6796-6797	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-13	6797-6799	45	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-14	6800-6810	cigarettes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-15	6811-6812	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-16	6812-6816	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-17	6816-6817	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-18	6817-6818	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-19	6818-6819	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-20	6819-6821	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-21	6821-6822	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-22	6823-6825	21	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-23	6825-6826	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-24	6826-6827	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-25	6827-6828	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-26	6828-6832	1.76	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-27	6832-6833	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-28	6834-6837	per	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-29	6838-6841	day	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]
42-30	6841-6842	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[21]

#Text=CIAS, self-rating anxiety scale (SAS), self-rating depression scale (SDS), Barratt impulsiveness scale-11 (BIS-11), and Fagerstrom test of nicotine dependence (FTND) were performed to assess the clinical characteristics of the participants.
43-1	6843-6847	CIAS	_
43-2	6847-6848	,	_
43-3	6849-6860	self-rating	http://maven.renci.org/NeuroBridge/neurobridge#SimpsonAngusScale[23]
43-4	6861-6868	anxiety	http://maven.renci.org/NeuroBridge/neurobridge#SimpsonAngusScale[23]
43-5	6869-6874	scale	http://maven.renci.org/NeuroBridge/neurobridge#SimpsonAngusScale[23]
43-6	6875-6876	(	http://maven.renci.org/NeuroBridge/neurobridge#SimpsonAngusScale[23]
43-7	6876-6879	SAS	http://maven.renci.org/NeuroBridge/neurobridge#SimpsonAngusScale[23]
43-8	6879-6880	)	http://maven.renci.org/NeuroBridge/neurobridge#SimpsonAngusScale[23]
43-9	6880-6881	,	_
43-10	6882-6893	self-rating	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[24]
43-11	6894-6904	depression	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[24]
43-12	6905-6910	scale	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[24]
43-13	6911-6912	(	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[24]
43-14	6912-6915	SDS	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[24]
43-15	6915-6916	)	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[24]
43-16	6916-6917	,	_
43-17	6918-6925	Barratt	_
43-18	6926-6939	impulsiveness	_
43-19	6940-6945	scale	_
43-20	6945-6946	-	_
43-21	6946-6948	11	_
43-22	6949-6950	(	_
43-23	6950-6953	BIS	_
43-24	6953-6954	-	_
43-25	6954-6956	11	_
43-26	6956-6957	)	_
43-27	6957-6958	,	_
43-28	6959-6962	and	_
43-29	6963-6973	Fagerstrom	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[25]
43-30	6974-6978	test	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[25]
43-31	6979-6981	of	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[25]
43-32	6982-6990	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[25]
43-33	6991-7001	dependence	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[25]
43-34	7002-7003	(	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[25]
43-35	7003-7007	FTND	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[25]
43-36	7007-7008	)	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[25]
43-37	7009-7013	were	_
43-38	7014-7023	performed	_
43-39	7024-7026	to	_
43-40	7027-7033	assess	_
43-41	7034-7037	the	_
43-42	7038-7046	clinical	_
43-43	7047-7062	characteristics	_
43-44	7063-7065	of	_
43-45	7066-7069	the	_
43-46	7070-7082	participants	_
43-47	7082-7083	.	_

#Text=CIAS is a self-reported measure with good reliability and validity and has been used to measure the severity of internet addiction.
44-1	7084-7088	CIAS	_
44-2	7089-7091	is	_
44-3	7092-7093	a	_
44-4	7094-7107	self-reported	_
44-5	7108-7115	measure	_
44-6	7116-7120	with	_
44-7	7121-7125	good	_
44-8	7126-7137	reliability	_
44-9	7138-7141	and	_
44-10	7142-7150	validity	_
44-11	7151-7154	and	_
44-12	7155-7158	has	_
44-13	7159-7163	been	_
44-14	7164-7168	used	_
44-15	7169-7171	to	_
44-16	7172-7179	measure	_
44-17	7180-7183	the	_
44-18	7184-7192	severity	_
44-19	7193-7195	of	_
44-20	7196-7204	internet	_
44-21	7205-7214	addiction	_
44-22	7214-7215	.	_

#Text=The FTND is a six-item self-report questionnaire used to assess the severity of nicotine dependence.
45-1	7216-7219	The	_
45-2	7220-7224	FTND	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
45-3	7225-7227	is	_
45-4	7228-7229	a	_
45-5	7230-7238	six-item	_
45-6	7239-7250	self-report	_
45-7	7251-7264	questionnaire	_
45-8	7265-7269	used	_
45-9	7270-7272	to	_
45-10	7273-7279	assess	_
45-11	7280-7283	the	_
45-12	7284-7292	severity	_
45-13	7293-7295	of	_
45-14	7296-7304	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#DrugDependence[26]
45-15	7305-7315	dependence	http://maven.renci.org/NeuroBridge/neurobridge#DrugDependence[26]
45-16	7315-7316	.	_

#Text=All questionnaires were initially written in English and then translated into Chinese.
46-1	7317-7320	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-2	7321-7335	questionnaires	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-3	7336-7340	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-4	7341-7350	initially	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-5	7351-7358	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-6	7359-7361	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-7	7362-7369	English	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-8	7370-7373	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-9	7374-7378	then	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-10	7379-7389	translated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-11	7390-7394	into	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-12	7395-7402	Chinese	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
46-13	7402-7403	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]

#Text=All the participants were right handed, and none of participants had (1) previous hospitalization for a history of major psychiatric disorders or psychiatric disorders; (2) a substance use disorders other than nicotine addiction; (3) mental retardation; (4) neurological illness or injury; (5) intolerance to MRI.
47-1	7404-7407	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-2	7408-7411	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-3	7412-7424	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-4	7425-7429	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-5	7430-7435	right	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-6	7436-7442	handed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-7	7442-7443	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-8	7444-7447	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-9	7448-7452	none	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-10	7453-7455	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-11	7456-7468	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-12	7469-7472	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-13	7473-7474	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-14	7474-7475	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-15	7475-7476	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-16	7477-7485	previous	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-17	7486-7501	hospitalization	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-18	7502-7505	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-19	7506-7507	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-20	7508-7515	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-21	7516-7518	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-22	7519-7524	major	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-23	7525-7536	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-24	7537-7546	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-25	7547-7549	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-26	7550-7561	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-27	7562-7571	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-28	7571-7572	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-29	7573-7574	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-30	7574-7575	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-31	7575-7576	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-32	7577-7578	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-33	7579-7588	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-34	7589-7592	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-35	7593-7602	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-36	7603-7608	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-37	7609-7613	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-38	7614-7622	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-39	7623-7632	addiction	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-40	7632-7633	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-41	7634-7635	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-42	7635-7636	3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-43	7636-7637	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-44	7638-7644	mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-45	7645-7656	retardation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-46	7656-7657	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-47	7658-7659	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-48	7659-7660	4	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-49	7660-7661	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-50	7662-7674	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-51	7675-7682	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-52	7683-7685	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-53	7686-7692	injury	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-54	7692-7693	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-55	7694-7695	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-56	7695-7696	5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-57	7696-7697	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-58	7698-7709	intolerance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-59	7710-7712	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-60	7713-7716	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]
47-61	7716-7717	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[27]

#Text=MRI acquisition
#Text=Images were obtained using a 3.0T MRI scanner (GE Signa HDxt 3T, USA) with a standard head coil.
48-1	7718-7721	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
48-2	7722-7733	acquisition	_
48-3	7734-7740	Images	_
48-4	7741-7745	were	_
48-5	7746-7754	obtained	_
48-6	7755-7760	using	_
48-7	7761-7762	a	_
48-8	7763-7767	3.0T	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[28]
48-9	7768-7771	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[28]
48-10	7772-7779	scanner	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[28]
48-11	7780-7781	(	_
48-12	7781-7783	GE	_
48-13	7784-7789	Signa	_
48-14	7790-7794	HDxt	_
48-15	7795-7797	3T	_
48-16	7797-7798	,	_
48-17	7799-7802	USA	_
48-18	7802-7803	)	_
48-19	7804-7808	with	_
48-20	7809-7810	a	_
48-21	7811-7819	standard	_
48-22	7820-7824	head	_
48-23	7825-7829	coil	_
48-24	7829-7830	.	_

#Text=Restraining foam pads was used to reduce head motion and earplugs were used to reduce scanner noise.
49-1	7831-7842	Restraining	_
49-2	7843-7847	foam	_
49-3	7848-7852	pads	_
49-4	7853-7856	was	_
49-5	7857-7861	used	_
49-6	7862-7864	to	_
49-7	7865-7871	reduce	_
49-8	7872-7876	head	_
49-9	7877-7883	motion	_
49-10	7884-7887	and	_
49-11	7888-7896	earplugs	_
49-12	7897-7901	were	_
49-13	7902-7906	used	_
49-14	7907-7909	to	_
49-15	7910-7916	reduce	_
49-16	7917-7924	scanner	_
49-17	7925-7930	noise	_
49-18	7930-7931	.	_

#Text=The SND group was required to abstain from smoking 1 h before scanning.
50-1	7932-7935	The	_
50-2	7936-7939	SND	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
50-3	7940-7945	group	_
50-4	7946-7949	was	_
50-5	7950-7958	required	_
50-6	7959-7961	to	_
50-7	7962-7969	abstain	_
50-8	7970-7974	from	_
50-9	7975-7982	smoking	_
50-10	7983-7984	1	_
50-11	7984-7985	 	_
50-12	7985-7986	h	_
50-13	7987-7993	before	_
50-14	7994-8002	scanning	_
50-15	8002-8003	.	_

#Text=Resting-state functional MRI data were acquired using a gradient-echo echo-planar sequence as described in our previously study.
51-1	8004-8017	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[29]
51-2	8018-8028	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[29]
51-3	8029-8032	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[29]
51-4	8033-8037	data	_
51-5	8038-8042	were	_
51-6	8043-8051	acquired	_
51-7	8052-8057	using	_
51-8	8058-8059	a	_
51-9	8060-8073	gradient-echo	_
51-10	8074-8085	echo-planar	_
51-11	8086-8094	sequence	_
51-12	8095-8097	as	_
51-13	8098-8107	described	_
51-14	8108-8110	in	_
51-15	8111-8114	our	_
51-16	8115-8125	previously	_
51-17	8126-8131	study	_
51-18	8131-8132	.	_

#Text=Afterward, 34 transverse slices (repetition time [TR] = 2000 ms, echo time [TE] = 30 ms; field of view [FOV] = 230 × 230 mm2; 3.6 × 3.6 × 4 mm3 voxel size) were obtained aligned along the anterior commissure-posterior commissure line.
52-1	8133-8142	Afterward	_
52-2	8142-8143	,	_
52-3	8144-8146	34	_
52-4	8147-8157	transverse	_
52-5	8158-8164	slices	_
52-6	8165-8166	(	_
52-7	8166-8176	repetition	_
52-8	8177-8181	time	_
52-9	8182-8183	[	_
52-10	8183-8185	TR	_
52-11	8185-8186	]	_
52-12	8186-8187	 	_
52-13	8187-8188	=	_
52-14	8188-8189	 	_
52-15	8189-8193	2000	_
52-16	8193-8194	 	_
52-17	8194-8196	ms	_
52-18	8196-8197	,	_
52-19	8198-8202	echo	_
52-20	8203-8207	time	_
52-21	8208-8209	[	_
52-22	8209-8211	TE	_
52-23	8211-8212	]	_
52-24	8212-8213	 	_
52-25	8213-8214	=	_
52-26	8214-8215	 	_
52-27	8215-8217	30	_
52-28	8217-8218	 	_
52-29	8218-8220	ms	_
52-30	8220-8221	;	_
52-31	8222-8227	field	_
52-32	8228-8230	of	_
52-33	8231-8235	view	_
52-34	8236-8237	[	_
52-35	8237-8240	FOV	_
52-36	8240-8241	]	_
52-37	8241-8242	 	_
52-38	8242-8243	=	_
52-39	8243-8244	 	_
52-40	8244-8247	230	_
52-41	8247-8248	 	_
52-42	8248-8249	×	_
52-43	8249-8250	 	_
52-44	8250-8253	230	_
52-45	8253-8254	 	_
52-46	8254-8257	mm2	_
52-47	8257-8258	;	_
52-48	8259-8262	3.6	_
52-49	8262-8263	 	_
52-50	8263-8264	×	_
52-51	8264-8265	 	_
52-52	8265-8268	3.6	_
52-53	8268-8269	 	_
52-54	8269-8270	×	_
52-55	8270-8271	 	_
52-56	8271-8272	4	_
52-57	8272-8273	 	_
52-58	8273-8276	mm3	_
52-59	8277-8282	voxel	_
52-60	8283-8287	size	_
52-61	8287-8288	)	_
52-62	8289-8293	were	_
52-63	8294-8302	obtained	_
52-64	8303-8310	aligned	_
52-65	8311-8316	along	_
52-66	8317-8320	the	_
52-67	8321-8329	anterior	_
52-68	8330-8350	commissure-posterior	_
52-69	8351-8361	commissure	_
52-70	8362-8366	line	_
52-71	8366-8367	.	_

#Text=Each fMRI scan lasted 440 s.
53-1	8368-8372	Each	_
53-2	8373-8377	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
53-3	8378-8382	scan	_
53-4	8383-8389	lasted	_
53-5	8390-8393	440	_
53-6	8393-8394	 	_
53-7	8394-8395	s	_
53-8	8395-8396	.	_

#Text=During the scanning, the participants were instructed to stay awake with their eyes closed and do not think any specific subjects.
54-1	8397-8403	During	_
54-2	8404-8407	the	_
54-3	8408-8416	scanning	_
54-4	8416-8417	,	_
54-5	8418-8421	the	_
54-6	8422-8434	participants	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-7	8435-8439	were	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-8	8440-8450	instructed	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-9	8451-8453	to	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-10	8454-8458	stay	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-11	8459-8464	awake	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-12	8465-8469	with	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-13	8470-8475	their	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-14	8476-8480	eyes	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-15	8481-8487	closed	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-16	8488-8491	and	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-17	8492-8494	do	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-18	8495-8498	not	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-19	8499-8504	think	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-20	8505-8508	any	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-21	8509-8517	specific	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-22	8518-8526	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]
54-23	8526-8527	.	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[30]

#Text=After scanning, the subjects were asked to confirm they remain awake during the scan.
55-1	8528-8533	After	_
55-2	8534-8542	scanning	_
55-3	8542-8543	,	_
55-4	8544-8547	the	_
55-5	8548-8556	subjects	_
55-6	8557-8561	were	_
55-7	8562-8567	asked	_
55-8	8568-8570	to	_
55-9	8571-8578	confirm	_
55-10	8579-8583	they	_
55-11	8584-8590	remain	_
55-12	8591-8596	awake	_
55-13	8597-8603	during	_
55-14	8604-8607	the	_
55-15	8608-8612	scan	_
55-16	8612-8613	.	_

#Text=In addition, high-resolution T1-weighted anatomical images (TR = 6.1 ms, TE = 2.8 ms, TI = 450 ms, slice thickness = 1 mm, gap = 0, flip angle = 15°, FOV = 256 × 256 mm2, number of slices = 166, 1 × 1 × 1 mm3 voxel size) using a 3D fast spoiled gradient recalled sequence images.
56-1	8614-8616	In	_
56-2	8617-8625	addition	_
56-3	8625-8626	,	_
56-4	8627-8642	high-resolution	_
56-5	8643-8645	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[31]
56-6	8645-8646	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[31]
56-7	8646-8654	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[31]
56-8	8655-8665	anatomical	_
56-9	8666-8672	images	_
56-10	8673-8674	(	_
56-11	8674-8676	TR	_
56-12	8676-8677	 	_
56-13	8677-8678	=	_
56-14	8678-8679	 	_
56-15	8679-8682	6.1	_
56-16	8682-8683	 	_
56-17	8683-8685	ms	_
56-18	8685-8686	,	_
56-19	8687-8689	TE	_
56-20	8689-8690	 	_
56-21	8690-8691	=	_
56-22	8691-8692	 	_
56-23	8692-8695	2.8	_
56-24	8695-8696	 	_
56-25	8696-8698	ms	_
56-26	8698-8699	,	_
56-27	8700-8702	TI	_
56-28	8702-8703	 	_
56-29	8703-8704	=	_
56-30	8704-8705	 	_
56-31	8705-8708	450	_
56-32	8708-8709	 	_
56-33	8709-8711	ms	_
56-34	8711-8712	,	_
56-35	8713-8718	slice	_
56-36	8719-8728	thickness	_
56-37	8728-8729	 	_
56-38	8729-8730	=	_
56-39	8730-8731	 	_
56-40	8731-8732	1	_
56-41	8732-8733	 	_
56-42	8733-8735	mm	_
56-43	8735-8736	,	_
56-44	8737-8740	gap	_
56-45	8740-8741	 	_
56-46	8741-8742	=	_
56-47	8742-8743	 	_
56-48	8743-8744	0	_
56-49	8744-8745	,	_
56-50	8746-8750	flip	_
56-51	8751-8756	angle	_
56-52	8756-8757	 	_
56-53	8757-8758	=	_
56-54	8758-8759	 	_
56-55	8759-8761	15	_
56-56	8761-8762	°	_
56-57	8762-8763	,	_
56-58	8764-8767	FOV	_
56-59	8767-8768	 	_
56-60	8768-8769	=	_
56-61	8769-8770	 	_
56-62	8770-8773	256	_
56-63	8773-8774	 	_
56-64	8774-8775	×	_
56-65	8775-8776	 	_
56-66	8776-8779	256	_
56-67	8779-8780	 	_
56-68	8780-8783	mm2	_
56-69	8783-8784	,	_
56-70	8785-8791	number	_
56-71	8792-8794	of	_
56-72	8795-8801	slices	_
56-73	8801-8802	 	_
56-74	8802-8803	=	_
56-75	8803-8804	 	_
56-76	8804-8807	166	_
56-77	8807-8808	,	_
56-78	8809-8810	1	_
56-79	8810-8811	 	_
56-80	8811-8812	×	_
56-81	8812-8813	 	_
56-82	8813-8814	1	_
56-83	8814-8815	 	_
56-84	8815-8816	×	_
56-85	8816-8817	 	_
56-86	8817-8818	1	_
56-87	8818-8819	 	_
56-88	8819-8822	mm3	_
56-89	8823-8828	voxel	_
56-90	8829-8833	size	_
56-91	8833-8834	)	_
56-92	8835-8840	using	_
56-93	8841-8842	a	_
56-94	8843-8845	3D	_
56-95	8846-8850	fast	_
56-96	8851-8858	spoiled	_
56-97	8859-8867	gradient	_
56-98	8868-8876	recalled	_
56-99	8877-8885	sequence	_
56-100	8886-8892	images	_
56-101	8892-8893	.	_

#Text=Statistical analysis
#Text=The demographic and clinical measures of the groups were compared.
57-1	8894-8905	Statistical	_
57-2	8906-8914	analysis	_
57-3	8915-8918	The	_
57-4	8919-8930	demographic	_
57-5	8931-8934	and	_
57-6	8935-8943	clinical	_
57-7	8944-8952	measures	_
57-8	8953-8955	of	_
57-9	8956-8959	the	_
57-10	8960-8966	groups	_
57-11	8967-8971	were	_
57-12	8972-8980	compared	_
57-13	8980-8981	.	_

#Text=One-way ANOVA tests were carried out using Statistical Package for the Social Sciences software (version 18) to assess the differences among the 3 groups.
58-1	8982-8989	One-way	_
58-2	8990-8995	ANOVA	_
58-3	8996-9001	tests	_
58-4	9002-9006	were	_
58-5	9007-9014	carried	_
58-6	9015-9018	out	_
58-7	9019-9024	using	_
58-8	9025-9036	Statistical	_
58-9	9037-9044	Package	_
58-10	9045-9048	for	_
58-11	9049-9052	the	_
58-12	9053-9059	Social	_
58-13	9060-9068	Sciences	_
58-14	9069-9077	software	_
58-15	9078-9079	(	_
58-16	9079-9086	version	_
58-17	9087-9089	18	_
58-18	9089-9090	)	_
58-19	9091-9093	to	_
58-20	9094-9100	assess	_
58-21	9101-9104	the	_
58-22	9105-9116	differences	_
58-23	9117-9122	among	_
58-24	9123-9126	the	_
58-25	9127-9128	3	_
58-26	9129-9135	groups	_
58-27	9135-9136	.	_

#Text=Bonferroni post hoc tests were then performed to assess the differences between each pair of groups.
59-1	9137-9147	Bonferroni	_
59-2	9148-9152	post	_
59-3	9153-9156	hoc	_
59-4	9157-9162	tests	_
59-5	9163-9167	were	_
59-6	9168-9172	then	_
59-7	9173-9182	performed	_
59-8	9183-9185	to	_
59-9	9186-9192	assess	_
59-10	9193-9196	the	_
59-11	9197-9208	differences	_
59-12	9209-9216	between	_
59-13	9217-9221	each	_
59-14	9222-9226	pair	_
59-15	9227-9229	of	_
59-16	9230-9236	groups	_
59-17	9236-9237	.	_

#Text=A 2-tailed p value of 0.05 was considered statistically significant for all analyses.
60-1	9238-9239	A	_
60-2	9240-9241	2	_
60-3	9241-9242	-	_
60-4	9242-9248	tailed	_
60-5	9249-9250	p	_
60-6	9251-9256	value	_
60-7	9257-9259	of	_
60-8	9260-9264	0.05	_
60-9	9265-9268	was	_
60-10	9269-9279	considered	_
60-11	9280-9293	statistically	_
60-12	9294-9305	significant	_
60-13	9306-9309	for	_
60-14	9310-9313	all	_
60-15	9314-9322	analyses	_
60-16	9322-9323	.	_

#Text=Functional MRI preprocessing was performed using a toolbox for data processing and analysis for brain imaging (http://rfmri.org/dpabi).
61-1	9324-9334	Functional	_
61-2	9335-9338	MRI	_
61-3	9339-9352	preprocessing	_
61-4	9353-9356	was	_
61-5	9357-9366	performed	_
61-6	9367-9372	using	_
61-7	9373-9374	a	_
61-8	9375-9382	toolbox	_
61-9	9383-9386	for	_
61-10	9387-9391	data	_
61-11	9392-9402	processing	_
61-12	9403-9406	and	_
61-13	9407-9415	analysis	_
61-14	9416-9419	for	_
61-15	9420-9425	brain	_
61-16	9426-9433	imaging	_
61-17	9434-9435	(	_
61-18	9435-9439	http	_
61-19	9439-9440	:	_
61-20	9440-9441	/	_
61-21	9441-9442	/	_
61-22	9442-9451	rfmri.org	_
61-23	9451-9452	/	_
61-24	9452-9457	dpabi	_
61-25	9457-9458	)	_
61-26	9458-9459	.	_

#Text=After discarding the first 10 volumes of each functional time series, the remaining 210 images were preprocessed.
62-1	9460-9465	After	_
62-2	9466-9476	discarding	_
62-3	9477-9480	the	_
62-4	9481-9486	first	_
62-5	9487-9489	10	_
62-6	9490-9497	volumes	_
62-7	9498-9500	of	_
62-8	9501-9505	each	_
62-9	9506-9516	functional	_
62-10	9517-9521	time	_
62-11	9522-9528	series	_
62-12	9528-9529	,	_
62-13	9530-9533	the	_
62-14	9534-9543	remaining	_
62-15	9544-9547	210	_
62-16	9548-9554	images	_
62-17	9555-9559	were	_
62-18	9560-9572	preprocessed	_
62-19	9572-9573	.	_

#Text=Slice-timing correction, realignment, and spatial normalization, as well as smoothing (6 mm full width at half maximum), were conducted.
63-1	9574-9586	Slice-timing	_
63-2	9587-9597	correction	_
63-3	9597-9598	,	_
63-4	9599-9610	realignment	_
63-5	9610-9611	,	_
63-6	9612-9615	and	_
63-7	9616-9623	spatial	_
63-8	9624-9637	normalization	_
63-9	9637-9638	,	_
63-10	9639-9641	as	_
63-11	9642-9646	well	_
63-12	9647-9649	as	_
63-13	9650-9659	smoothing	_
63-14	9660-9661	(	_
63-15	9661-9662	6	_
63-16	9662-9663	 	_
63-17	9663-9665	mm	_
63-18	9666-9670	full	_
63-19	9671-9676	width	_
63-20	9677-9679	at	_
63-21	9680-9684	half	_
63-22	9685-9692	maximum	_
63-23	9692-9693	)	_
63-24	9693-9694	,	_
63-25	9695-9699	were	_
63-26	9700-9709	conducted	_
63-27	9709-9710	.	_

#Text=Nuisance covariates, including time-series predictors for global, cerebrospinal fluid, white matter and six movement parameters were regressed out to improve the signal-to-noise ratio and minimize the motion artifact.
64-1	9711-9719	Nuisance	_
64-2	9720-9730	covariates	_
64-3	9730-9731	,	_
64-4	9732-9741	including	_
64-5	9742-9753	time-series	_
64-6	9754-9764	predictors	_
64-7	9765-9768	for	_
64-8	9769-9775	global	_
64-9	9775-9776	,	_
64-10	9777-9790	cerebrospinal	_
64-11	9791-9796	fluid	_
64-12	9796-9797	,	_
64-13	9798-9803	white	_
64-14	9804-9810	matter	_
64-15	9811-9814	and	_
64-16	9815-9818	six	_
64-17	9819-9827	movement	_
64-18	9828-9838	parameters	_
64-19	9839-9843	were	_
64-20	9844-9853	regressed	_
64-21	9854-9857	out	_
64-22	9858-9860	to	_
64-23	9861-9868	improve	_
64-24	9869-9872	the	_
64-25	9873-9888	signal-to-noise	_
64-26	9889-9894	ratio	_
64-27	9895-9898	and	_
64-28	9899-9907	minimize	_
64-29	9908-9911	the	_
64-30	9912-9918	motion	_
64-31	9919-9927	artifact	_
64-32	9927-9928	.	_

#Text=No participant in this study exhibited movement greater than 1.5 mm with maximum translation in x, y, or z, axes or maximum rotation of 1.5° in the 3 axes.
65-1	9929-9931	No	_
65-2	9932-9943	participant	_
65-3	9944-9946	in	_
65-4	9947-9951	this	_
65-5	9952-9957	study	_
65-6	9958-9967	exhibited	_
65-7	9968-9976	movement	_
65-8	9977-9984	greater	_
65-9	9985-9989	than	_
65-10	9990-9993	1.5	_
65-11	9993-9994	 	_
65-12	9994-9996	mm	_
65-13	9997-10001	with	_
65-14	10002-10009	maximum	_
65-15	10010-10021	translation	_
65-16	10022-10024	in	_
65-17	10025-10026	x	_
65-18	10026-10027	,	_
65-19	10028-10029	y	_
65-20	10029-10030	,	_
65-21	10031-10033	or	_
65-22	10034-10035	z	_
65-23	10035-10036	,	_
65-24	10037-10041	axes	_
65-25	10042-10044	or	_
65-26	10045-10052	maximum	_
65-27	10053-10061	rotation	_
65-28	10062-10064	of	_
65-29	10065-10068	1.5	_
65-30	10068-10069	°	_
65-31	10070-10072	in	_
65-32	10073-10076	the	_
65-33	10077-10078	3	_
65-34	10079-10083	axes	_
65-35	10083-10084	.	_

#Text=Moreover, the mean framewise displacement (FD) was computed by averaging the FDi of each subject from each time point.
66-1	10085-10093	Moreover	_
66-2	10093-10094	,	_
66-3	10095-10098	the	_
66-4	10099-10103	mean	_
66-5	10104-10113	framewise	_
66-6	10114-10126	displacement	_
66-7	10127-10128	(	_
66-8	10128-10130	FD	_
66-9	10130-10131	)	_
66-10	10132-10135	was	_
66-11	10136-10144	computed	_
66-12	10145-10147	by	_
66-13	10148-10157	averaging	_
66-14	10158-10161	the	_
66-15	10162-10165	FDi	_
66-16	10166-10168	of	_
66-17	10169-10173	each	_
66-18	10174-10181	subject	_
66-19	10182-10186	from	_
66-20	10187-10191	each	_
66-21	10192-10196	time	_
66-22	10197-10202	point	_
66-23	10202-10203	.	_

#Text=No difference among the mean FD values of the groups (p = 0.71).
67-1	10204-10206	No	_
67-2	10207-10217	difference	_
67-3	10218-10223	among	_
67-4	10224-10227	the	_
67-5	10228-10232	mean	_
67-6	10233-10235	FD	_
67-7	10236-10242	values	_
67-8	10243-10245	of	_
67-9	10246-10249	the	_
67-10	10250-10256	groups	_
67-11	10257-10258	(	_
67-12	10258-10259	p	_
67-13	10259-10260	 	_
67-14	10260-10261	=	_
67-15	10261-10262	 	_
67-16	10262-10266	0.71	_
67-17	10266-10267	)	_
67-18	10267-10268	.	_

#Text=Then, we applied temporal filtering (0.01–0.08 Hz) to the time series of each voxel to reduce the influence of high-frequency noise and low-frequency drift.
68-1	10269-10273	Then	_
68-2	10273-10274	,	_
68-3	10275-10277	we	_
68-4	10278-10285	applied	_
68-5	10286-10294	temporal	_
68-6	10295-10304	filtering	_
68-7	10305-10306	(	_
68-8	10306-10310	0.01	_
68-9	10310-10311	–	_
68-10	10311-10315	0.08	_
68-11	10315-10316	 	_
68-12	10316-10318	Hz	_
68-13	10318-10319	)	_
68-14	10320-10322	to	_
68-15	10323-10326	the	_
68-16	10327-10331	time	_
68-17	10332-10338	series	_
68-18	10339-10341	of	_
68-19	10342-10346	each	_
68-20	10347-10352	voxel	_
68-21	10353-10355	to	_
68-22	10356-10362	reduce	_
68-23	10363-10366	the	_
68-24	10367-10376	influence	_
68-25	10377-10379	of	_
68-26	10380-10394	high-frequency	_
68-27	10395-10400	noise	_
68-28	10401-10404	and	_
68-29	10405-10418	low-frequency	_
68-30	10419-10424	drift	_
68-31	10424-10425	.	_

#Text=DLPFC was used as the region of interest (ROI) seed in the current study, and the DLPFC template was made as described in previous research.
69-1	10426-10431	DLPFC	_
69-2	10432-10435	was	_
69-3	10436-10440	used	_
69-4	10441-10443	as	_
69-5	10444-10447	the	_
69-6	10448-10454	region	_
69-7	10455-10457	of	_
69-8	10458-10466	interest	_
69-9	10467-10468	(	_
69-10	10468-10471	ROI	_
69-11	10471-10472	)	_
69-12	10473-10477	seed	_
69-13	10478-10480	in	_
69-14	10481-10484	the	_
69-15	10485-10492	current	_
69-16	10493-10498	study	_
69-17	10498-10499	,	_
69-18	10500-10503	and	_
69-19	10504-10507	the	_
69-20	10508-10513	DLPFC	_
69-21	10514-10522	template	_
69-22	10523-10526	was	_
69-23	10527-10531	made	_
69-24	10532-10534	as	_
69-25	10535-10544	described	_
69-26	10545-10547	in	_
69-27	10548-10556	previous	_
69-28	10557-10565	research	_
69-29	10565-10566	.	_

#Text=Then, the blood-oxygen-level-dependent signal time series of the in each voxel within the seed region were averaged to generate the reference time series.
70-1	10567-10571	Then	_
70-2	10571-10572	,	_
70-3	10573-10576	the	_
70-4	10577-10605	blood-oxygen-level-dependent	_
70-5	10606-10612	signal	_
70-6	10613-10617	time	_
70-7	10618-10624	series	_
70-8	10625-10627	of	_
70-9	10628-10631	the	_
70-10	10632-10634	in	_
70-11	10635-10639	each	_
70-12	10640-10645	voxel	_
70-13	10646-10652	within	_
70-14	10653-10656	the	_
70-15	10657-10661	seed	_
70-16	10662-10668	region	_
70-17	10669-10673	were	_
70-18	10674-10682	averaged	_
70-19	10683-10685	to	_
70-20	10686-10694	generate	_
70-21	10695-10698	the	_
70-22	10699-10708	reference	_
70-23	10709-10713	time	_
70-24	10714-10720	series	_
70-25	10720-10721	.	_

#Text=A correlation map for each subject was produced by computing the correlation coefficients between the reference time series and time series from the other brain voxels.
71-1	10722-10723	A	_
71-2	10724-10735	correlation	_
71-3	10736-10739	map	_
71-4	10740-10743	for	_
71-5	10744-10748	each	_
71-6	10749-10756	subject	_
71-7	10757-10760	was	_
71-8	10761-10769	produced	_
71-9	10770-10772	by	_
71-10	10773-10782	computing	_
71-11	10783-10786	the	_
71-12	10787-10798	correlation	_
71-13	10799-10811	coefficients	_
71-14	10812-10819	between	_
71-15	10820-10823	the	_
71-16	10824-10833	reference	_
71-17	10834-10838	time	_
71-18	10839-10845	series	_
71-19	10846-10849	and	_
71-20	10850-10854	time	_
71-21	10855-10861	series	_
71-22	10862-10866	from	_
71-23	10867-10870	the	_
71-24	10871-10876	other	_
71-25	10877-10882	brain	_
71-26	10883-10889	voxels	_
71-27	10889-10890	.	_

#Text=Z values were converted from the correlation coefficients by Fisher’s z-transform to improve the normality of the distribution.
72-1	10891-10892	Z	_
72-2	10893-10899	values	_
72-3	10900-10904	were	_
72-4	10905-10914	converted	_
72-5	10915-10919	from	_
72-6	10920-10923	the	_
72-7	10924-10935	correlation	_
72-8	10936-10948	coefficients	_
72-9	10949-10951	by	_
72-10	10952-10958	Fisher	_
72-11	10958-10959	’	_
72-12	10959-10960	s	_
72-13	10961-10972	z-transform	_
72-14	10973-10975	to	_
72-15	10976-10983	improve	_
72-16	10984-10987	the	_
72-17	10988-10997	normality	_
72-18	10998-11000	of	_
72-19	11001-11004	the	_
72-20	11005-11017	distribution	_
72-21	11017-11018	.	_

#Text=Afterwards, the individual z-scores were entered into SPM8 for the one-sample t test in a voxel-wise manner, which was performed to determine the brain regions with significant positive or negative correlation with the DLPFC within each group.
73-1	11019-11029	Afterwards	_
73-2	11029-11030	,	_
73-3	11031-11034	the	_
73-4	11035-11045	individual	_
73-5	11046-11054	z-scores	_
73-6	11055-11059	were	_
73-7	11060-11067	entered	_
73-8	11068-11072	into	_
73-9	11073-11077	SPM8	_
73-10	11078-11081	for	_
73-11	11082-11085	the	_
73-12	11086-11096	one-sample	_
73-13	11097-11098	t	_
73-14	11099-11103	test	_
73-15	11104-11106	in	_
73-16	11107-11108	a	_
73-17	11109-11119	voxel-wise	_
73-18	11120-11126	manner	_
73-19	11126-11127	,	_
73-20	11128-11133	which	_
73-21	11134-11137	was	_
73-22	11138-11147	performed	_
73-23	11148-11150	to	_
73-24	11151-11160	determine	_
73-25	11161-11164	the	_
73-26	11165-11170	brain	_
73-27	11171-11178	regions	_
73-28	11179-11183	with	_
73-29	11184-11195	significant	_
73-30	11196-11204	positive	_
73-31	11205-11207	or	_
73-32	11208-11216	negative	_
73-33	11217-11228	correlation	_
73-34	11229-11233	with	_
73-35	11234-11237	the	_
73-36	11238-11243	DLPFC	_
73-37	11244-11250	within	_
73-38	11251-11255	each	_
73-39	11256-11261	group	_
73-40	11261-11262	.	_

#Text=Individual scores were entered into SPM8 for random effect analysis, and then one-way ANOVA were performed.
74-1	11263-11273	Individual	_
74-2	11274-11280	scores	_
74-3	11281-11285	were	_
74-4	11286-11293	entered	_
74-5	11294-11298	into	_
74-6	11299-11303	SPM8	_
74-7	11304-11307	for	_
74-8	11308-11314	random	_
74-9	11315-11321	effect	_
74-10	11322-11330	analysis	_
74-11	11330-11331	,	_
74-12	11332-11335	and	_
74-13	11336-11340	then	_
74-14	11341-11348	one-way	_
74-15	11349-11354	ANOVA	_
74-16	11355-11359	were	_
74-17	11360-11369	performed	_
74-18	11369-11370	.	_

#Text=Differences with regard to age, sex, education, SAS scores, SDS scores, and BIS-11 scores were regressed for each rsFC along the subject dimension.
75-1	11371-11382	Differences	_
75-2	11383-11387	with	_
75-3	11388-11394	regard	_
75-4	11395-11397	to	_
75-5	11398-11401	age	_
75-6	11401-11402	,	_
75-7	11403-11406	sex	_
75-8	11406-11407	,	_
75-9	11408-11417	education	_
75-10	11417-11418	,	_
75-11	11419-11422	SAS	_
75-12	11423-11429	scores	_
75-13	11429-11430	,	_
75-14	11431-11434	SDS	_
75-15	11435-11441	scores	_
75-16	11441-11442	,	_
75-17	11443-11446	and	_
75-18	11447-11450	BIS	_
75-19	11450-11451	-	_
75-20	11451-11453	11	_
75-21	11454-11460	scores	_
75-22	11461-11465	were	_
75-23	11466-11475	regressed	_
75-24	11476-11479	for	_
75-25	11480-11484	each	_
75-26	11485-11489	rsFC	_
75-27	11490-11495	along	_
75-28	11496-11499	the	_
75-29	11500-11507	subject	_
75-30	11508-11517	dimension	_
75-31	11517-11518	.	_

#Text=Multiple comparison corrections were performed using the AlphaSim program in the Analysis of Functional Neuroimages (AFNI) software package (NIMH, Bethesda, MD USA; available at http://afni.nimh.nih.gov/afni), as determined by Monte Carlo simulations.
76-1	11519-11527	Multiple	_
76-2	11528-11538	comparison	_
76-3	11539-11550	corrections	_
76-4	11551-11555	were	_
76-5	11556-11565	performed	_
76-6	11566-11571	using	_
76-7	11572-11575	the	_
76-8	11576-11584	AlphaSim	_
76-9	11585-11592	program	_
76-10	11593-11595	in	_
76-11	11596-11599	the	_
76-12	11600-11608	Analysis	_
76-13	11609-11611	of	_
76-14	11612-11622	Functional	_
76-15	11623-11634	Neuroimages	_
76-16	11635-11636	(	_
76-17	11636-11640	AFNI	_
76-18	11640-11641	)	_
76-19	11642-11650	software	_
76-20	11651-11658	package	_
76-21	11659-11660	(	_
76-22	11660-11664	NIMH	_
76-23	11664-11665	,	_
76-24	11666-11674	Bethesda	_
76-25	11674-11675	,	_
76-26	11676-11678	MD	_
76-27	11679-11682	USA	_
76-28	11682-11683	;	_
76-29	11684-11693	available	_
76-30	11694-11696	at	_
76-31	11697-11701	http	_
76-32	11701-11702	:	_
76-33	11702-11703	/	_
76-34	11703-11704	/	_
76-35	11704-11721	afni.nimh.nih.gov	_
76-36	11721-11722	/	_
76-37	11722-11726	afni	_
76-38	11726-11727	)	_
76-39	11727-11728	,	_
76-40	11729-11731	as	_
76-41	11732-11742	determined	_
76-42	11743-11745	by	_
76-43	11746-11751	Monte	_
76-44	11752-11757	Carlo	_
76-45	11758-11769	simulations	_
76-46	11769-11770	.	_

#Text=Significant differences were defined as those which survived a threshold of p < 0.05, AlphaSim corrected (a combined threshold of p < 0.001 for each voxel and a cluster size >11 voxels, yielding a corrected threshold of p < 0.05).
77-1	11771-11782	Significant	_
77-2	11783-11794	differences	_
77-3	11795-11799	were	_
77-4	11800-11807	defined	_
77-5	11808-11810	as	_
77-6	11811-11816	those	_
77-7	11817-11822	which	_
77-8	11823-11831	survived	_
77-9	11832-11833	a	_
77-10	11834-11843	threshold	_
77-11	11844-11846	of	_
77-12	11847-11848	p	_
77-13	11848-11849	 	_
77-14	11849-11850	<	_
77-15	11850-11851	 	_
77-16	11851-11855	0.05	_
77-17	11855-11856	,	_
77-18	11857-11865	AlphaSim	_
77-19	11866-11875	corrected	_
77-20	11876-11877	(	_
77-21	11877-11878	a	_
77-22	11879-11887	combined	_
77-23	11888-11897	threshold	_
77-24	11898-11900	of	_
77-25	11901-11902	p	_
77-26	11902-11903	 	_
77-27	11903-11904	<	_
77-28	11904-11905	 	_
77-29	11905-11910	0.001	_
77-30	11911-11914	for	_
77-31	11915-11919	each	_
77-32	11920-11925	voxel	_
77-33	11926-11929	and	_
77-34	11930-11931	a	_
77-35	11932-11939	cluster	_
77-36	11940-11944	size	_
77-37	11945-11946	>	_
77-38	11946-11948	11	_
77-39	11949-11955	voxels	_
77-40	11955-11956	,	_
77-41	11957-11965	yielding	_
77-42	11966-11967	a	_
77-43	11968-11977	corrected	_
77-44	11978-11987	threshold	_
77-45	11988-11990	of	_
77-46	11991-11992	p	_
77-47	11992-11993	 	_
77-48	11993-11994	<	_
77-49	11994-11995	 	_
77-50	11995-11999	0.05	_
77-51	11999-12000	)	_
77-52	12000-12001	.	_

#Text=Group interaction analyses were then carried out with two-sample t-tests.
78-1	12002-12007	Group	_
78-2	12008-12019	interaction	_
78-3	12020-12028	analyses	_
78-4	12029-12033	were	_
78-5	12034-12038	then	_
78-6	12039-12046	carried	_
78-7	12047-12050	out	_
78-8	12051-12055	with	_
78-9	12056-12066	two-sample	_
78-10	12067-12074	t-tests	_
78-11	12074-12075	.	_

#Text=The differences were obtained according to the results of ANOVA by applying the mask to limit the t-tests to the significant brain areas.
79-1	12076-12079	The	_
79-2	12080-12091	differences	_
79-3	12092-12096	were	_
79-4	12097-12105	obtained	_
79-5	12106-12115	according	_
79-6	12116-12118	to	_
79-7	12119-12122	the	_
79-8	12123-12130	results	_
79-9	12131-12133	of	_
79-10	12134-12139	ANOVA	_
79-11	12140-12142	by	_
79-12	12143-12151	applying	_
79-13	12152-12155	the	_
79-14	12156-12160	mask	_
79-15	12161-12163	to	_
79-16	12164-12169	limit	_
79-17	12170-12173	the	_
79-18	12174-12181	t-tests	_
79-19	12182-12184	to	_
79-20	12185-12188	the	_
79-21	12189-12200	significant	_
79-22	12201-12206	brain	_
79-23	12207-12212	areas	_
79-24	12212-12213	.	_

#Text=AlphaSim corrected threshold p < 0.05 (a combined threshold of p < 0.001 and a cluster size >11 voxels) was performed as multiple comparison correction.
80-1	12214-12222	AlphaSim	_
80-2	12223-12232	corrected	_
80-3	12233-12242	threshold	_
80-4	12243-12244	p	_
80-5	12244-12245	 	_
80-6	12245-12246	<	_
80-7	12246-12247	 	_
80-8	12247-12251	0.05	_
80-9	12252-12253	(	_
80-10	12253-12254	a	_
80-11	12255-12263	combined	_
80-12	12264-12273	threshold	_
80-13	12274-12276	of	_
80-14	12277-12278	p	_
80-15	12278-12279	 	_
80-16	12279-12280	<	_
80-17	12280-12281	 	_
80-18	12281-12286	0.001	_
80-19	12287-12290	and	_
80-20	12291-12292	a	_
80-21	12293-12300	cluster	_
80-22	12301-12305	size	_
80-23	12306-12307	>	_
80-24	12307-12309	11	_
80-25	12310-12316	voxels	_
80-26	12316-12317	)	_
80-27	12318-12321	was	_
80-28	12322-12331	performed	_
80-29	12332-12334	as	_
80-30	12335-12343	multiple	_
80-31	12344-12354	comparison	_
80-32	12355-12365	correction	_
80-33	12365-12366	.	_

#Text=Brain regions exhibiting significant differences were then masked on the MNI brain templates.
81-1	12367-12372	Brain	_
81-2	12373-12380	regions	_
81-3	12381-12391	exhibiting	_
81-4	12392-12403	significant	_
81-5	12404-12415	differences	_
81-6	12416-12420	were	_
81-7	12421-12425	then	_
81-8	12426-12432	masked	_
81-9	12433-12435	on	_
81-10	12436-12439	the	_
81-11	12440-12443	MNI	_
81-12	12444-12449	brain	_
81-13	12450-12459	templates	_
81-14	12459-12460	.	_

#Text=Results
#Text=Demographic and clinical characteristics
#Text=Demographic and clinical characteristics of the three groups
#Text=\tIGD (n = 27)\tHC (n = 33)\tSND (n = 29)\tF value (p value)\tp1-2\tp1-3\tp2-3\t \t(Mean ± SD)\t(Mean ± SD)\t(Mean ± SD)\t \tAge (years)\t20.78 ± 2.20\t20.78 ± 2.51\t22.58 ± 2.41\t5.56(0.005)\t1\t0.02\t0.01\t \tSex (F/M)\t8/19\t6/27\t0/33\t12.091(0.001)\t0.30\t0.001\t0.02\t \tEducation (years)\t11.26 ± 1.67\t12.67 ± 2.58\t13.03 ± 2.06\t5.19(0.007)\t0.43\t0.01\t1\t \tChen Internet Addiction Scale (CIAS)\t75.15 ± 9.95\t44.27 ± 9.81\t46.76 ± 8.34\t98.29(<0.001)\t<0.001\t<0.001\t0.45\t \tSelf-Rating Anxiety Scale (SAS)\t51.33 ± 10.16\t39.61 ± 6.39\t44.48 ± 8.96\t14.09(<0.001)\t<0.001\t0.01\t0.08\t \tSelf-rating depression scale (SDS)\t54.56 ± 10.80\t43.12 ± 8.85\t47.44 ± 9.13\t10.66(<0.001)\t<0.001\t0.02\t0.24\t \tBarratt Impulsiveness Scale-11 (BIS-11)\t61.22 ± 8.44\t52.82 ± 6.64\t52.41 ± 7.50\t12.36(<0.001)\t<0.001\t<0.001\t1\t \tFTND\t\t\t6.52 ± 2.11\t\t\t\t\t \t
#Text=p 1-2 for IGD group versus HC group, p 1-3 for IGD group versus SND group, p 2-3 for HC group versus SND group
#Text=
#Text=SD standard deviation, HC healthy control, IGD internet gaming disorder, SND smokers with nicotine dependence, FTND Fagerstrom test of nicotine dependence
#Text=Table 1 listed the demographic and clinical measures for each group.
82-1	12461-12468	Results	_
82-2	12469-12480	Demographic	_
82-3	12481-12484	and	_
82-4	12485-12493	clinical	_
82-5	12494-12509	characteristics	_
82-6	12510-12521	Demographic	_
82-7	12522-12525	and	_
82-8	12526-12534	clinical	_
82-9	12535-12550	characteristics	_
82-10	12551-12553	of	_
82-11	12554-12557	the	_
82-12	12558-12563	three	_
82-13	12564-12570	groups	_
82-14	12572-12575	IGD	_
82-15	12576-12577	(	_
82-16	12577-12578	n	_
82-17	12578-12579	 	_
82-18	12579-12580	=	_
82-19	12580-12581	 	_
82-20	12581-12583	27	_
82-21	12583-12584	)	_
82-22	12585-12587	HC	_
82-23	12588-12589	(	_
82-24	12589-12590	n	_
82-25	12590-12591	 	_
82-26	12591-12592	=	_
82-27	12592-12593	 	_
82-28	12593-12595	33	_
82-29	12595-12596	)	_
82-30	12597-12600	SND	_
82-31	12601-12602	(	_
82-32	12602-12603	n	_
82-33	12603-12604	 	_
82-34	12604-12605	=	_
82-35	12605-12606	 	_
82-36	12606-12608	29	_
82-37	12608-12609	)	_
82-38	12610-12611	F	_
82-39	12612-12617	value	_
82-40	12618-12619	(	_
82-41	12619-12620	p	_
82-42	12621-12626	value	_
82-43	12626-12627	)	_
82-44	12628-12630	p1	_
82-45	12630-12631	-	_
82-46	12631-12632	2	_
82-47	12633-12635	p1	_
82-48	12635-12636	-	_
82-49	12636-12637	3	_
82-50	12638-12640	p2	_
82-51	12640-12641	-	_
82-52	12641-12642	3	_
82-53	12645-12646	(	_
82-54	12646-12650	Mean	_
82-55	12650-12651	 	_
82-56	12651-12652	±	_
82-57	12652-12653	 	_
82-58	12653-12655	SD	_
82-59	12655-12656	)	_
82-60	12657-12658	(	_
82-61	12658-12662	Mean	_
82-62	12662-12663	 	_
82-63	12663-12664	±	_
82-64	12664-12665	 	_
82-65	12665-12667	SD	_
82-66	12667-12668	)	_
82-67	12669-12670	(	_
82-68	12670-12674	Mean	_
82-69	12674-12675	 	_
82-70	12675-12676	±	_
82-71	12676-12677	 	_
82-72	12677-12679	SD	_
82-73	12679-12680	)	_
82-74	12683-12686	Age	_
82-75	12687-12688	(	_
82-76	12688-12693	years	_
82-77	12693-12694	)	_
82-78	12695-12700	20.78	_
82-79	12700-12701	 	_
82-80	12701-12702	±	_
82-81	12702-12703	 	_
82-82	12703-12707	2.20	_
82-83	12708-12713	20.78	_
82-84	12713-12714	 	_
82-85	12714-12715	±	_
82-86	12715-12716	 	_
82-87	12716-12720	2.51	_
82-88	12721-12726	22.58	_
82-89	12726-12727	 	_
82-90	12727-12728	±	_
82-91	12728-12729	 	_
82-92	12729-12733	2.41	_
82-93	12734-12738	5.56	_
82-94	12738-12739	(	_
82-95	12739-12744	0.005	_
82-96	12744-12745	)	_
82-97	12746-12747	1	_
82-98	12748-12752	0.02	_
82-99	12753-12757	0.01	_
82-100	12760-12763	Sex	_
82-101	12764-12765	(	_
82-102	12765-12766	F	_
82-103	12766-12767	/	_
82-104	12767-12768	M	_
82-105	12768-12769	)	_
82-106	12770-12771	8	_
82-107	12771-12772	/	_
82-108	12772-12774	19	_
82-109	12775-12776	6	_
82-110	12776-12777	/	_
82-111	12777-12779	27	_
82-112	12780-12781	0	_
82-113	12781-12782	/	_
82-114	12782-12784	33	_
82-115	12785-12791	12.091	_
82-116	12791-12792	(	_
82-117	12792-12797	0.001	_
82-118	12797-12798	)	_
82-119	12799-12803	0.30	_
82-120	12804-12809	0.001	_
82-121	12810-12814	0.02	_
82-122	12817-12826	Education	_
82-123	12827-12828	(	_
82-124	12828-12833	years	_
82-125	12833-12834	)	_
82-126	12835-12840	11.26	_
82-127	12840-12841	 	_
82-128	12841-12842	±	_
82-129	12842-12843	 	_
82-130	12843-12847	1.67	_
82-131	12848-12853	12.67	_
82-132	12853-12854	 	_
82-133	12854-12855	±	_
82-134	12855-12856	 	_
82-135	12856-12860	2.58	_
82-136	12861-12866	13.03	_
82-137	12866-12867	 	_
82-138	12867-12868	±	_
82-139	12868-12869	 	_
82-140	12869-12873	2.06	_
82-141	12874-12878	5.19	_
82-142	12878-12879	(	_
82-143	12879-12884	0.007	_
82-144	12884-12885	)	_
82-145	12886-12890	0.43	_
82-146	12891-12895	0.01	_
82-147	12896-12897	1	_
82-148	12900-12904	Chen	_
82-149	12905-12913	Internet	_
82-150	12914-12923	Addiction	_
82-151	12924-12929	Scale	_
82-152	12930-12931	(	_
82-153	12931-12935	CIAS	_
82-154	12935-12936	)	_
82-155	12937-12942	75.15	_
82-156	12942-12943	 	_
82-157	12943-12944	±	_
82-158	12944-12945	 	_
82-159	12945-12949	9.95	_
82-160	12950-12955	44.27	_
82-161	12955-12956	 	_
82-162	12956-12957	±	_
82-163	12957-12958	 	_
82-164	12958-12962	9.81	_
82-165	12963-12968	46.76	_
82-166	12968-12969	 	_
82-167	12969-12970	±	_
82-168	12970-12971	 	_
82-169	12971-12975	8.34	_
82-170	12976-12981	98.29	_
82-171	12981-12982	(	_
82-172	12982-12983	<	_
82-173	12983-12988	0.001	_
82-174	12988-12989	)	_
82-175	12990-12991	<	_
82-176	12991-12996	0.001	_
82-177	12997-12998	<	_
82-178	12998-13003	0.001	_
82-179	13004-13008	0.45	_
82-180	13011-13022	Self-Rating	_
82-181	13023-13030	Anxiety	_
82-182	13031-13036	Scale	_
82-183	13037-13038	(	_
82-184	13038-13041	SAS	_
82-185	13041-13042	)	_
82-186	13043-13048	51.33	_
82-187	13048-13049	 	_
82-188	13049-13050	±	_
82-189	13050-13051	 	_
82-190	13051-13056	10.16	_
82-191	13057-13062	39.61	_
82-192	13062-13063	 	_
82-193	13063-13064	±	_
82-194	13064-13065	 	_
82-195	13065-13069	6.39	_
82-196	13070-13075	44.48	_
82-197	13075-13076	 	_
82-198	13076-13077	±	_
82-199	13077-13078	 	_
82-200	13078-13082	8.96	_
82-201	13083-13088	14.09	_
82-202	13088-13089	(	_
82-203	13089-13090	<	_
82-204	13090-13095	0.001	_
82-205	13095-13096	)	_
82-206	13097-13098	<	_
82-207	13098-13103	0.001	_
82-208	13104-13108	0.01	_
82-209	13109-13113	0.08	_
82-210	13116-13127	Self-rating	_
82-211	13128-13138	depression	_
82-212	13139-13144	scale	_
82-213	13145-13146	(	_
82-214	13146-13149	SDS	_
82-215	13149-13150	)	_
82-216	13151-13156	54.56	_
82-217	13156-13157	 	_
82-218	13157-13158	±	_
82-219	13158-13159	 	_
82-220	13159-13164	10.80	_
82-221	13165-13170	43.12	_
82-222	13170-13171	 	_
82-223	13171-13172	±	_
82-224	13172-13173	 	_
82-225	13173-13177	8.85	_
82-226	13178-13183	47.44	_
82-227	13183-13184	 	_
82-228	13184-13185	±	_
82-229	13185-13186	 	_
82-230	13186-13190	9.13	_
82-231	13191-13196	10.66	_
82-232	13196-13197	(	_
82-233	13197-13198	<	_
82-234	13198-13203	0.001	_
82-235	13203-13204	)	_
82-236	13205-13206	<	_
82-237	13206-13211	0.001	_
82-238	13212-13216	0.02	_
82-239	13217-13221	0.24	_
82-240	13224-13231	Barratt	_
82-241	13232-13245	Impulsiveness	_
82-242	13246-13251	Scale	_
82-243	13251-13252	-	_
82-244	13252-13254	11	_
82-245	13255-13256	(	_
82-246	13256-13259	BIS	_
82-247	13259-13260	-	_
82-248	13260-13262	11	_
82-249	13262-13263	)	_
82-250	13264-13269	61.22	_
82-251	13269-13270	 	_
82-252	13270-13271	±	_
82-253	13271-13272	 	_
82-254	13272-13276	8.44	_
82-255	13277-13282	52.82	_
82-256	13282-13283	 	_
82-257	13283-13284	±	_
82-258	13284-13285	 	_
82-259	13285-13289	6.64	_
82-260	13290-13295	52.41	_
82-261	13295-13296	 	_
82-262	13296-13297	±	_
82-263	13297-13298	 	_
82-264	13298-13302	7.50	_
82-265	13303-13308	12.36	_
82-266	13308-13309	(	_
82-267	13309-13310	<	_
82-268	13310-13315	0.001	_
82-269	13315-13316	)	_
82-270	13317-13318	<	_
82-271	13318-13323	0.001	_
82-272	13324-13325	<	_
82-273	13325-13330	0.001	_
82-274	13331-13332	1	_
82-275	13335-13339	FTND	_
82-276	13342-13346	6.52	_
82-277	13346-13347	 	_
82-278	13347-13348	±	_
82-279	13348-13349	 	_
82-280	13349-13353	2.11	_
82-281	13361-13362	p	_
82-282	13363-13364	1	_
82-283	13364-13365	-	_
82-284	13365-13366	2	_
82-285	13367-13370	for	_
82-286	13371-13374	IGD	_
82-287	13375-13380	group	_
82-288	13381-13387	versus	_
82-289	13388-13390	HC	_
82-290	13391-13396	group	_
82-291	13396-13397	,	_
82-292	13398-13399	p	_
82-293	13400-13401	1	_
82-294	13401-13402	-	_
82-295	13402-13403	3	_
82-296	13404-13407	for	_
82-297	13408-13411	IGD	_
82-298	13412-13417	group	_
82-299	13418-13424	versus	_
82-300	13425-13428	SND	_
82-301	13429-13434	group	_
82-302	13434-13435	,	_
82-303	13436-13437	p	_
82-304	13438-13439	2	_
82-305	13439-13440	-	_
82-306	13440-13441	3	_
82-307	13442-13445	for	_
82-308	13446-13448	HC	_
82-309	13449-13454	group	_
82-310	13455-13461	versus	_
82-311	13462-13465	SND	_
82-312	13466-13471	group	_
82-313	13473-13475	SD	_
82-314	13476-13484	standard	_
82-315	13485-13494	deviation	_
82-316	13494-13495	,	_
82-317	13496-13498	HC	_
82-318	13499-13506	healthy	_
82-319	13507-13514	control	_
82-320	13514-13515	,	_
82-321	13516-13519	IGD	_
82-322	13520-13528	internet	_
82-323	13529-13535	gaming	_
82-324	13536-13544	disorder	_
82-325	13544-13545	,	_
82-326	13546-13549	SND	_
82-327	13550-13557	smokers	_
82-328	13558-13562	with	_
82-329	13563-13571	nicotine	_
82-330	13572-13582	dependence	_
82-331	13582-13583	,	_
82-332	13584-13588	FTND	_
82-333	13589-13599	Fagerstrom	_
82-334	13600-13604	test	_
82-335	13605-13607	of	_
82-336	13608-13616	nicotine	_
82-337	13617-13627	dependence	_
82-338	13628-13633	Table	_
82-339	13633-13634	 	_
82-340	13634-13635	1	_
82-341	13636-13642	listed	_
82-342	13643-13646	the	_
82-343	13647-13658	demographic	_
82-344	13659-13662	and	_
82-345	13663-13671	clinical	_
82-346	13672-13680	measures	_
82-347	13681-13684	for	_
82-348	13685-13689	each	_
82-349	13690-13695	group	_
82-350	13695-13696	.	_

#Text=No significant difference was observed between the IGD and HC groups in terms of age and years of education.
83-1	13697-13699	No	_
83-2	13700-13711	significant	_
83-3	13712-13722	difference	_
83-4	13723-13726	was	_
83-5	13727-13735	observed	_
83-6	13736-13743	between	_
83-7	13744-13747	the	_
83-8	13748-13751	IGD	_
83-9	13752-13755	and	_
83-10	13756-13758	HC	_
83-11	13759-13765	groups	_
83-12	13766-13768	in	_
83-13	13769-13774	terms	_
83-14	13775-13777	of	_
83-15	13778-13781	age	_
83-16	13782-13785	and	_
83-17	13786-13791	years	_
83-18	13792-13794	of	_
83-19	13795-13804	education	_
83-20	13804-13805	.	_

#Text=However, significant differences were found between the IGD and SND groups and between the HC and SND groups.
84-1	13806-13813	However	_
84-2	13813-13814	,	_
84-3	13815-13826	significant	_
84-4	13827-13838	differences	_
84-5	13839-13843	were	_
84-6	13844-13849	found	_
84-7	13850-13857	between	_
84-8	13858-13861	the	_
84-9	13862-13865	IGD	_
84-10	13866-13869	and	_
84-11	13870-13873	SND	_
84-12	13874-13880	groups	_
84-13	13881-13884	and	_
84-14	13885-13892	between	_
84-15	13893-13896	the	_
84-16	13897-13899	HC	_
84-17	13900-13903	and	_
84-18	13904-13907	SND	_
84-19	13908-13914	groups	_
84-20	13914-13915	.	_

#Text=Difference with respect to sex was obtained because no female smoker participated in the study.
85-1	13916-13926	Difference	_
85-2	13927-13931	with	_
85-3	13932-13939	respect	_
85-4	13940-13942	to	_
85-5	13943-13946	sex	_
85-6	13947-13950	was	_
85-7	13951-13959	obtained	_
85-8	13960-13967	because	_
85-9	13968-13970	no	_
85-10	13971-13977	female	_
85-11	13978-13984	smoker	_
85-12	13985-13997	participated	_
85-13	13998-14000	in	_
85-14	14001-14004	the	_
85-15	14005-14010	study	_
85-16	14010-14011	.	_

#Text=The IGD subjects had higher CIAS, SAS, SDS, and BIS-11 compared with other 2 groups.
86-1	14012-14015	The	_
86-2	14016-14019	IGD	_
86-3	14020-14028	subjects	_
86-4	14029-14032	had	_
86-5	14033-14039	higher	_
86-6	14040-14044	CIAS	_
86-7	14044-14045	,	_
86-8	14046-14049	SAS	_
86-9	14049-14050	,	_
86-10	14051-14054	SDS	_
86-11	14054-14055	,	_
86-12	14056-14059	and	_
86-13	14060-14063	BIS	_
86-14	14063-14064	-	_
86-15	14064-14066	11	_
86-16	14067-14075	compared	_
86-17	14076-14080	with	_
86-18	14081-14086	other	_
86-19	14087-14088	2	_
86-20	14089-14095	groups	_
86-21	14095-14096	.	_

#Text=DLPFC connectivity analysis
#Text=One-way ANOVA analysis in three groups
#Text=Significant differences in functional connectivity of different brain regions with DLPFC changes among the three groups
#Text=\tPeak MNI coordinate region\tPeak MNI coordinates\tNumber of cluster voxels\tPeak F value\t \tx\ty\tz\t \t1\tLeft inferior temporal gyrus (BA20)\t−51\t−15\t−27\t29\t15.69\t \t2\tLeft insula (BA48)\t−36\t16\t−11\t20\t8.46\t \t3\tLeft inferior frontal gyrus (BA45)\t−51\t27\t6\t22\t14.70\t \t4\tRight middle temporal gyrus (BA19)\t42\t−72\t0\t47\t21.28\t \t5\tRight supramarginal gyrus (BA40)\t63\t−48\t27\t30\t11.32\t \t6\tRight cuneus (BA19)\t15\t−84\t30\t75\t13.43\t \t7\tRight superior orbital frontal gyrus (BA11)\t15\t54\t−21\t39\t13.96\t \t8\tRight insula (BA47)\t27\t21\t−18\t22\t13.61\t \t9\tRight inferior orbital frontal gyrus (BA38)\t48\t27\t−12\t61\t10.56\t \t10\tRight superior frontal gyrus (BA9)\t24\t42\t42\t15\t9.68\t \t
#Text=
#Text=MNI Montreal Neurological Institute, BA Brodmann’s area, DLPFC dorsolateral prefrontal cortex
#Text=
#Text=p < 0.05, AlphaSim-corrected
#Text=Significant differences in functional connectivity of different brain regions with DLPFC changes among the three groups.
87-1	14098-14103	DLPFC	_
87-2	14104-14116	connectivity	_
87-3	14117-14125	analysis	_
87-4	14126-14133	One-way	_
87-5	14134-14139	ANOVA	_
87-6	14140-14148	analysis	_
87-7	14149-14151	in	_
87-8	14152-14157	three	_
87-9	14158-14164	groups	_
87-10	14165-14176	Significant	_
87-11	14177-14188	differences	_
87-12	14189-14191	in	_
87-13	14192-14202	functional	_
87-14	14203-14215	connectivity	_
87-15	14216-14218	of	_
87-16	14219-14228	different	_
87-17	14229-14234	brain	_
87-18	14235-14242	regions	_
87-19	14243-14247	with	_
87-20	14248-14253	DLPFC	_
87-21	14254-14261	changes	_
87-22	14262-14267	among	_
87-23	14268-14271	the	_
87-24	14272-14277	three	_
87-25	14278-14284	groups	_
87-26	14286-14290	Peak	_
87-27	14291-14294	MNI	_
87-28	14295-14305	coordinate	_
87-29	14306-14312	region	_
87-30	14313-14317	Peak	_
87-31	14318-14321	MNI	_
87-32	14322-14333	coordinates	_
87-33	14334-14340	Number	_
87-34	14341-14343	of	_
87-35	14344-14351	cluster	_
87-36	14352-14358	voxels	_
87-37	14359-14363	Peak	_
87-38	14364-14365	F	_
87-39	14366-14371	value	_
87-40	14374-14375	x	_
87-41	14376-14377	y	_
87-42	14378-14379	z	_
87-43	14382-14383	1	_
87-44	14384-14388	Left	_
87-45	14389-14397	inferior	_
87-46	14398-14406	temporal	_
87-47	14407-14412	gyrus	_
87-48	14413-14414	(	_
87-49	14414-14418	BA20	_
87-50	14418-14419	)	_
87-51	14420-14421	−	_
87-52	14421-14423	51	_
87-53	14424-14425	−	_
87-54	14425-14427	15	_
87-55	14428-14429	−	_
87-56	14429-14431	27	_
87-57	14432-14434	29	_
87-58	14435-14440	15.69	_
87-59	14443-14444	2	_
87-60	14445-14449	Left	_
87-61	14450-14456	insula	_
87-62	14457-14458	(	_
87-63	14458-14462	BA48	_
87-64	14462-14463	)	_
87-65	14464-14465	−	_
87-66	14465-14467	36	_
87-67	14468-14470	16	_
87-68	14471-14472	−	_
87-69	14472-14474	11	_
87-70	14475-14477	20	_
87-71	14478-14482	8.46	_
87-72	14485-14486	3	_
87-73	14487-14491	Left	_
87-74	14492-14500	inferior	_
87-75	14501-14508	frontal	_
87-76	14509-14514	gyrus	_
87-77	14515-14516	(	_
87-78	14516-14520	BA45	_
87-79	14520-14521	)	_
87-80	14522-14523	−	_
87-81	14523-14525	51	_
87-82	14526-14528	27	_
87-83	14529-14530	6	_
87-84	14531-14533	22	_
87-85	14534-14539	14.70	_
87-86	14542-14543	4	_
87-87	14544-14549	Right	_
87-88	14550-14556	middle	_
87-89	14557-14565	temporal	_
87-90	14566-14571	gyrus	_
87-91	14572-14573	(	_
87-92	14573-14577	BA19	_
87-93	14577-14578	)	_
87-94	14579-14581	42	_
87-95	14582-14583	−	_
87-96	14583-14585	72	_
87-97	14586-14587	0	_
87-98	14588-14590	47	_
87-99	14591-14596	21.28	_
87-100	14599-14600	5	_
87-101	14601-14606	Right	_
87-102	14607-14620	supramarginal	_
87-103	14621-14626	gyrus	_
87-104	14627-14628	(	_
87-105	14628-14632	BA40	_
87-106	14632-14633	)	_
87-107	14634-14636	63	_
87-108	14637-14638	−	_
87-109	14638-14640	48	_
87-110	14641-14643	27	_
87-111	14644-14646	30	_
87-112	14647-14652	11.32	_
87-113	14655-14656	6	_
87-114	14657-14662	Right	_
87-115	14663-14669	cuneus	_
87-116	14670-14671	(	_
87-117	14671-14675	BA19	_
87-118	14675-14676	)	_
87-119	14677-14679	15	_
87-120	14680-14681	−	_
87-121	14681-14683	84	_
87-122	14684-14686	30	_
87-123	14687-14689	75	_
87-124	14690-14695	13.43	_
87-125	14698-14699	7	_
87-126	14700-14705	Right	_
87-127	14706-14714	superior	_
87-128	14715-14722	orbital	_
87-129	14723-14730	frontal	_
87-130	14731-14736	gyrus	_
87-131	14737-14738	(	_
87-132	14738-14742	BA11	_
87-133	14742-14743	)	_
87-134	14744-14746	15	_
87-135	14747-14749	54	_
87-136	14750-14751	−	_
87-137	14751-14753	21	_
87-138	14754-14756	39	_
87-139	14757-14762	13.96	_
87-140	14765-14766	8	_
87-141	14767-14772	Right	_
87-142	14773-14779	insula	_
87-143	14780-14781	(	_
87-144	14781-14785	BA47	_
87-145	14785-14786	)	_
87-146	14787-14789	27	_
87-147	14790-14792	21	_
87-148	14793-14794	−	_
87-149	14794-14796	18	_
87-150	14797-14799	22	_
87-151	14800-14805	13.61	_
87-152	14808-14809	9	_
87-153	14810-14815	Right	_
87-154	14816-14824	inferior	_
87-155	14825-14832	orbital	_
87-156	14833-14840	frontal	_
87-157	14841-14846	gyrus	_
87-158	14847-14848	(	_
87-159	14848-14852	BA38	_
87-160	14852-14853	)	_
87-161	14854-14856	48	_
87-162	14857-14859	27	_
87-163	14860-14861	−	_
87-164	14861-14863	12	_
87-165	14864-14866	61	_
87-166	14867-14872	10.56	_
87-167	14875-14877	10	_
87-168	14878-14883	Right	_
87-169	14884-14892	superior	_
87-170	14893-14900	frontal	_
87-171	14901-14906	gyrus	_
87-172	14907-14908	(	_
87-173	14908-14911	BA9	_
87-174	14911-14912	)	_
87-175	14913-14915	24	_
87-176	14916-14918	42	_
87-177	14919-14921	42	_
87-178	14922-14924	15	_
87-179	14925-14929	9.68	_
87-180	14934-14937	MNI	_
87-181	14938-14946	Montreal	_
87-182	14947-14959	Neurological	_
87-183	14960-14969	Institute	_
87-184	14969-14970	,	_
87-185	14971-14973	BA	_
87-186	14974-14982	Brodmann	_
87-187	14982-14983	’	_
87-188	14983-14984	s	_
87-189	14985-14989	area	_
87-190	14989-14990	,	_
87-191	14991-14996	DLPFC	_
87-192	14997-15009	dorsolateral	_
87-193	15010-15020	prefrontal	_
87-194	15021-15027	cortex	_
87-195	15029-15030	p	_
87-196	15030-15031	 	_
87-197	15031-15032	<	_
87-198	15032-15033	 	_
87-199	15033-15037	0.05	_
87-200	15037-15038	,	_
87-201	15039-15057	AlphaSim-corrected	_
87-202	15058-15069	Significant	_
87-203	15070-15081	differences	_
87-204	15082-15084	in	_
87-205	15085-15095	functional	_
87-206	15096-15108	connectivity	_
87-207	15109-15111	of	_
87-208	15112-15121	different	_
87-209	15122-15127	brain	_
87-210	15128-15135	regions	_
87-211	15136-15140	with	_
87-212	15141-15146	DLPFC	_
87-213	15147-15154	changes	_
87-214	15155-15160	among	_
87-215	15161-15164	the	_
87-216	15165-15170	three	_
87-217	15171-15177	groups	_
87-218	15177-15178	.	_

#Text=Note: The left part of figure represents the participant’s right side, and right represents the participant’s left side.
88-1	15179-15183	Note	_
88-2	15183-15184	:	_
88-3	15185-15188	The	_
88-4	15189-15193	left	_
88-5	15194-15198	part	_
88-6	15199-15201	of	_
88-7	15202-15208	figure	_
88-8	15209-15219	represents	_
88-9	15220-15223	the	_
88-10	15224-15235	participant	_
88-11	15235-15236	’	_
88-12	15236-15237	s	_
88-13	15238-15243	right	_
88-14	15244-15248	side	_
88-15	15248-15249	,	_
88-16	15250-15253	and	_
88-17	15254-15259	right	_
88-18	15260-15270	represents	_
88-19	15271-15274	the	_
88-20	15275-15286	participant	_
88-21	15286-15287	’	_
88-22	15287-15288	s	_
88-23	15289-15293	left	_
88-24	15294-15298	side	_
88-25	15298-15299	.	_

#Text=DLPFC dorsolateral prefrontal cortex
#Text=Significant differences were observed among the rsFC with the DLPFC in the left side of inferior temporal gyrus, insula, inferior frontal gyrus, right side of the middle temporal gyrus, supramarginal gyrus, cuneus, superior orbital frontal gyrus, insula, inferior orbital frontal gyrus, and superior frontal gyrus (Table 2; Fig. 1).
89-1	15300-15305	DLPFC	_
89-2	15306-15318	dorsolateral	_
89-3	15319-15329	prefrontal	_
89-4	15330-15336	cortex	_
89-5	15337-15348	Significant	_
89-6	15349-15360	differences	_
89-7	15361-15365	were	_
89-8	15366-15374	observed	_
89-9	15375-15380	among	_
89-10	15381-15384	the	_
89-11	15385-15389	rsFC	_
89-12	15390-15394	with	_
89-13	15395-15398	the	_
89-14	15399-15404	DLPFC	_
89-15	15405-15407	in	_
89-16	15408-15411	the	_
89-17	15412-15416	left	_
89-18	15417-15421	side	_
89-19	15422-15424	of	_
89-20	15425-15433	inferior	_
89-21	15434-15442	temporal	_
89-22	15443-15448	gyrus	_
89-23	15448-15449	,	_
89-24	15450-15456	insula	_
89-25	15456-15457	,	_
89-26	15458-15466	inferior	_
89-27	15467-15474	frontal	_
89-28	15475-15480	gyrus	_
89-29	15480-15481	,	_
89-30	15482-15487	right	_
89-31	15488-15492	side	_
89-32	15493-15495	of	_
89-33	15496-15499	the	_
89-34	15500-15506	middle	_
89-35	15507-15515	temporal	_
89-36	15516-15521	gyrus	_
89-37	15521-15522	,	_
89-38	15523-15536	supramarginal	_
89-39	15537-15542	gyrus	_
89-40	15542-15543	,	_
89-41	15544-15550	cuneus	_
89-42	15550-15551	,	_
89-43	15552-15560	superior	_
89-44	15561-15568	orbital	_
89-45	15569-15576	frontal	_
89-46	15577-15582	gyrus	_
89-47	15582-15583	,	_
89-48	15584-15590	insula	_
89-49	15590-15591	,	_
89-50	15592-15600	inferior	_
89-51	15601-15608	orbital	_
89-52	15609-15616	frontal	_
89-53	15617-15622	gyrus	_
89-54	15622-15623	,	_
89-55	15624-15627	and	_
89-56	15628-15636	superior	_
89-57	15637-15644	frontal	_
89-58	15645-15650	gyrus	_
89-59	15651-15652	(	_
89-60	15652-15657	Table	_
89-61	15657-15658	 	_
89-62	15658-15659	2	_
89-63	15659-15660	;	_
89-64	15661-15664	Fig	_
89-65	15664-15665	.	_
89-66	15665-15666	 	_
89-67	15666-15667	1	_
89-68	15667-15668	)	_
89-69	15668-15669	.	_

#Text=Between-group analysis of DLPFC connectivity: IGD versus HC
#Text=Summary of functional connectivity with DLPFC changes in IGD compared with the HC group
#Text=\tPeak MNI coordinate region\tPeak MNI coordinates\tNumber of cluster voxels\tPeak t value\t \tx\ty\tz\t \t1\tLeft inferior temporal gyrus (BA20)\t−54\t−21\t−27\t29\t4.14\t \t2\tRight superior temporal gyrus (BA38)\t48\t24\t−21\t14\t2.51\t \t3\tRight middle frontal gyrus (BA9)\t27\t42\t42\t15\t3.15\t \t4\tLeft inferior frontal gyrus (BA45)\t−45\t24\t0\t22\t−2.81\t \t5\tRight medial frontal orbital lobe (BA11)\t18\t57\t−18\t16\t−1.88\t \t6\tRight insula (BA48)\t27\t15\t−18\t21\t−2.22\t \t7\tRight middle occipital gyrus (BA19)\t39\t−75\t3\t47\t−2.26\t \t8\tRight superior temporal gyrus (BA22)\t65\t−45\t24\t30\t−3.62\t \t9\tRight cuneus (BA19)\t18\t−84\t27\t67\t−3.67\t \t
#Text=
#Text=t > 0 indicates IGD group >HC group in functional connectivity, t < 0 indicates IGD group <HC group in functional connectivity with DLPFC
#Text=
#Text=MNI Montreal Neurological Institute, BA Brodmann’s area, DLPFC dorsolateral prefrontal cortex, IGD internet gaming disorder, HC healthy control
#Text=p < 0.05, AlphaSim-corrected
#Text=Significant between-group differences in functional connectivity of different brain regions with DLPFC between the IDG with HC subjects.
90-1	15672-15685	Between-group	_
90-2	15686-15694	analysis	_
90-3	15695-15697	of	_
90-4	15698-15703	DLPFC	_
90-5	15704-15716	connectivity	_
90-6	15716-15717	:	_
90-7	15718-15721	IGD	_
90-8	15722-15728	versus	_
90-9	15729-15731	HC	_
90-10	15732-15739	Summary	_
90-11	15740-15742	of	_
90-12	15743-15753	functional	_
90-13	15754-15766	connectivity	_
90-14	15767-15771	with	_
90-15	15772-15777	DLPFC	_
90-16	15778-15785	changes	_
90-17	15786-15788	in	_
90-18	15789-15792	IGD	_
90-19	15793-15801	compared	_
90-20	15802-15806	with	_
90-21	15807-15810	the	_
90-22	15811-15813	HC	_
90-23	15814-15819	group	_
90-24	15821-15825	Peak	_
90-25	15826-15829	MNI	_
90-26	15830-15840	coordinate	_
90-27	15841-15847	region	_
90-28	15848-15852	Peak	_
90-29	15853-15856	MNI	_
90-30	15857-15868	coordinates	_
90-31	15869-15875	Number	_
90-32	15876-15878	of	_
90-33	15879-15886	cluster	_
90-34	15887-15893	voxels	_
90-35	15894-15898	Peak	_
90-36	15899-15900	t	_
90-37	15901-15906	value	_
90-38	15909-15910	x	_
90-39	15911-15912	y	_
90-40	15913-15914	z	_
90-41	15917-15918	1	_
90-42	15919-15923	Left	_
90-43	15924-15932	inferior	_
90-44	15933-15941	temporal	_
90-45	15942-15947	gyrus	_
90-46	15948-15949	(	_
90-47	15949-15953	BA20	_
90-48	15953-15954	)	_
90-49	15955-15956	−	_
90-50	15956-15958	54	_
90-51	15959-15960	−	_
90-52	15960-15962	21	_
90-53	15963-15964	−	_
90-54	15964-15966	27	_
90-55	15967-15969	29	_
90-56	15970-15974	4.14	_
90-57	15977-15978	2	_
90-58	15979-15984	Right	_
90-59	15985-15993	superior	_
90-60	15994-16002	temporal	_
90-61	16003-16008	gyrus	_
90-62	16009-16010	(	_
90-63	16010-16014	BA38	_
90-64	16014-16015	)	_
90-65	16016-16018	48	_
90-66	16019-16021	24	_
90-67	16022-16023	−	_
90-68	16023-16025	21	_
90-69	16026-16028	14	_
90-70	16029-16033	2.51	_
90-71	16036-16037	3	_
90-72	16038-16043	Right	_
90-73	16044-16050	middle	_
90-74	16051-16058	frontal	_
90-75	16059-16064	gyrus	_
90-76	16065-16066	(	_
90-77	16066-16069	BA9	_
90-78	16069-16070	)	_
90-79	16071-16073	27	_
90-80	16074-16076	42	_
90-81	16077-16079	42	_
90-82	16080-16082	15	_
90-83	16083-16087	3.15	_
90-84	16090-16091	4	_
90-85	16092-16096	Left	_
90-86	16097-16105	inferior	_
90-87	16106-16113	frontal	_
90-88	16114-16119	gyrus	_
90-89	16120-16121	(	_
90-90	16121-16125	BA45	_
90-91	16125-16126	)	_
90-92	16127-16128	−	_
90-93	16128-16130	45	_
90-94	16131-16133	24	_
90-95	16134-16135	0	_
90-96	16136-16138	22	_
90-97	16139-16140	−	_
90-98	16140-16144	2.81	_
90-99	16147-16148	5	_
90-100	16149-16154	Right	_
90-101	16155-16161	medial	_
90-102	16162-16169	frontal	_
90-103	16170-16177	orbital	_
90-104	16178-16182	lobe	_
90-105	16183-16184	(	_
90-106	16184-16188	BA11	_
90-107	16188-16189	)	_
90-108	16190-16192	18	_
90-109	16193-16195	57	_
90-110	16196-16197	−	_
90-111	16197-16199	18	_
90-112	16200-16202	16	_
90-113	16203-16204	−	_
90-114	16204-16208	1.88	_
90-115	16211-16212	6	_
90-116	16213-16218	Right	_
90-117	16219-16225	insula	_
90-118	16226-16227	(	_
90-119	16227-16231	BA48	_
90-120	16231-16232	)	_
90-121	16233-16235	27	_
90-122	16236-16238	15	_
90-123	16239-16240	−	_
90-124	16240-16242	18	_
90-125	16243-16245	21	_
90-126	16246-16247	−	_
90-127	16247-16251	2.22	_
90-128	16254-16255	7	_
90-129	16256-16261	Right	_
90-130	16262-16268	middle	_
90-131	16269-16278	occipital	_
90-132	16279-16284	gyrus	_
90-133	16285-16286	(	_
90-134	16286-16290	BA19	_
90-135	16290-16291	)	_
90-136	16292-16294	39	_
90-137	16295-16296	−	_
90-138	16296-16298	75	_
90-139	16299-16300	3	_
90-140	16301-16303	47	_
90-141	16304-16305	−	_
90-142	16305-16309	2.26	_
90-143	16312-16313	8	_
90-144	16314-16319	Right	_
90-145	16320-16328	superior	_
90-146	16329-16337	temporal	_
90-147	16338-16343	gyrus	_
90-148	16344-16345	(	_
90-149	16345-16349	BA22	_
90-150	16349-16350	)	_
90-151	16351-16353	65	_
90-152	16354-16355	−	_
90-153	16355-16357	45	_
90-154	16358-16360	24	_
90-155	16361-16363	30	_
90-156	16364-16365	−	_
90-157	16365-16369	3.62	_
90-158	16372-16373	9	_
90-159	16374-16379	Right	_
90-160	16380-16386	cuneus	_
90-161	16387-16388	(	_
90-162	16388-16392	BA19	_
90-163	16392-16393	)	_
90-164	16394-16396	18	_
90-165	16397-16398	−	_
90-166	16398-16400	84	_
90-167	16401-16403	27	_
90-168	16404-16406	67	_
90-169	16407-16408	−	_
90-170	16408-16412	3.67	_
90-171	16417-16418	t	_
90-172	16418-16419	 	_
90-173	16419-16420	>	_
90-174	16420-16421	 	_
90-175	16421-16422	0	_
90-176	16423-16432	indicates	_
90-177	16433-16436	IGD	_
90-178	16437-16442	group	_
90-179	16443-16444	>	_
90-180	16444-16446	HC	_
90-181	16447-16452	group	_
90-182	16453-16455	in	_
90-183	16456-16466	functional	_
90-184	16467-16479	connectivity	_
90-185	16479-16480	,	_
90-186	16481-16482	t	_
90-187	16482-16483	 	_
90-188	16483-16484	<	_
90-189	16484-16485	 	_
90-190	16485-16486	0	_
90-191	16487-16496	indicates	_
90-192	16497-16500	IGD	_
90-193	16501-16506	group	_
90-194	16507-16508	<	_
90-195	16508-16510	HC	_
90-196	16511-16516	group	_
90-197	16517-16519	in	_
90-198	16520-16530	functional	_
90-199	16531-16543	connectivity	_
90-200	16544-16548	with	_
90-201	16549-16554	DLPFC	_
90-202	16556-16559	MNI	_
90-203	16560-16568	Montreal	_
90-204	16569-16581	Neurological	_
90-205	16582-16591	Institute	_
90-206	16591-16592	,	_
90-207	16593-16595	BA	_
90-208	16596-16604	Brodmann	_
90-209	16604-16605	’	_
90-210	16605-16606	s	_
90-211	16607-16611	area	_
90-212	16611-16612	,	_
90-213	16613-16618	DLPFC	_
90-214	16619-16631	dorsolateral	_
90-215	16632-16642	prefrontal	_
90-216	16643-16649	cortex	_
90-217	16649-16650	,	_
90-218	16651-16654	IGD	_
90-219	16655-16663	internet	_
90-220	16664-16670	gaming	_
90-221	16671-16679	disorder	_
90-222	16679-16680	,	_
90-223	16681-16683	HC	_
90-224	16684-16691	healthy	_
90-225	16692-16699	control	_
90-226	16700-16701	p	_
90-227	16701-16702	 	_
90-228	16702-16703	<	_
90-229	16703-16704	 	_
90-230	16704-16708	0.05	_
90-231	16708-16709	,	_
90-232	16710-16728	AlphaSim-corrected	_
90-233	16729-16740	Significant	_
90-234	16741-16754	between-group	_
90-235	16755-16766	differences	_
90-236	16767-16769	in	_
90-237	16770-16780	functional	_
90-238	16781-16793	connectivity	_
90-239	16794-16796	of	_
90-240	16797-16806	different	_
90-241	16807-16812	brain	_
90-242	16813-16820	regions	_
90-243	16821-16825	with	_
90-244	16826-16831	DLPFC	_
90-245	16832-16839	between	_
90-246	16840-16843	the	_
90-247	16844-16847	IDG	_
90-248	16848-16852	with	_
90-249	16853-16855	HC	_
90-250	16856-16864	subjects	_
90-251	16864-16865	.	_

#Text=The t-score bars are shown on the left.
91-1	16866-16869	The	_
91-2	16870-16877	t-score	_
91-3	16878-16882	bars	_
91-4	16883-16886	are	_
91-5	16887-16892	shown	_
91-6	16893-16895	on	_
91-7	16896-16899	the	_
91-8	16900-16904	left	_
91-9	16904-16905	.	_

#Text=Red indicates IGD > HC, and blue indicates IDG < HC.
92-1	16906-16909	Red	_
92-2	16910-16919	indicates	_
92-3	16920-16923	IGD	_
92-4	16923-16924	 	_
92-5	16924-16925	>	_
92-6	16925-16926	 	_
92-7	16926-16928	HC	_
92-8	16928-16929	,	_
92-9	16930-16933	and	_
92-10	16934-16938	blue	_
92-11	16939-16948	indicates	_
92-12	16949-16952	IDG	_
92-13	16952-16953	 	_
92-14	16953-16954	<	_
92-15	16954-16955	 	_
92-16	16955-16957	HC	_
92-17	16957-16958	.	_

#Text=Note: The left part of figure represents the participant’s right side, and right represents the participant’s left side.
93-1	16959-16963	Note	_
93-2	16963-16964	:	_
93-3	16965-16968	The	_
93-4	16969-16973	left	_
93-5	16974-16978	part	_
93-6	16979-16981	of	_
93-7	16982-16988	figure	_
93-8	16989-16999	represents	_
93-9	17000-17003	the	_
93-10	17004-17015	participant	_
93-11	17015-17016	’	_
93-12	17016-17017	s	_
93-13	17018-17023	right	_
93-14	17024-17028	side	_
93-15	17028-17029	,	_
93-16	17030-17033	and	_
93-17	17034-17039	right	_
93-18	17040-17050	represents	_
93-19	17051-17054	the	_
93-20	17055-17066	participant	_
93-21	17066-17067	’	_
93-22	17067-17068	s	_
93-23	17069-17073	left	_
93-24	17074-17078	side	_
93-25	17078-17079	.	_

#Text=DLPFC dorsolateral prefrontal cortex, IGD internet gaming disorder, HC healthy control
#Text=The IGD group exhibited significantly increased rsFC in left inferior temporal gyrus, right superior temporal gyrus, and right middle frontal gyrus with the DLPFC, compared with the HC group.
94-1	17080-17085	DLPFC	_
94-2	17086-17098	dorsolateral	_
94-3	17099-17109	prefrontal	_
94-4	17110-17116	cortex	_
94-5	17116-17117	,	_
94-6	17118-17121	IGD	_
94-7	17122-17130	internet	_
94-8	17131-17137	gaming	_
94-9	17138-17146	disorder	_
94-10	17146-17147	,	_
94-11	17148-17150	HC	_
94-12	17151-17158	healthy	_
94-13	17159-17166	control	_
94-14	17167-17170	The	_
94-15	17171-17174	IGD	_
94-16	17175-17180	group	_
94-17	17181-17190	exhibited	_
94-18	17191-17204	significantly	_
94-19	17205-17214	increased	_
94-20	17215-17219	rsFC	_
94-21	17220-17222	in	_
94-22	17223-17227	left	_
94-23	17228-17236	inferior	_
94-24	17237-17245	temporal	_
94-25	17246-17251	gyrus	_
94-26	17251-17252	,	_
94-27	17253-17258	right	_
94-28	17259-17267	superior	_
94-29	17268-17276	temporal	_
94-30	17277-17282	gyrus	_
94-31	17282-17283	,	_
94-32	17284-17287	and	_
94-33	17288-17293	right	_
94-34	17294-17300	middle	_
94-35	17301-17308	frontal	_
94-36	17309-17314	gyrus	_
94-37	17315-17319	with	_
94-38	17320-17323	the	_
94-39	17324-17329	DLPFC	_
94-40	17329-17330	,	_
94-41	17331-17339	compared	_
94-42	17340-17344	with	_
94-43	17345-17348	the	_
94-44	17349-17351	HC	_
94-45	17352-17357	group	_
94-46	17357-17358	.	_

#Text=In addition, decreased rsFC was found in the left inferior frontal lobe, right side of the medial frontal orbital gyrus, insula, middle occipital gyrus, superior temporal gyrus, and cuneus with the DLPFC (Table 3; Fig. 2).
95-1	17359-17361	In	_
95-2	17362-17370	addition	_
95-3	17370-17371	,	_
95-4	17372-17381	decreased	_
95-5	17382-17386	rsFC	_
95-6	17387-17390	was	_
95-7	17391-17396	found	_
95-8	17397-17399	in	_
95-9	17400-17403	the	_
95-10	17404-17408	left	_
95-11	17409-17417	inferior	_
95-12	17418-17425	frontal	_
95-13	17426-17430	lobe	_
95-14	17430-17431	,	_
95-15	17432-17437	right	_
95-16	17438-17442	side	_
95-17	17443-17445	of	_
95-18	17446-17449	the	_
95-19	17450-17456	medial	_
95-20	17457-17464	frontal	_
95-21	17465-17472	orbital	_
95-22	17473-17478	gyrus	_
95-23	17478-17479	,	_
95-24	17480-17486	insula	_
95-25	17486-17487	,	_
95-26	17488-17494	middle	_
95-27	17495-17504	occipital	_
95-28	17505-17510	gyrus	_
95-29	17510-17511	,	_
95-30	17512-17520	superior	_
95-31	17521-17529	temporal	_
95-32	17530-17535	gyrus	_
95-33	17535-17536	,	_
95-34	17537-17540	and	_
95-35	17541-17547	cuneus	_
95-36	17548-17552	with	_
95-37	17553-17556	the	_
95-38	17557-17562	DLPFC	_
95-39	17563-17564	(	_
95-40	17564-17569	Table	_
95-41	17569-17570	 	_
95-42	17570-17571	3	_
95-43	17571-17572	;	_
95-44	17573-17576	Fig	_
95-45	17576-17577	.	_
95-46	17577-17578	 	_
95-47	17578-17579	2	_
95-48	17579-17580	)	_
95-49	17580-17581	.	_

#Text=Between-group analysis of DLPFC connectivity: SND versus HC
#Text=Summary of functional connectivity with DLPFC changes in SND group compared with the HC group
#Text=\tPeak MNI coordinate region\tPeak MNI coordinates\tNumber of cluster voxels\tPeak t value\t \tx\ty\tz\t \t1\tLeft inferior frontal gyrus (BA45)\t−51\t27\t6\t20\t−5.47\t \t2\tLeft insula (BA48)\t−42\t15\t−9\t13\t−4.10\t \t3\tRight insula (BA47)\t27\t21\t−18\t21\t−5.41\t \t4\tRight inferior orbital frontal gyrus (BA38)\t48\t27\t−12\t27\t−5.70\t \t
#Text=
#Text=t < 0 indicates SND group <HC group in functional connectivity with DLPFC
#Text=
#Text=MNI Montreal Neurological Institute, BA Brodmann’s area, DLPFC dorsolateral prefrontal cortex, SND smokers with nicotine dependence, HC healthy control
#Text=
#Text=p < 0.05, AlphaSim-corrected
#Text=Significant between-group differences in functional connectivity of different brain regions with DLPFC between SND and HC subjects.
96-1	17584-17597	Between-group	_
96-2	17598-17606	analysis	_
96-3	17607-17609	of	_
96-4	17610-17615	DLPFC	_
96-5	17616-17628	connectivity	_
96-6	17628-17629	:	_
96-7	17630-17633	SND	_
96-8	17634-17640	versus	_
96-9	17641-17643	HC	_
96-10	17644-17651	Summary	_
96-11	17652-17654	of	_
96-12	17655-17665	functional	_
96-13	17666-17678	connectivity	_
96-14	17679-17683	with	_
96-15	17684-17689	DLPFC	_
96-16	17690-17697	changes	_
96-17	17698-17700	in	_
96-18	17701-17704	SND	_
96-19	17705-17710	group	_
96-20	17711-17719	compared	_
96-21	17720-17724	with	_
96-22	17725-17728	the	_
96-23	17729-17731	HC	_
96-24	17732-17737	group	_
96-25	17739-17743	Peak	_
96-26	17744-17747	MNI	_
96-27	17748-17758	coordinate	_
96-28	17759-17765	region	_
96-29	17766-17770	Peak	_
96-30	17771-17774	MNI	_
96-31	17775-17786	coordinates	_
96-32	17787-17793	Number	_
96-33	17794-17796	of	_
96-34	17797-17804	cluster	_
96-35	17805-17811	voxels	_
96-36	17812-17816	Peak	_
96-37	17817-17818	t	_
96-38	17819-17824	value	_
96-39	17827-17828	x	_
96-40	17829-17830	y	_
96-41	17831-17832	z	_
96-42	17835-17836	1	_
96-43	17837-17841	Left	_
96-44	17842-17850	inferior	_
96-45	17851-17858	frontal	_
96-46	17859-17864	gyrus	_
96-47	17865-17866	(	_
96-48	17866-17870	BA45	_
96-49	17870-17871	)	_
96-50	17872-17873	−	_
96-51	17873-17875	51	_
96-52	17876-17878	27	_
96-53	17879-17880	6	_
96-54	17881-17883	20	_
96-55	17884-17885	−	_
96-56	17885-17889	5.47	_
96-57	17892-17893	2	_
96-58	17894-17898	Left	_
96-59	17899-17905	insula	_
96-60	17906-17907	(	_
96-61	17907-17911	BA48	_
96-62	17911-17912	)	_
96-63	17913-17914	−	_
96-64	17914-17916	42	_
96-65	17917-17919	15	_
96-66	17920-17921	−	_
96-67	17921-17922	9	_
96-68	17923-17925	13	_
96-69	17926-17927	−	_
96-70	17927-17931	4.10	_
96-71	17934-17935	3	_
96-72	17936-17941	Right	_
96-73	17942-17948	insula	_
96-74	17949-17950	(	_
96-75	17950-17954	BA47	_
96-76	17954-17955	)	_
96-77	17956-17958	27	_
96-78	17959-17961	21	_
96-79	17962-17963	−	_
96-80	17963-17965	18	_
96-81	17966-17968	21	_
96-82	17969-17970	−	_
96-83	17970-17974	5.41	_
96-84	17977-17978	4	_
96-85	17979-17984	Right	_
96-86	17985-17993	inferior	_
96-87	17994-18001	orbital	_
96-88	18002-18009	frontal	_
96-89	18010-18015	gyrus	_
96-90	18016-18017	(	_
96-91	18017-18021	BA38	_
96-92	18021-18022	)	_
96-93	18023-18025	48	_
96-94	18026-18028	27	_
96-95	18029-18030	−	_
96-96	18030-18032	12	_
96-97	18033-18035	27	_
96-98	18036-18037	−	_
96-99	18037-18041	5.70	_
96-100	18046-18047	t	_
96-101	18047-18048	 	_
96-102	18048-18049	<	_
96-103	18049-18050	 	_
96-104	18050-18051	0	_
96-105	18052-18061	indicates	_
96-106	18062-18065	SND	_
96-107	18066-18071	group	_
96-108	18072-18073	<	_
96-109	18073-18075	HC	_
96-110	18076-18081	group	_
96-111	18082-18084	in	_
96-112	18085-18095	functional	_
96-113	18096-18108	connectivity	_
96-114	18109-18113	with	_
96-115	18114-18119	DLPFC	_
96-116	18121-18124	MNI	_
96-117	18125-18133	Montreal	_
96-118	18134-18146	Neurological	_
96-119	18147-18156	Institute	_
96-120	18156-18157	,	_
96-121	18158-18160	BA	_
96-122	18161-18169	Brodmann	_
96-123	18169-18170	’	_
96-124	18170-18171	s	_
96-125	18172-18176	area	_
96-126	18176-18177	,	_
96-127	18178-18183	DLPFC	_
96-128	18184-18196	dorsolateral	_
96-129	18197-18207	prefrontal	_
96-130	18208-18214	cortex	_
96-131	18214-18215	,	_
96-132	18216-18219	SND	_
96-133	18220-18227	smokers	_
96-134	18228-18232	with	_
96-135	18233-18241	nicotine	_
96-136	18242-18252	dependence	_
96-137	18252-18253	,	_
96-138	18254-18256	HC	_
96-139	18257-18264	healthy	_
96-140	18265-18272	control	_
96-141	18274-18275	p	_
96-142	18275-18276	 	_
96-143	18276-18277	<	_
96-144	18277-18278	 	_
96-145	18278-18282	0.05	_
96-146	18282-18283	,	_
96-147	18284-18302	AlphaSim-corrected	_
96-148	18303-18314	Significant	_
96-149	18315-18328	between-group	_
96-150	18329-18340	differences	_
96-151	18341-18343	in	_
96-152	18344-18354	functional	_
96-153	18355-18367	connectivity	_
96-154	18368-18370	of	_
96-155	18371-18380	different	_
96-156	18381-18386	brain	_
96-157	18387-18394	regions	_
96-158	18395-18399	with	_
96-159	18400-18405	DLPFC	_
96-160	18406-18413	between	_
96-161	18414-18417	SND	_
96-162	18418-18421	and	_
96-163	18422-18424	HC	_
96-164	18425-18433	subjects	_
96-165	18433-18434	.	_

#Text=The t-score bar is shown on the left.
97-1	18435-18438	The	_
97-2	18439-18446	t-score	_
97-3	18447-18450	bar	_
97-4	18451-18453	is	_
97-5	18454-18459	shown	_
97-6	18460-18462	on	_
97-7	18463-18466	the	_
97-8	18467-18471	left	_
97-9	18471-18472	.	_

#Text=Blue indicates SND group < HC.
98-1	18473-18477	Blue	_
98-2	18478-18487	indicates	_
98-3	18488-18491	SND	_
98-4	18492-18497	group	_
98-5	18497-18498	 	_
98-6	18498-18499	<	_
98-7	18499-18500	 	_
98-8	18500-18502	HC	_
98-9	18502-18503	.	_

#Text=Note: The left part of figure represents the participant’s right side, and right represents the participant’s left side.
99-1	18504-18508	Note	_
99-2	18508-18509	:	_
99-3	18510-18513	The	_
99-4	18514-18518	left	_
99-5	18519-18523	part	_
99-6	18524-18526	of	_
99-7	18527-18533	figure	_
99-8	18534-18544	represents	_
99-9	18545-18548	the	_
99-10	18549-18560	participant	_
99-11	18560-18561	’	_
99-12	18561-18562	s	_
99-13	18563-18568	right	_
99-14	18569-18573	side	_
99-15	18573-18574	,	_
99-16	18575-18578	and	_
99-17	18579-18584	right	_
99-18	18585-18595	represents	_
99-19	18596-18599	the	_
99-20	18600-18611	participant	_
99-21	18611-18612	’	_
99-22	18612-18613	s	_
99-23	18614-18618	left	_
99-24	18619-18623	side	_
99-25	18623-18624	.	_

#Text=DLPFC dorsolateral prefrontal cortex, SND smokers with nicotine dependence, HC healthy control
#Text=The SND group showed significantly decreased rsFC in bilateral insula, left inferior frontal gyrus, and right inferior orbital frontal gyrus with the DLPFC (Table 4; Fig. 3).
100-1	18625-18630	DLPFC	_
100-2	18631-18643	dorsolateral	_
100-3	18644-18654	prefrontal	_
100-4	18655-18661	cortex	_
100-5	18661-18662	,	_
100-6	18663-18666	SND	_
100-7	18667-18674	smokers	_
100-8	18675-18679	with	_
100-9	18680-18688	nicotine	_
100-10	18689-18699	dependence	_
100-11	18699-18700	,	_
100-12	18701-18703	HC	_
100-13	18704-18711	healthy	_
100-14	18712-18719	control	_
100-15	18720-18723	The	_
100-16	18724-18727	SND	_
100-17	18728-18733	group	_
100-18	18734-18740	showed	_
100-19	18741-18754	significantly	_
100-20	18755-18764	decreased	_
100-21	18765-18769	rsFC	_
100-22	18770-18772	in	_
100-23	18773-18782	bilateral	_
100-24	18783-18789	insula	_
100-25	18789-18790	,	_
100-26	18791-18795	left	_
100-27	18796-18804	inferior	_
100-28	18805-18812	frontal	_
100-29	18813-18818	gyrus	_
100-30	18818-18819	,	_
100-31	18820-18823	and	_
100-32	18824-18829	right	_
100-33	18830-18838	inferior	_
100-34	18839-18846	orbital	_
100-35	18847-18854	frontal	_
100-36	18855-18860	gyrus	_
100-37	18861-18865	with	_
100-38	18866-18869	the	_
100-39	18870-18875	DLPFC	_
100-40	18876-18877	(	_
100-41	18877-18882	Table	_
100-42	18882-18883	 	_
100-43	18883-18884	4	_
100-44	18884-18885	;	_
100-45	18886-18889	Fig	_
100-46	18889-18890	.	_
100-47	18890-18891	 	_
100-48	18891-18892	3	_
100-49	18892-18893	)	_
100-50	18893-18894	.	_

#Text=Between-group analysis of DLPFC connectivity: IGD versus SND
#Text=Summary of functional connectivity with DLPFC changes in IGD group compared with the SND group
#Text=\tPeak MNI coordinate region\tPeak MNI coordinates\tNumber of cluster voxels\tPeak t value\t \tx\ty\tz\t \t1\tLeft inferior temporal gyrus (BA20)\t−51\t−15\t−27\t12\t5.17\t \t2\tRight inferior orbital frontal gyrus (BA38)\t48\t27\t−12\t27\t5.01\t \t3\tRight middle occipital gyrus (BA19)\t42\t−73\t0\t39\t−6.70\t \t4\tRight supramarginal gyrus (BA48)\t63\t−48\t27\t26\t−4.54\t \t5\tRight cuneus (BA19)\t12\t86\t30\t46\t−4.58\t \t
#Text=
#Text=t > 0 indicates IGD group >SND group in functional connectivity with DLPFC, t < 0 indicates IGD group <SND group in functional connectivity with DLPFC
#Text=
#Text=MNI Montreal Neurological Institute, BA Brodmann’s area, DLPFC dorsolateral prefrontal cortex, IGD internet gaming disorder, SND smokers with nicotine dependence
#Text=
#Text=p < 0.05, AlphaSim-corrected
#Text=Significant between-group differences in functional connectivity of different brain regions with DLPFC between IGD and SND groups.
101-1	18897-18910	Between-group	_
101-2	18911-18919	analysis	_
101-3	18920-18922	of	_
101-4	18923-18928	DLPFC	_
101-5	18929-18941	connectivity	_
101-6	18941-18942	:	_
101-7	18943-18946	IGD	_
101-8	18947-18953	versus	_
101-9	18954-18957	SND	_
101-10	18958-18965	Summary	_
101-11	18966-18968	of	_
101-12	18969-18979	functional	_
101-13	18980-18992	connectivity	_
101-14	18993-18997	with	_
101-15	18998-19003	DLPFC	_
101-16	19004-19011	changes	_
101-17	19012-19014	in	_
101-18	19015-19018	IGD	_
101-19	19019-19024	group	_
101-20	19025-19033	compared	_
101-21	19034-19038	with	_
101-22	19039-19042	the	_
101-23	19043-19046	SND	_
101-24	19047-19052	group	_
101-25	19054-19058	Peak	_
101-26	19059-19062	MNI	_
101-27	19063-19073	coordinate	_
101-28	19074-19080	region	_
101-29	19081-19085	Peak	_
101-30	19086-19089	MNI	_
101-31	19090-19101	coordinates	_
101-32	19102-19108	Number	_
101-33	19109-19111	of	_
101-34	19112-19119	cluster	_
101-35	19120-19126	voxels	_
101-36	19127-19131	Peak	_
101-37	19132-19133	t	_
101-38	19134-19139	value	_
101-39	19142-19143	x	_
101-40	19144-19145	y	_
101-41	19146-19147	z	_
101-42	19150-19151	1	_
101-43	19152-19156	Left	_
101-44	19157-19165	inferior	_
101-45	19166-19174	temporal	_
101-46	19175-19180	gyrus	_
101-47	19181-19182	(	_
101-48	19182-19186	BA20	_
101-49	19186-19187	)	_
101-50	19188-19189	−	_
101-51	19189-19191	51	_
101-52	19192-19193	−	_
101-53	19193-19195	15	_
101-54	19196-19197	−	_
101-55	19197-19199	27	_
101-56	19200-19202	12	_
101-57	19203-19207	5.17	_
101-58	19210-19211	2	_
101-59	19212-19217	Right	_
101-60	19218-19226	inferior	_
101-61	19227-19234	orbital	_
101-62	19235-19242	frontal	_
101-63	19243-19248	gyrus	_
101-64	19249-19250	(	_
101-65	19250-19254	BA38	_
101-66	19254-19255	)	_
101-67	19256-19258	48	_
101-68	19259-19261	27	_
101-69	19262-19263	−	_
101-70	19263-19265	12	_
101-71	19266-19268	27	_
101-72	19269-19273	5.01	_
101-73	19276-19277	3	_
101-74	19278-19283	Right	_
101-75	19284-19290	middle	_
101-76	19291-19300	occipital	_
101-77	19301-19306	gyrus	_
101-78	19307-19308	(	_
101-79	19308-19312	BA19	_
101-80	19312-19313	)	_
101-81	19314-19316	42	_
101-82	19317-19318	−	_
101-83	19318-19320	73	_
101-84	19321-19322	0	_
101-85	19323-19325	39	_
101-86	19326-19327	−	_
101-87	19327-19331	6.70	_
101-88	19334-19335	4	_
101-89	19336-19341	Right	_
101-90	19342-19355	supramarginal	_
101-91	19356-19361	gyrus	_
101-92	19362-19363	(	_
101-93	19363-19367	BA48	_
101-94	19367-19368	)	_
101-95	19369-19371	63	_
101-96	19372-19373	−	_
101-97	19373-19375	48	_
101-98	19376-19378	27	_
101-99	19379-19381	26	_
101-100	19382-19383	−	_
101-101	19383-19387	4.54	_
101-102	19390-19391	5	_
101-103	19392-19397	Right	_
101-104	19398-19404	cuneus	_
101-105	19405-19406	(	_
101-106	19406-19410	BA19	_
101-107	19410-19411	)	_
101-108	19412-19414	12	_
101-109	19415-19417	86	_
101-110	19418-19420	30	_
101-111	19421-19423	46	_
101-112	19424-19425	−	_
101-113	19425-19429	4.58	_
101-114	19434-19435	t	_
101-115	19435-19436	 	_
101-116	19436-19437	>	_
101-117	19437-19438	 	_
101-118	19438-19439	0	_
101-119	19440-19449	indicates	_
101-120	19450-19453	IGD	_
101-121	19454-19459	group	_
101-122	19460-19461	>	_
101-123	19461-19464	SND	_
101-124	19465-19470	group	_
101-125	19471-19473	in	_
101-126	19474-19484	functional	_
101-127	19485-19497	connectivity	_
101-128	19498-19502	with	_
101-129	19503-19508	DLPFC	_
101-130	19508-19509	,	_
101-131	19510-19511	t	_
101-132	19511-19512	 	_
101-133	19512-19513	<	_
101-134	19513-19514	 	_
101-135	19514-19515	0	_
101-136	19516-19525	indicates	_
101-137	19526-19529	IGD	_
101-138	19530-19535	group	_
101-139	19536-19537	<	_
101-140	19537-19540	SND	_
101-141	19541-19546	group	_
101-142	19547-19549	in	_
101-143	19550-19560	functional	_
101-144	19561-19573	connectivity	_
101-145	19574-19578	with	_
101-146	19579-19584	DLPFC	_
101-147	19586-19589	MNI	_
101-148	19590-19598	Montreal	_
101-149	19599-19611	Neurological	_
101-150	19612-19621	Institute	_
101-151	19621-19622	,	_
101-152	19623-19625	BA	_
101-153	19626-19634	Brodmann	_
101-154	19634-19635	’	_
101-155	19635-19636	s	_
101-156	19637-19641	area	_
101-157	19641-19642	,	_
101-158	19643-19648	DLPFC	_
101-159	19649-19661	dorsolateral	_
101-160	19662-19672	prefrontal	_
101-161	19673-19679	cortex	_
101-162	19679-19680	,	_
101-163	19681-19684	IGD	_
101-164	19685-19693	internet	_
101-165	19694-19700	gaming	_
101-166	19701-19709	disorder	_
101-167	19709-19710	,	_
101-168	19711-19714	SND	_
101-169	19715-19722	smokers	_
101-170	19723-19727	with	_
101-171	19728-19736	nicotine	_
101-172	19737-19747	dependence	_
101-173	19749-19750	p	_
101-174	19750-19751	 	_
101-175	19751-19752	<	_
101-176	19752-19753	 	_
101-177	19753-19757	0.05	_
101-178	19757-19758	,	_
101-179	19759-19777	AlphaSim-corrected	_
101-180	19778-19789	Significant	_
101-181	19790-19803	between-group	_
101-182	19804-19815	differences	_
101-183	19816-19818	in	_
101-184	19819-19829	functional	_
101-185	19830-19842	connectivity	_
101-186	19843-19845	of	_
101-187	19846-19855	different	_
101-188	19856-19861	brain	_
101-189	19862-19869	regions	_
101-190	19870-19874	with	_
101-191	19875-19880	DLPFC	_
101-192	19881-19888	between	_
101-193	19889-19892	IGD	_
101-194	19893-19896	and	_
101-195	19897-19900	SND	_
101-196	19901-19907	groups	_
101-197	19907-19908	.	_

#Text=The t-score bars are shown on the left.
102-1	19909-19912	The	_
102-2	19913-19920	t-score	_
102-3	19921-19925	bars	_
102-4	19926-19929	are	_
102-5	19930-19935	shown	_
102-6	19936-19938	on	_
102-7	19939-19942	the	_
102-8	19943-19947	left	_
102-9	19947-19948	.	_

#Text=Red indicates IGD > SND, and blue indicates IGD < SND.
103-1	19949-19952	Red	_
103-2	19953-19962	indicates	_
103-3	19963-19966	IGD	_
103-4	19966-19967	 	_
103-5	19967-19968	>	_
103-6	19968-19969	 	_
103-7	19969-19972	SND	_
103-8	19972-19973	,	_
103-9	19974-19977	and	_
103-10	19978-19982	blue	_
103-11	19983-19992	indicates	_
103-12	19993-19996	IGD	_
103-13	19996-19997	 	_
103-14	19997-19998	<	_
103-15	19998-19999	 	_
103-16	19999-20002	SND	_
103-17	20002-20003	.	_

#Text=Note: The left part of figure represents the participant’s right side, and right represents the participant’s left side.
104-1	20004-20008	Note	_
104-2	20008-20009	:	_
104-3	20010-20013	The	_
104-4	20014-20018	left	_
104-5	20019-20023	part	_
104-6	20024-20026	of	_
104-7	20027-20033	figure	_
104-8	20034-20044	represents	_
104-9	20045-20048	the	_
104-10	20049-20060	participant	_
104-11	20060-20061	’	_
104-12	20061-20062	s	_
104-13	20063-20068	right	_
104-14	20069-20073	side	_
104-15	20073-20074	,	_
104-16	20075-20078	and	_
104-17	20079-20084	right	_
104-18	20085-20095	represents	_
104-19	20096-20099	the	_
104-20	20100-20111	participant	_
104-21	20111-20112	’	_
104-22	20112-20113	s	_
104-23	20114-20118	left	_
104-24	20119-20123	side	_
104-25	20123-20124	.	_

#Text=DLPFC dorsolateral prefrontal cortex, IGD internet gaming disorder, SND smokers with nicotine dependence
#Text=Compared with the SND group, the IGD subjects had increased rsFC in the left inferior temporal gyrus and right inferior orbital frontal gyrus and decreased rsFC in the right side of the middle occipital gyrus, supramarginal gyrus, and cuneus with the DLPFC (Table 5; Fig. 4).
105-1	20125-20130	DLPFC	_
105-2	20131-20143	dorsolateral	_
105-3	20144-20154	prefrontal	_
105-4	20155-20161	cortex	_
105-5	20161-20162	,	_
105-6	20163-20166	IGD	_
105-7	20167-20175	internet	_
105-8	20176-20182	gaming	_
105-9	20183-20191	disorder	_
105-10	20191-20192	,	_
105-11	20193-20196	SND	_
105-12	20197-20204	smokers	_
105-13	20205-20209	with	_
105-14	20210-20218	nicotine	_
105-15	20219-20229	dependence	_
105-16	20230-20238	Compared	_
105-17	20239-20243	with	_
105-18	20244-20247	the	_
105-19	20248-20251	SND	_
105-20	20252-20257	group	_
105-21	20257-20258	,	_
105-22	20259-20262	the	_
105-23	20263-20266	IGD	_
105-24	20267-20275	subjects	_
105-25	20276-20279	had	_
105-26	20280-20289	increased	_
105-27	20290-20294	rsFC	_
105-28	20295-20297	in	_
105-29	20298-20301	the	_
105-30	20302-20306	left	_
105-31	20307-20315	inferior	_
105-32	20316-20324	temporal	_
105-33	20325-20330	gyrus	_
105-34	20331-20334	and	_
105-35	20335-20340	right	_
105-36	20341-20349	inferior	_
105-37	20350-20357	orbital	_
105-38	20358-20365	frontal	_
105-39	20366-20371	gyrus	_
105-40	20372-20375	and	_
105-41	20376-20385	decreased	_
105-42	20386-20390	rsFC	_
105-43	20391-20393	in	_
105-44	20394-20397	the	_
105-45	20398-20403	right	_
105-46	20404-20408	side	_
105-47	20409-20411	of	_
105-48	20412-20415	the	_
105-49	20416-20422	middle	_
105-50	20423-20432	occipital	_
105-51	20433-20438	gyrus	_
105-52	20438-20439	,	_
105-53	20440-20453	supramarginal	_
105-54	20454-20459	gyrus	_
105-55	20459-20460	,	_
105-56	20461-20464	and	_
105-57	20465-20471	cuneus	_
105-58	20472-20476	with	_
105-59	20477-20480	the	_
105-60	20481-20486	DLPFC	_
105-61	20487-20488	(	_
105-62	20488-20493	Table	_
105-63	20493-20494	 	_
105-64	20494-20495	5	_
105-65	20495-20496	;	_
105-66	20497-20500	Fig	_
105-67	20500-20501	.	_
105-68	20501-20502	 	_
105-69	20502-20503	4	_
105-70	20503-20504	)	_
105-71	20504-20505	.	_

#Text=Correlation between DLPFC connectivity and CIAS of IGD, DLPFC connectivity, and FTND of SND
#Text=Compared with the HC group, the IGD and SND both had decreased rsFC in the left inferior frontal gyrus and right insula with DLPFC.
106-1	20508-20519	Correlation	_
106-2	20520-20527	between	_
106-3	20528-20533	DLPFC	_
106-4	20534-20546	connectivity	_
106-5	20547-20550	and	_
106-6	20551-20555	CIAS	_
106-7	20556-20558	of	_
106-8	20559-20562	IGD	_
106-9	20562-20563	,	_
106-10	20564-20569	DLPFC	_
106-11	20570-20582	connectivity	_
106-12	20582-20583	,	_
106-13	20584-20587	and	_
106-14	20588-20592	FTND	_
106-15	20593-20595	of	_
106-16	20596-20599	SND	_
106-17	20600-20608	Compared	_
106-18	20609-20613	with	_
106-19	20614-20617	the	_
106-20	20618-20620	HC	_
106-21	20621-20626	group	_
106-22	20626-20627	,	_
106-23	20628-20631	the	_
106-24	20632-20635	IGD	_
106-25	20636-20639	and	_
106-26	20640-20643	SND	_
106-27	20644-20648	both	_
106-28	20649-20652	had	_
106-29	20653-20662	decreased	_
106-30	20663-20667	rsFC	_
106-31	20668-20670	in	_
106-32	20671-20674	the	_
106-33	20675-20679	left	_
106-34	20680-20688	inferior	_
106-35	20689-20696	frontal	_
106-36	20697-20702	gyrus	_
106-37	20703-20706	and	_
106-38	20707-20712	right	_
106-39	20713-20719	insula	_
106-40	20720-20724	with	_
106-41	20725-20730	DLPFC	_
106-42	20730-20731	.	_

#Text=The rsFC strength values (mean zFC values) were extracted and averaged within a spherical ROI (radius of 10 mm) centered on the difference peak of the rsFC group (Tables 2, 3) in the IGD and SND groups.
107-1	20732-20735	The	_
107-2	20736-20740	rsFC	_
107-3	20741-20749	strength	_
107-4	20750-20756	values	_
107-5	20757-20758	(	_
107-6	20758-20762	mean	_
107-7	20763-20766	zFC	_
107-8	20767-20773	values	_
107-9	20773-20774	)	_
107-10	20775-20779	were	_
107-11	20780-20789	extracted	_
107-12	20790-20793	and	_
107-13	20794-20802	averaged	_
107-14	20803-20809	within	_
107-15	20810-20811	a	_
107-16	20812-20821	spherical	_
107-17	20822-20825	ROI	_
107-18	20826-20827	(	_
107-19	20827-20833	radius	_
107-20	20834-20836	of	_
107-21	20837-20839	10	_
107-22	20839-20840	 	_
107-23	20840-20842	mm	_
107-24	20842-20843	)	_
107-25	20844-20852	centered	_
107-26	20853-20855	on	_
107-27	20856-20859	the	_
107-28	20860-20870	difference	_
107-29	20871-20875	peak	_
107-30	20876-20878	of	_
107-31	20879-20882	the	_
107-32	20883-20887	rsFC	_
107-33	20888-20893	group	_
107-34	20894-20895	(	_
107-35	20895-20901	Tables	_
107-36	20901-20902	 	_
107-37	20902-20903	2	_
107-38	20903-20904	,	_
107-39	20905-20906	3	_
107-40	20906-20907	)	_
107-41	20908-20910	in	_
107-42	20911-20914	the	_
107-43	20915-20918	IGD	_
107-44	20919-20922	and	_
107-45	20923-20926	SND	_
107-46	20927-20933	groups	_
107-47	20933-20934	.	_

#Text=Pearson correlations were performed between the rsFC values with CIAS of the IGD group and the FTND score in SND group.
108-1	20935-20942	Pearson	_
108-2	20943-20955	correlations	_
108-3	20956-20960	were	_
108-4	20961-20970	performed	_
108-5	20971-20978	between	_
108-6	20979-20982	the	_
108-7	20983-20987	rsFC	_
108-8	20988-20994	values	_
108-9	20995-20999	with	_
108-10	21000-21004	CIAS	_
108-11	21005-21007	of	_
108-12	21008-21011	the	_
108-13	21012-21015	IGD	_
108-14	21016-21021	group	_
108-15	21022-21025	and	_
108-16	21026-21029	the	_
108-17	21030-21034	FTND	_
108-18	21035-21040	score	_
108-19	21041-21043	in	_
108-20	21044-21047	SND	_
108-21	21048-21053	group	_
108-22	21053-21054	.	_

#Text=However, no significant correlation was found.
109-1	21055-21062	However	_
109-2	21062-21063	,	_
109-3	21064-21066	no	_
109-4	21067-21078	significant	_
109-5	21079-21090	correlation	_
109-6	21091-21094	was	_
109-7	21095-21100	found	_
109-8	21100-21101	.	_

#Text=Discussion
#Text=In this study, we observe both similar and different brain connectivities in IGD group related to SND group.
110-1	21102-21112	Discussion	_
110-2	21113-21115	In	_
110-3	21116-21120	this	_
110-4	21121-21126	study	_
110-5	21126-21127	,	_
110-6	21128-21130	we	_
110-7	21131-21138	observe	_
110-8	21139-21143	both	_
110-9	21144-21151	similar	_
110-10	21152-21155	and	_
110-11	21156-21165	different	_
110-12	21166-21171	brain	_
110-13	21172-21186	connectivities	_
110-14	21187-21189	in	_
110-15	21190-21193	IGD	_
110-16	21194-21199	group	_
110-17	21200-21207	related	_
110-18	21208-21210	to	_
110-19	21211-21214	SND	_
110-20	21215-21220	group	_
110-21	21220-21221	.	_

#Text=We detected that both the SND and IGD groups had decreased rsFC with DLPFC in the right insula and left inferior frontal gyrus.
111-1	21222-21224	We	_
111-2	21225-21233	detected	_
111-3	21234-21238	that	_
111-4	21239-21243	both	_
111-5	21244-21247	the	_
111-6	21248-21251	SND	_
111-7	21252-21255	and	_
111-8	21256-21259	IGD	_
111-9	21260-21266	groups	_
111-10	21267-21270	had	_
111-11	21271-21280	decreased	_
111-12	21281-21285	rsFC	_
111-13	21286-21290	with	_
111-14	21291-21296	DLPFC	_
111-15	21297-21299	in	_
111-16	21300-21303	the	_
111-17	21304-21309	right	_
111-18	21310-21316	insula	_
111-19	21317-21320	and	_
111-20	21321-21325	left	_
111-21	21326-21334	inferior	_
111-22	21335-21342	frontal	_
111-23	21343-21348	gyrus	_
111-24	21348-21349	.	_

#Text=Furthermore, the IGD subjects exhibited different rsFC with DLPFC in the orbital frontal cortex and temporal, occipital, and parietal lobes.
112-1	21350-21361	Furthermore	_
112-2	21361-21362	,	_
112-3	21363-21366	the	_
112-4	21367-21370	IGD	_
112-5	21371-21379	subjects	_
112-6	21380-21389	exhibited	_
112-7	21390-21399	different	_
112-8	21400-21404	rsFC	_
112-9	21405-21409	with	_
112-10	21410-21415	DLPFC	_
112-11	21416-21418	in	_
112-12	21419-21422	the	_
112-13	21423-21430	orbital	_
112-14	21431-21438	frontal	_
112-15	21439-21445	cortex	_
112-16	21446-21449	and	_
112-17	21450-21458	temporal	_
112-18	21458-21459	,	_
112-19	21460-21469	occipital	_
112-20	21469-21470	,	_
112-21	21471-21474	and	_
112-22	21475-21483	parietal	_
112-23	21484-21489	lobes	_
112-24	21489-21490	.	_

#Text=Evidence revealed that many of the behavioral symptoms, even the neural mechanisms underlying IGD, resemble SUD.
113-1	21491-21499	Evidence	_
113-2	21500-21508	revealed	_
113-3	21509-21513	that	_
113-4	21514-21518	many	_
113-5	21519-21521	of	_
113-6	21522-21525	the	_
113-7	21526-21536	behavioral	_
113-8	21537-21545	symptoms	_
113-9	21545-21546	,	_
113-10	21547-21551	even	_
113-11	21552-21555	the	_
113-12	21556-21562	neural	_
113-13	21563-21573	mechanisms	_
113-14	21574-21584	underlying	_
113-15	21585-21588	IGD	_
113-16	21588-21589	,	_
113-17	21590-21598	resemble	_
113-18	21599-21602	SUD	_
113-19	21602-21603	.	_

#Text=SUD involves a chronic, recurrent pattern of drug, nicotine, or alcohol use, and nicotine dependence is one of its most common forms.
114-1	21604-21607	SUD	_
114-2	21608-21616	involves	_
114-3	21617-21618	a	_
114-4	21619-21626	chronic	_
114-5	21626-21627	,	_
114-6	21628-21637	recurrent	_
114-7	21638-21645	pattern	_
114-8	21646-21648	of	_
114-9	21649-21653	drug	_
114-10	21653-21654	,	_
114-11	21655-21663	nicotine	_
114-12	21663-21664	,	_
114-13	21665-21667	or	_
114-14	21668-21675	alcohol	_
114-15	21676-21679	use	_
114-16	21679-21680	,	_
114-17	21681-21684	and	_
114-18	21685-21693	nicotine	_
114-19	21694-21704	dependence	_
114-20	21705-21707	is	_
114-21	21708-21711	one	_
114-22	21712-21714	of	_
114-23	21715-21718	its	_
114-24	21719-21723	most	_
114-25	21724-21730	common	_
114-26	21731-21736	forms	_
114-27	21736-21737	.	_

#Text=SUD could result in neurological alterations, particularly in frontal lobe structures implicated in cognitive-behavioral control.
115-1	21738-21741	SUD	_
115-2	21742-21747	could	_
115-3	21748-21754	result	_
115-4	21755-21757	in	_
115-5	21758-21770	neurological	_
115-6	21771-21782	alterations	_
115-7	21782-21783	,	_
115-8	21784-21796	particularly	_
115-9	21797-21799	in	_
115-10	21800-21807	frontal	_
115-11	21808-21812	lobe	_
115-12	21813-21823	structures	_
115-13	21824-21834	implicated	_
115-14	21835-21837	in	_
115-15	21838-21858	cognitive-behavioral	_
115-16	21859-21866	control	_
115-17	21866-21867	.	_

#Text=The network of cortical regions dysfunction, including the DLPFC, anterior cingulate cortex and lateral parietal cortex, relates to deficits in behavioral inhibition.
116-1	21868-21871	The	_
116-2	21872-21879	network	_
116-3	21880-21882	of	_
116-4	21883-21891	cortical	_
116-5	21892-21899	regions	_
116-6	21900-21911	dysfunction	_
116-7	21911-21912	,	_
116-8	21913-21922	including	_
116-9	21923-21926	the	_
116-10	21927-21932	DLPFC	_
116-11	21932-21933	,	_
116-12	21934-21942	anterior	_
116-13	21943-21952	cingulate	_
116-14	21953-21959	cortex	_
116-15	21960-21963	and	_
116-16	21964-21971	lateral	_
116-17	21972-21980	parietal	_
116-18	21981-21987	cortex	_
116-19	21987-21988	,	_
116-20	21989-21996	relates	_
116-21	21997-21999	to	_
116-22	22000-22008	deficits	_
116-23	22009-22011	in	_
116-24	22012-22022	behavioral	_
116-25	22023-22033	inhibition	_
116-26	22033-22034	.	_

#Text=This dysfunction has been linked to the loss of control over substance intake, which could be a critical step in the progression of SUD pathology.
117-1	22035-22039	This	_
117-2	22040-22051	dysfunction	_
117-3	22052-22055	has	_
117-4	22056-22060	been	_
117-5	22061-22067	linked	_
117-6	22068-22070	to	_
117-7	22071-22074	the	_
117-8	22075-22079	loss	_
117-9	22080-22082	of	_
117-10	22083-22090	control	_
117-11	22091-22095	over	_
117-12	22096-22105	substance	_
117-13	22106-22112	intake	_
117-14	22112-22113	,	_
117-15	22114-22119	which	_
117-16	22120-22125	could	_
117-17	22126-22128	be	_
117-18	22129-22130	a	_
117-19	22131-22139	critical	_
117-20	22140-22144	step	_
117-21	22145-22147	in	_
117-22	22148-22151	the	_
117-23	22152-22163	progression	_
117-24	22164-22166	of	_
117-25	22167-22170	SUD	_
117-26	22171-22180	pathology	_
117-27	22180-22181	.	_

#Text=IGD is different from SUD in that no chemical or substance intake is involved; however, excessive internet use may also lead to physical dependence similar to that observed in other addictions.
118-1	22182-22185	IGD	_
118-2	22186-22188	is	_
118-3	22189-22198	different	_
118-4	22199-22203	from	_
118-5	22204-22207	SUD	_
118-6	22208-22210	in	_
118-7	22211-22215	that	_
118-8	22216-22218	no	_
118-9	22219-22227	chemical	_
118-10	22228-22230	or	_
118-11	22231-22240	substance	_
118-12	22241-22247	intake	_
118-13	22248-22250	is	_
118-14	22251-22259	involved	_
118-15	22259-22260	;	_
118-16	22261-22268	however	_
118-17	22268-22269	,	_
118-18	22270-22279	excessive	_
118-19	22280-22288	internet	_
118-20	22289-22292	use	_
118-21	22293-22296	may	_
118-22	22297-22301	also	_
118-23	22302-22306	lead	_
118-24	22307-22309	to	_
118-25	22310-22318	physical	_
118-26	22319-22329	dependence	_
118-27	22330-22337	similar	_
118-28	22338-22340	to	_
118-29	22341-22345	that	_
118-30	22346-22354	observed	_
118-31	22355-22357	in	_
118-32	22358-22363	other	_
118-33	22364-22374	addictions	_
118-34	22374-22375	.	_

#Text=Particularly, the hypo-activation of the inhibition circuit is a shared neural mechanism in SUD and behavioral addiction.
119-1	22376-22388	Particularly	_
119-2	22388-22389	,	_
119-3	22390-22393	the	_
119-4	22394-22409	hypo-activation	_
119-5	22410-22412	of	_
119-6	22413-22416	the	_
119-7	22417-22427	inhibition	_
119-8	22428-22435	circuit	_
119-9	22436-22438	is	_
119-10	22439-22440	a	_
119-11	22441-22447	shared	_
119-12	22448-22454	neural	_
119-13	22455-22464	mechanism	_
119-14	22465-22467	in	_
119-15	22468-22471	SUD	_
119-16	22472-22475	and	_
119-17	22476-22486	behavioral	_
119-18	22487-22496	addiction	_
119-19	22496-22497	.	_

#Text=Impaired function of the prefrontal cortex may relate to high impulsivity, which in turn, may contribute to impaired cognitive control and development of IGD.
120-1	22498-22506	Impaired	_
120-2	22507-22515	function	_
120-3	22516-22518	of	_
120-4	22519-22522	the	_
120-5	22523-22533	prefrontal	_
120-6	22534-22540	cortex	_
120-7	22541-22544	may	_
120-8	22545-22551	relate	_
120-9	22552-22554	to	_
120-10	22555-22559	high	_
120-11	22560-22571	impulsivity	_
120-12	22571-22572	,	_
120-13	22573-22578	which	_
120-14	22579-22581	in	_
120-15	22582-22586	turn	_
120-16	22586-22587	,	_
120-17	22588-22591	may	_
120-18	22592-22602	contribute	_
120-19	22603-22605	to	_
120-20	22606-22614	impaired	_
120-21	22615-22624	cognitive	_
120-22	22625-22632	control	_
120-23	22633-22636	and	_
120-24	22637-22648	development	_
120-25	22649-22651	of	_
120-26	22652-22655	IGD	_
120-27	22655-22656	.	_

#Text=Although the exact mechanism of IGD requires further investigation, its cognitive–behavioral model has been proposed.
121-1	22657-22665	Although	_
121-2	22666-22669	the	_
121-3	22670-22675	exact	_
121-4	22676-22685	mechanism	_
121-5	22686-22688	of	_
121-6	22689-22692	IGD	_
121-7	22693-22701	requires	_
121-8	22702-22709	further	_
121-9	22710-22723	investigation	_
121-10	22723-22724	,	_
121-11	22725-22728	its	_
121-12	22729-22749	cognitive–behavioral	_
121-13	22750-22755	model	_
121-14	22756-22759	has	_
121-15	22760-22764	been	_
121-16	22765-22773	proposed	_
121-17	22773-22774	.	_

#Text=The model focuses on three domains including motivational drives related to reward-seeking and stress-reduction, behavioral control relating to executive inhibition, and decision-making that involves weighing the pros and cons of engaging in motivated behaviors.
122-1	22775-22778	The	_
122-2	22779-22784	model	_
122-3	22785-22792	focuses	_
122-4	22793-22795	on	_
122-5	22796-22801	three	_
122-6	22802-22809	domains	_
122-7	22810-22819	including	_
122-8	22820-22832	motivational	_
122-9	22833-22839	drives	_
122-10	22840-22847	related	_
122-11	22848-22850	to	_
122-12	22851-22865	reward-seeking	_
122-13	22866-22869	and	_
122-14	22870-22886	stress-reduction	_
122-15	22886-22887	,	_
122-16	22888-22898	behavioral	_
122-17	22899-22906	control	_
122-18	22907-22915	relating	_
122-19	22916-22918	to	_
122-20	22919-22928	executive	_
122-21	22929-22939	inhibition	_
122-22	22939-22940	,	_
122-23	22941-22944	and	_
122-24	22945-22960	decision-making	_
122-25	22961-22965	that	_
122-26	22966-22974	involves	_
122-27	22975-22983	weighing	_
122-28	22984-22987	the	_
122-29	22988-22992	pros	_
122-30	22993-22996	and	_
122-31	22997-23001	cons	_
122-32	23002-23004	of	_
122-33	23005-23013	engaging	_
122-34	23014-23016	in	_
122-35	23017-23026	motivated	_
122-36	23027-23036	behaviors	_
122-37	23036-23037	.	_

#Text=Based on previous studies, both functional and structural abnormalities of the DLPFC have been commonly observed in IGD.
123-1	23038-23043	Based	_
123-2	23044-23046	on	_
123-3	23047-23055	previous	_
123-4	23056-23063	studies	_
123-5	23063-23064	,	_
123-6	23065-23069	both	_
123-7	23070-23080	functional	_
123-8	23081-23084	and	_
123-9	23085-23095	structural	_
123-10	23096-23109	abnormalities	_
123-11	23110-23112	of	_
123-12	23113-23116	the	_
123-13	23117-23122	DLPFC	_
123-14	23123-23127	have	_
123-15	23128-23132	been	_
123-16	23133-23141	commonly	_
123-17	23142-23150	observed	_
123-18	23151-23153	in	_
123-19	23154-23157	IGD	_
123-20	23157-23158	.	_

#Text=Complex cognitive functions have usually been associated with activations in DLPFC such as conflict-induced behavioral adjustment, attention, working memory, and inhibitory control.
124-1	23159-23166	Complex	_
124-2	23167-23176	cognitive	_
124-3	23177-23186	functions	_
124-4	23187-23191	have	_
124-5	23192-23199	usually	_
124-6	23200-23204	been	_
124-7	23205-23215	associated	_
124-8	23216-23220	with	_
124-9	23221-23232	activations	_
124-10	23233-23235	in	_
124-11	23236-23241	DLPFC	_
124-12	23242-23246	such	_
124-13	23247-23249	as	_
124-14	23250-23266	conflict-induced	_
124-15	23267-23277	behavioral	_
124-16	23278-23288	adjustment	_
124-17	23288-23289	,	_
124-18	23290-23299	attention	_
124-19	23299-23300	,	_
124-20	23301-23308	working	_
124-21	23309-23315	memory	_
124-22	23315-23316	,	_
124-23	23317-23320	and	_
124-24	23321-23331	inhibitory	_
124-25	23332-23339	control	_
124-26	23339-23340	.	_

#Text=DLPFC is connected with other cortical areas and links current sensory experiences to memory of past experiences to direct and generate properly goal-directed action.
125-1	23341-23346	DLPFC	_
125-2	23347-23349	is	_
125-3	23350-23359	connected	_
125-4	23360-23364	with	_
125-5	23365-23370	other	_
125-6	23371-23379	cortical	_
125-7	23380-23385	areas	_
125-8	23386-23389	and	_
125-9	23390-23395	links	_
125-10	23396-23403	current	_
125-11	23404-23411	sensory	_
125-12	23412-23423	experiences	_
125-13	23424-23426	to	_
125-14	23427-23433	memory	_
125-15	23434-23436	of	_
125-16	23437-23441	past	_
125-17	23442-23453	experiences	_
125-18	23454-23456	to	_
125-19	23457-23463	direct	_
125-20	23464-23467	and	_
125-21	23468-23476	generate	_
125-22	23477-23485	properly	_
125-23	23486-23499	goal-directed	_
125-24	23500-23506	action	_
125-25	23506-23507	.	_

#Text=Therefore, the DLPFC may contribute to the coordination and keeping of the representations accepted from the other brain regions during the craving response when substance cues are present and a positive expectancy has been generated.
126-1	23508-23517	Therefore	_
126-2	23517-23518	,	_
126-3	23519-23522	the	_
126-4	23523-23528	DLPFC	_
126-5	23529-23532	may	_
126-6	23533-23543	contribute	_
126-7	23544-23546	to	_
126-8	23547-23550	the	_
126-9	23551-23563	coordination	_
126-10	23564-23567	and	_
126-11	23568-23575	keeping	_
126-12	23576-23578	of	_
126-13	23579-23582	the	_
126-14	23583-23598	representations	_
126-15	23599-23607	accepted	_
126-16	23608-23612	from	_
126-17	23613-23616	the	_
126-18	23617-23622	other	_
126-19	23623-23628	brain	_
126-20	23629-23636	regions	_
126-21	23637-23643	during	_
126-22	23644-23647	the	_
126-23	23648-23655	craving	_
126-24	23656-23664	response	_
126-25	23665-23669	when	_
126-26	23670-23679	substance	_
126-27	23680-23684	cues	_
126-28	23685-23688	are	_
126-29	23689-23696	present	_
126-30	23697-23700	and	_
126-31	23701-23702	a	_
126-32	23703-23711	positive	_
126-33	23712-23722	expectancy	_
126-34	23723-23726	has	_
126-35	23727-23731	been	_
126-36	23732-23741	generated	_
126-37	23741-23742	.	_

#Text=We detected that both the SND and IGD groups had decreased rsFC in the right insula and left inferior frontal gyrus with DLPFC.
127-1	23743-23745	We	_
127-2	23746-23754	detected	_
127-3	23755-23759	that	_
127-4	23760-23764	both	_
127-5	23765-23768	the	_
127-6	23769-23772	SND	_
127-7	23773-23776	and	_
127-8	23777-23780	IGD	_
127-9	23781-23787	groups	_
127-10	23788-23791	had	_
127-11	23792-23801	decreased	_
127-12	23802-23806	rsFC	_
127-13	23807-23809	in	_
127-14	23810-23813	the	_
127-15	23814-23819	right	_
127-16	23820-23826	insula	_
127-17	23827-23830	and	_
127-18	23831-23835	left	_
127-19	23836-23844	inferior	_
127-20	23845-23852	frontal	_
127-21	23853-23858	gyrus	_
127-22	23859-23863	with	_
127-23	23864-23869	DLPFC	_
127-24	23869-23870	.	_

#Text=The insula has been implicated in cue-induced craving and relapse in nicotine-dependent tobacco cigarette smokers.
128-1	23871-23874	The	_
128-2	23875-23881	insula	_
128-3	23882-23885	has	_
128-4	23886-23890	been	_
128-5	23891-23901	implicated	_
128-6	23902-23904	in	_
128-7	23905-23916	cue-induced	_
128-8	23917-23924	craving	_
128-9	23925-23928	and	_
128-10	23929-23936	relapse	_
128-11	23937-23939	in	_
128-12	23940-23958	nicotine-dependent	_
128-13	23959-23966	tobacco	_
128-14	23967-23976	cigarette	_
128-15	23977-23984	smokers	_
128-16	23984-23985	.	_

#Text=And the orbitofrontal cortex is involved in the evaluation of the reward of stimuli and explicit representation of reward expectancy for the substance.
129-1	23986-23989	And	_
129-2	23990-23993	the	_
129-3	23994-24007	orbitofrontal	_
129-4	24008-24014	cortex	_
129-5	24015-24017	is	_
129-6	24018-24026	involved	_
129-7	24027-24029	in	_
129-8	24030-24033	the	_
129-9	24034-24044	evaluation	_
129-10	24045-24047	of	_
129-11	24048-24051	the	_
129-12	24052-24058	reward	_
129-13	24059-24061	of	_
129-14	24062-24069	stimuli	_
129-15	24070-24073	and	_
129-16	24074-24082	explicit	_
129-17	24083-24097	representation	_
129-18	24098-24100	of	_
129-19	24101-24107	reward	_
129-20	24108-24118	expectancy	_
129-21	24119-24122	for	_
129-22	24123-24126	the	_
129-23	24127-24136	substance	_
129-24	24136-24137	.	_

#Text=Our results were consistent with the previous studies, which emphasized the brain regions, such as ventromedial prefrontal cortex, insula, thalamus, and cerebellum, which was critically linked with cigarette smoking.
130-1	24138-24141	Our	_
130-2	24142-24149	results	_
130-3	24150-24154	were	_
130-4	24155-24165	consistent	_
130-5	24166-24170	with	_
130-6	24171-24174	the	_
130-7	24175-24183	previous	_
130-8	24184-24191	studies	_
130-9	24191-24192	,	_
130-10	24193-24198	which	_
130-11	24199-24209	emphasized	_
130-12	24210-24213	the	_
130-13	24214-24219	brain	_
130-14	24220-24227	regions	_
130-15	24227-24228	,	_
130-16	24229-24233	such	_
130-17	24234-24236	as	_
130-18	24237-24249	ventromedial	_
130-19	24250-24260	prefrontal	_
130-20	24261-24267	cortex	_
130-21	24267-24268	,	_
130-22	24269-24275	insula	_
130-23	24275-24276	,	_
130-24	24277-24285	thalamus	_
130-25	24285-24286	,	_
130-26	24287-24290	and	_
130-27	24291-24301	cerebellum	_
130-28	24301-24302	,	_
130-29	24303-24308	which	_
130-30	24309-24312	was	_
130-31	24313-24323	critically	_
130-32	24324-24330	linked	_
130-33	24331-24335	with	_
130-34	24336-24345	cigarette	_
130-35	24346-24353	smoking	_
130-36	24353-24354	.	_

#Text=Structural MRI studies revealed that the integrities of the gray matters in the prefrontal cortex, anterior cingulate cortex, insula, thalamus, and cerebellum were reduced in smokers.
131-1	24355-24365	Structural	_
131-2	24366-24369	MRI	_
131-3	24370-24377	studies	_
131-4	24378-24386	revealed	_
131-5	24387-24391	that	_
131-6	24392-24395	the	_
131-7	24396-24407	integrities	_
131-8	24408-24410	of	_
131-9	24411-24414	the	_
131-10	24415-24419	gray	_
131-11	24420-24427	matters	_
131-12	24428-24430	in	_
131-13	24431-24434	the	_
131-14	24435-24445	prefrontal	_
131-15	24446-24452	cortex	_
131-16	24452-24453	,	_
131-17	24454-24462	anterior	_
131-18	24463-24472	cingulate	_
131-19	24473-24479	cortex	_
131-20	24479-24480	,	_
131-21	24481-24487	insula	_
131-22	24487-24488	,	_
131-23	24489-24497	thalamus	_
131-24	24497-24498	,	_
131-25	24499-24502	and	_
131-26	24503-24513	cerebellum	_
131-27	24514-24518	were	_
131-28	24519-24526	reduced	_
131-29	24527-24529	in	_
131-30	24530-24537	smokers	_
131-31	24537-24538	.	_

#Text=Liu et al. investigated the brain function of IGD individuals using task-state fMRI.
132-1	24539-24542	Liu	_
132-2	24543-24545	et	_
132-3	24546-24548	al	_
132-4	24548-24549	.	_
132-5	24550-24562	investigated	_
132-6	24563-24566	the	_
132-7	24567-24572	brain	_
132-8	24573-24581	function	_
132-9	24582-24584	of	_
132-10	24585-24588	IGD	_
132-11	24589-24600	individuals	_
132-12	24601-24606	using	_
132-13	24607-24617	task-state	_
132-14	24618-24622	fMRI	_
132-15	24622-24623	.	_

#Text=The IGD group showed increased activation in the right side of superior parietal lobule, insular lobe, precuneus, cingulated gyrus, superior temporal gyrus, and left side of brainstem.
133-1	24624-24627	The	_
133-2	24628-24631	IGD	_
133-3	24632-24637	group	_
133-4	24638-24644	showed	_
133-5	24645-24654	increased	_
133-6	24655-24665	activation	_
133-7	24666-24668	in	_
133-8	24669-24672	the	_
133-9	24673-24678	right	_
133-10	24679-24683	side	_
133-11	24684-24686	of	_
133-12	24687-24695	superior	_
133-13	24696-24704	parietal	_
133-14	24705-24711	lobule	_
133-15	24711-24712	,	_
133-16	24713-24720	insular	_
133-17	24721-24725	lobe	_
133-18	24725-24726	,	_
133-19	24727-24736	precuneus	_
133-20	24736-24737	,	_
133-21	24738-24748	cingulated	_
133-22	24749-24754	gyrus	_
133-23	24754-24755	,	_
133-24	24756-24764	superior	_
133-25	24765-24773	temporal	_
133-26	24774-24779	gyrus	_
133-27	24779-24780	,	_
133-28	24781-24784	and	_
133-29	24785-24789	left	_
133-30	24790-24794	side	_
133-31	24795-24797	of	_
133-32	24798-24807	brainstem	_
133-33	24807-24808	.	_

#Text=Internet video games activate the space, attention, vision, and execution centers located in the temporal, parietal, occipital, and frontal gyri.
134-1	24809-24817	Internet	_
134-2	24818-24823	video	_
134-3	24824-24829	games	_
134-4	24830-24838	activate	_
134-5	24839-24842	the	_
134-6	24843-24848	space	_
134-7	24848-24849	,	_
134-8	24850-24859	attention	_
134-9	24859-24860	,	_
134-10	24861-24867	vision	_
134-11	24867-24868	,	_
134-12	24869-24872	and	_
134-13	24873-24882	execution	_
134-14	24883-24890	centers	_
134-15	24891-24898	located	_
134-16	24899-24901	in	_
134-17	24902-24905	the	_
134-18	24906-24914	temporal	_
134-19	24914-24915	,	_
134-20	24916-24924	parietal	_
134-21	24924-24925	,	_
134-22	24926-24935	occipital	_
134-23	24935-24936	,	_
134-24	24937-24940	and	_
134-25	24941-24948	frontal	_
134-26	24949-24953	gyri	_
134-27	24953-24954	.	_

#Text=Abnormal brain function was noted in IGD subjects with hypofunction of the frontal cortex.
135-1	24955-24963	Abnormal	_
135-2	24964-24969	brain	_
135-3	24970-24978	function	_
135-4	24979-24982	was	_
135-5	24983-24988	noted	_
135-6	24989-24991	in	_
135-7	24992-24995	IGD	_
135-8	24996-25004	subjects	_
135-9	25005-25009	with	_
135-10	25010-25022	hypofunction	_
135-11	25023-25025	of	_
135-12	25026-25029	the	_
135-13	25030-25037	frontal	_
135-14	25038-25044	cortex	_
135-15	25044-25045	.	_

#Text=Liu et al. detected IGD subjects that showed laterality activation of the right cerebral hemisphere, and they found that most areas were located in the right hemisphere.
136-1	25046-25049	Liu	_
136-2	25050-25052	et	_
136-3	25053-25055	al	_
136-4	25055-25056	.	_
136-5	25057-25065	detected	_
136-6	25066-25069	IGD	_
136-7	25070-25078	subjects	_
136-8	25079-25083	that	_
136-9	25084-25090	showed	_
136-10	25091-25101	laterality	_
136-11	25102-25112	activation	_
136-12	25113-25115	of	_
136-13	25116-25119	the	_
136-14	25120-25125	right	_
136-15	25126-25134	cerebral	_
136-16	25135-25145	hemisphere	_
136-17	25145-25146	,	_
136-18	25147-25150	and	_
136-19	25151-25155	they	_
136-20	25156-25161	found	_
136-21	25162-25166	that	_
136-22	25167-25171	most	_
136-23	25172-25177	areas	_
136-24	25178-25182	were	_
136-25	25183-25190	located	_
136-26	25191-25193	in	_
136-27	25194-25197	the	_
136-28	25198-25203	right	_
136-29	25204-25214	hemisphere	_
136-30	25214-25215	.	_

#Text=Neuroimaging studies in healthy subjects reported that the right hemisphere, especially in the right inferior frontal gyrus, is activated following successful response inhibition.
137-1	25216-25228	Neuroimaging	_
137-2	25229-25236	studies	_
137-3	25237-25239	in	_
137-4	25240-25247	healthy	_
137-5	25248-25256	subjects	_
137-6	25257-25265	reported	_
137-7	25266-25270	that	_
137-8	25271-25274	the	_
137-9	25275-25280	right	_
137-10	25281-25291	hemisphere	_
137-11	25291-25292	,	_
137-12	25293-25303	especially	_
137-13	25304-25306	in	_
137-14	25307-25310	the	_
137-15	25311-25316	right	_
137-16	25317-25325	inferior	_
137-17	25326-25333	frontal	_
137-18	25334-25339	gyrus	_
137-19	25339-25340	,	_
137-20	25341-25343	is	_
137-21	25344-25353	activated	_
137-22	25354-25363	following	_
137-23	25364-25374	successful	_
137-24	25375-25383	response	_
137-25	25384-25394	inhibition	_
137-26	25394-25395	.	_

#Text=During failed response inhibitions (i.e., trials that erroneously generated motor responses), the midline frontal structures, particularly the dorsomedial prefrontal cortex (dmPFC) encompassing pre-supplementary motor area and dorsal anterior cingulate cortex, are usually activated.
138-1	25396-25402	During	_
138-2	25403-25409	failed	_
138-3	25410-25418	response	_
138-4	25419-25430	inhibitions	_
138-5	25431-25432	(	_
138-6	25432-25435	i.e	_
138-7	25435-25436	.	_
138-8	25436-25437	,	_
138-9	25438-25444	trials	_
138-10	25445-25449	that	_
138-11	25450-25461	erroneously	_
138-12	25462-25471	generated	_
138-13	25472-25477	motor	_
138-14	25478-25487	responses	_
138-15	25487-25488	)	_
138-16	25488-25489	,	_
138-17	25490-25493	the	_
138-18	25494-25501	midline	_
138-19	25502-25509	frontal	_
138-20	25510-25520	structures	_
138-21	25520-25521	,	_
138-22	25522-25534	particularly	_
138-23	25535-25538	the	_
138-24	25539-25550	dorsomedial	_
138-25	25551-25561	prefrontal	_
138-26	25562-25568	cortex	_
138-27	25569-25570	(	_
138-28	25570-25575	dmPFC	_
138-29	25575-25576	)	_
138-30	25577-25589	encompassing	_
138-31	25590-25607	pre-supplementary	_
138-32	25608-25613	motor	_
138-33	25614-25618	area	_
138-34	25619-25622	and	_
138-35	25623-25629	dorsal	_
138-36	25630-25638	anterior	_
138-37	25639-25648	cingulate	_
138-38	25649-25655	cortex	_
138-39	25655-25656	,	_
138-40	25657-25660	are	_
138-41	25661-25668	usually	_
138-42	25669-25678	activated	_
138-43	25678-25679	.	_

#Text=Consequently, the right inferior frontal gyrus is critical for response inhibition, whereas dmPFC is associate with response monitoring, particularly conflict and error monitoring.
139-1	25680-25692	Consequently	_
139-2	25692-25693	,	_
139-3	25694-25697	the	_
139-4	25698-25703	right	_
139-5	25704-25712	inferior	_
139-6	25713-25720	frontal	_
139-7	25721-25726	gyrus	_
139-8	25727-25729	is	_
139-9	25730-25738	critical	_
139-10	25739-25742	for	_
139-11	25743-25751	response	_
139-12	25752-25762	inhibition	_
139-13	25762-25763	,	_
139-14	25764-25771	whereas	_
139-15	25772-25777	dmPFC	_
139-16	25778-25780	is	_
139-17	25781-25790	associate	_
139-18	25791-25795	with	_
139-19	25796-25804	response	_
139-20	25805-25815	monitoring	_
139-21	25815-25816	,	_
139-22	25817-25829	particularly	_
139-23	25830-25838	conflict	_
139-24	25839-25842	and	_
139-25	25843-25848	error	_
139-26	25849-25859	monitoring	_
139-27	25859-25860	.	_

#Text=The IGD subjects exhibited different rsFC with DLPFC in the orbital frontal cortex and temporal, occipital, and parietal lobes.
140-1	25861-25864	The	_
140-2	25865-25868	IGD	_
140-3	25869-25877	subjects	_
140-4	25878-25887	exhibited	_
140-5	25888-25897	different	_
140-6	25898-25902	rsFC	_
140-7	25903-25907	with	_
140-8	25908-25913	DLPFC	_
140-9	25914-25916	in	_
140-10	25917-25920	the	_
140-11	25921-25928	orbital	_
140-12	25929-25936	frontal	_
140-13	25937-25943	cortex	_
140-14	25944-25947	and	_
140-15	25948-25956	temporal	_
140-16	25956-25957	,	_
140-17	25958-25967	occipital	_
140-18	25967-25968	,	_
140-19	25969-25972	and	_
140-20	25973-25981	parietal	_
140-21	25982-25987	lobes	_
140-22	25987-25988	.	_

#Text=Our result was partly similar with the result of a previous research compared rsFC with DLPFC in alcohol dependence with those in IGD.
141-1	25989-25992	Our	_
141-2	25993-25999	result	_
141-3	26000-26003	was	_
141-4	26004-26010	partly	_
141-5	26011-26018	similar	_
141-6	26019-26023	with	_
141-7	26024-26027	the	_
141-8	26028-26034	result	_
141-9	26035-26037	of	_
141-10	26038-26039	a	_
141-11	26040-26048	previous	_
141-12	26049-26057	research	_
141-13	26058-26066	compared	_
141-14	26067-26071	rsFC	_
141-15	26072-26076	with	_
141-16	26077-26082	DLPFC	_
141-17	26083-26085	in	_
141-18	26086-26093	alcohol	_
141-19	26094-26104	dependence	_
141-20	26105-26109	with	_
141-21	26110-26115	those	_
141-22	26116-26118	in	_
141-23	26119-26122	IGD	_
141-24	26122-26123	.	_

#Text=They suggested that the connectivity observed in alcohol dependence is different from that in IGD because of the different comorbid diseases, early prevalence age, and visual and auditory stimulations in the former.
142-1	26124-26128	They	_
142-2	26129-26138	suggested	_
142-3	26139-26143	that	_
142-4	26144-26147	the	_
142-5	26148-26160	connectivity	_
142-6	26161-26169	observed	_
142-7	26170-26172	in	_
142-8	26173-26180	alcohol	_
142-9	26181-26191	dependence	_
142-10	26192-26194	is	_
142-11	26195-26204	different	_
142-12	26205-26209	from	_
142-13	26210-26214	that	_
142-14	26215-26217	in	_
142-15	26218-26221	IGD	_
142-16	26222-26229	because	_
142-17	26230-26232	of	_
142-18	26233-26236	the	_
142-19	26237-26246	different	_
142-20	26247-26255	comorbid	_
142-21	26256-26264	diseases	_
142-22	26264-26265	,	_
142-23	26266-26271	early	_
142-24	26272-26282	prevalence	_
142-25	26283-26286	age	_
142-26	26286-26287	,	_
142-27	26288-26291	and	_
142-28	26292-26298	visual	_
142-29	26299-26302	and	_
142-30	26303-26311	auditory	_
142-31	26312-26324	stimulations	_
142-32	26325-26327	in	_
142-33	26328-26331	the	_
142-34	26332-26338	former	_
142-35	26338-26339	.	_

#Text=Visual and auditory attentions are the results of the main sensory system inputs in response to internet game play.
143-1	26340-26346	Visual	_
143-2	26347-26350	and	_
143-3	26351-26359	auditory	_
143-4	26360-26370	attentions	_
143-5	26371-26374	are	_
143-6	26375-26378	the	_
143-7	26379-26386	results	_
143-8	26387-26389	of	_
143-9	26390-26393	the	_
143-10	26394-26398	main	_
143-11	26399-26406	sensory	_
143-12	26407-26413	system	_
143-13	26414-26420	inputs	_
143-14	26421-26423	in	_
143-15	26424-26432	response	_
143-16	26433-26435	to	_
143-17	26436-26444	internet	_
143-18	26445-26449	game	_
143-19	26450-26454	play	_
143-20	26454-26455	.	_

#Text=Visual acuity loss or hearing problems may cause by extreme internet gaming.
144-1	26456-26462	Visual	_
144-2	26463-26469	acuity	_
144-3	26470-26474	loss	_
144-4	26475-26477	or	_
144-5	26478-26485	hearing	_
144-6	26486-26494	problems	_
144-7	26495-26498	may	_
144-8	26499-26504	cause	_
144-9	26505-26507	by	_
144-10	26508-26515	extreme	_
144-11	26516-26524	internet	_
144-12	26525-26531	gaming	_
144-13	26531-26532	.	_

#Text=Increased cortical volume within the parietal cortex was related to long-term gaming in pro-gamers, and thus may be related to increased visuospatial attention.
145-1	26533-26542	Increased	_
145-2	26543-26551	cortical	_
145-3	26552-26558	volume	_
145-4	26559-26565	within	_
145-5	26566-26569	the	_
145-6	26570-26578	parietal	_
145-7	26579-26585	cortex	_
145-8	26586-26589	was	_
145-9	26590-26597	related	_
145-10	26598-26600	to	_
145-11	26601-26610	long-term	_
145-12	26611-26617	gaming	_
145-13	26618-26620	in	_
145-14	26621-26631	pro-gamers	_
145-15	26631-26632	,	_
145-16	26633-26636	and	_
145-17	26637-26641	thus	_
145-18	26642-26645	may	_
145-19	26646-26648	be	_
145-20	26649-26656	related	_
145-21	26657-26659	to	_
145-22	26660-26669	increased	_
145-23	26670-26682	visuospatial	_
145-24	26683-26692	attention	_
145-25	26692-26693	.	_

#Text=Naturally, this study also comes with limitations.
146-1	26694-26703	Naturally	_
146-2	26703-26704	,	_
146-3	26705-26709	this	_
146-4	26710-26715	study	_
146-5	26716-26720	also	_
146-6	26721-26726	comes	_
146-7	26727-26731	with	_
146-8	26732-26743	limitations	_
146-9	26743-26744	.	_

#Text=First, the cross-sectional design prevented us from determining whether the group differences in the rsFC are vulnerability factors for IGD and nicotine dependence.
147-1	26745-26750	First	_
147-2	26750-26751	,	_
147-3	26752-26755	the	_
147-4	26756-26771	cross-sectional	_
147-5	26772-26778	design	_
147-6	26779-26788	prevented	_
147-7	26789-26791	us	_
147-8	26792-26796	from	_
147-9	26797-26808	determining	_
147-10	26809-26816	whether	_
147-11	26817-26820	the	_
147-12	26821-26826	group	_
147-13	26827-26838	differences	_
147-14	26839-26841	in	_
147-15	26842-26845	the	_
147-16	26846-26850	rsFC	_
147-17	26851-26854	are	_
147-18	26855-26868	vulnerability	_
147-19	26869-26876	factors	_
147-20	26877-26880	for	_
147-21	26881-26884	IGD	_
147-22	26885-26888	and	_
147-23	26889-26897	nicotine	_
147-24	26898-26908	dependence	_
147-25	26908-26909	.	_

#Text=Second, the group sizes were unbalanced in our study, and the parameters such as sex, age, and education were not matched in the three groups.
148-1	26910-26916	Second	_
148-2	26916-26917	,	_
148-3	26918-26921	the	_
148-4	26922-26927	group	_
148-5	26928-26933	sizes	_
148-6	26934-26938	were	_
148-7	26939-26949	unbalanced	_
148-8	26950-26952	in	_
148-9	26953-26956	our	_
148-10	26957-26962	study	_
148-11	26962-26963	,	_
148-12	26964-26967	and	_
148-13	26968-26971	the	_
148-14	26972-26982	parameters	_
148-15	26983-26987	such	_
148-16	26988-26990	as	_
148-17	26991-26994	sex	_
148-18	26994-26995	,	_
148-19	26996-26999	age	_
148-20	26999-27000	,	_
148-21	27001-27004	and	_
148-22	27005-27014	education	_
148-23	27015-27019	were	_
148-24	27020-27023	not	_
148-25	27024-27031	matched	_
148-26	27032-27034	in	_
148-27	27035-27038	the	_
148-28	27039-27044	three	_
148-29	27045-27051	groups	_
148-30	27051-27052	.	_

#Text=The unbalance group sizes might have influenced the results even though the variety was controlled during the statistical analysis.
149-1	27053-27056	The	_
149-2	27057-27066	unbalance	_
149-3	27067-27072	group	_
149-4	27073-27078	sizes	_
149-5	27079-27084	might	_
149-6	27085-27089	have	_
149-7	27090-27100	influenced	_
149-8	27101-27104	the	_
149-9	27105-27112	results	_
149-10	27113-27117	even	_
149-11	27118-27124	though	_
149-12	27125-27128	the	_
149-13	27129-27136	variety	_
149-14	27137-27140	was	_
149-15	27141-27151	controlled	_
149-16	27152-27158	during	_
149-17	27159-27162	the	_
149-18	27163-27174	statistical	_
149-19	27175-27183	analysis	_
149-20	27183-27184	.	_

#Text=Third, the mean FTND in the SND group was 6.5, and thus the severity of nicotine dependence was not sufficiently high.
150-1	27185-27190	Third	_
150-2	27190-27191	,	_
150-3	27192-27195	the	_
150-4	27196-27200	mean	_
150-5	27201-27205	FTND	_
150-6	27206-27208	in	_
150-7	27209-27212	the	_
150-8	27213-27216	SND	_
150-9	27217-27222	group	_
150-10	27223-27226	was	_
150-11	27227-27230	6.5	_
150-12	27230-27231	,	_
150-13	27232-27235	and	_
150-14	27236-27240	thus	_
150-15	27241-27244	the	_
150-16	27245-27253	severity	_
150-17	27254-27256	of	_
150-18	27257-27265	nicotine	_
150-19	27266-27276	dependence	_
150-20	27277-27280	was	_
150-21	27281-27284	not	_
150-22	27285-27297	sufficiently	_
150-23	27298-27302	high	_
150-24	27302-27303	.	_

#Text=Thus, increasing the number of participants is necessary.
151-1	27304-27308	Thus	_
151-2	27308-27309	,	_
151-3	27310-27320	increasing	_
151-4	27321-27324	the	_
151-5	27325-27331	number	_
151-6	27332-27334	of	_
151-7	27335-27347	participants	_
151-8	27348-27350	is	_
151-9	27351-27360	necessary	_
151-10	27360-27361	.	_

#Text=Conclusion
#Text=The rsFC is a very powerful tool for exploring multifaceted neuropsychiatric diseases, such as substance and non-substance addiction at system level.
152-1	27362-27372	Conclusion	_
152-2	27373-27376	The	_
152-3	27377-27381	rsFC	_
152-4	27382-27384	is	_
152-5	27385-27386	a	_
152-6	27387-27391	very	_
152-7	27392-27400	powerful	_
152-8	27401-27405	tool	_
152-9	27406-27409	for	_
152-10	27410-27419	exploring	_
152-11	27420-27432	multifaceted	_
152-12	27433-27449	neuropsychiatric	_
152-13	27450-27458	diseases	_
152-14	27458-27459	,	_
152-15	27460-27464	such	_
152-16	27465-27467	as	_
152-17	27468-27477	substance	_
152-18	27478-27481	and	_
152-19	27482-27495	non-substance	_
152-20	27496-27505	addiction	_
152-21	27506-27508	at	_
152-22	27509-27515	system	_
152-23	27516-27521	level	_
152-24	27521-27522	.	_

#Text=Our results confirmed that nicotine dependence and IGD may share similar mechanisms related to craving and impulsive inhibition.
153-1	27523-27526	Our	_
153-2	27527-27534	results	_
153-3	27535-27544	confirmed	_
153-4	27545-27549	that	_
153-5	27550-27558	nicotine	_
153-6	27559-27569	dependence	_
153-7	27570-27573	and	_
153-8	27574-27577	IGD	_
153-9	27578-27581	may	_
153-10	27582-27587	share	_
153-11	27588-27595	similar	_
153-12	27596-27606	mechanisms	_
153-13	27607-27614	related	_
153-14	27615-27617	to	_
153-15	27618-27625	craving	_
153-16	27626-27629	and	_
153-17	27630-27639	impulsive	_
153-18	27640-27650	inhibition	_
153-19	27650-27651	.	_

#Text=The observed difference between the rsFC of subjects with IGD and those of SND may be attributed to the impairments in audiovisual information processing by long-term internet gaming.
154-1	27652-27655	The	_
154-2	27656-27664	observed	_
154-3	27665-27675	difference	_
154-4	27676-27683	between	_
154-5	27684-27687	the	_
154-6	27688-27692	rsFC	_
154-7	27693-27695	of	_
154-8	27696-27704	subjects	_
154-9	27705-27709	with	_
154-10	27710-27713	IGD	_
154-11	27714-27717	and	_
154-12	27718-27723	those	_
154-13	27724-27726	of	_
154-14	27727-27730	SND	_
154-15	27731-27734	may	_
154-16	27735-27737	be	_
154-17	27738-27748	attributed	_
154-18	27749-27751	to	_
154-19	27752-27755	the	_
154-20	27756-27767	impairments	_
154-21	27768-27770	in	_
154-22	27771-27782	audiovisual	_
154-23	27783-27794	information	_
154-24	27795-27805	processing	_
154-25	27806-27808	by	_
154-26	27809-27818	long-term	_
154-27	27819-27827	internet	_
154-28	27828-27834	gaming	_
154-29	27834-27835	.	_

#Text=Abbreviations
#Text=IGD
#Text=internet gaming disorder
#Text=SND
#Text=smokers with nicotine dependence
#Text=rsFC
#Text=resting-state functional connectivity
#Text=DLPFC
#Text=dorsolateral prefrontal cortex
#Text=HC
#Text=healthy controls
#Text=rs-fMRI
#Text=resting-state functional magnetic resonance imaging
#Text=PCC
#Text=post cingulate cortex
#Text=CIAS
#Text=Chen’s internet addiction score
#Text=AD
#Text=alcohol dependence
#Text=SUD
#Text=substance-related disorders
#Text=SAS
#Text=self-rating anxiety scale
#Text=SDS
#Text=self-rating depression scale
#Text=BIS-11
#Text=Barratt impulsiveness scale-11
#Text=FTND
#Text=Fagerstrom test of nicotine dependence
#Text=TR
#Text=repetition time
#Text=TE
#Text=echo time
#Text=FOV
#Text=field of view
#Text=FD
#Text=framewise displacement
#Text=ROI
#Text=region of interest
#Text=AFNI
#Text=Analysis of Functional Neuroimages
#Text=dmPFC
#Text=dorsomedial prefrontal cortex
#Text=Xin Ge and Yawen Sun have contributed equally to this work
#Text=References
#Text=The prefrontal dysfunction in individuals with internet gaming disorder: a meta-analysis of functional magnetic resonance imaging studies
#Text=Reward/punishment sensitivities among internet addicts: implications for their addictive behaviors
#Text=Perspective: behavioural addictions matter
#Text=Psychology of computer use: XL.
155-1	27836-27849	Abbreviations	_
155-2	27850-27853	IGD	_
155-3	27854-27862	internet	_
155-4	27863-27869	gaming	_
155-5	27870-27878	disorder	_
155-6	27879-27882	SND	_
155-7	27883-27890	smokers	_
155-8	27891-27895	with	_
155-9	27896-27904	nicotine	_
155-10	27905-27915	dependence	_
155-11	27916-27920	rsFC	_
155-12	27921-27934	resting-state	_
155-13	27935-27945	functional	_
155-14	27946-27958	connectivity	_
155-15	27959-27964	DLPFC	_
155-16	27965-27977	dorsolateral	_
155-17	27978-27988	prefrontal	_
155-18	27989-27995	cortex	_
155-19	27996-27998	HC	_
155-20	27999-28006	healthy	_
155-21	28007-28015	controls	_
155-22	28016-28023	rs-fMRI	_
155-23	28024-28037	resting-state	_
155-24	28038-28048	functional	_
155-25	28049-28057	magnetic	_
155-26	28058-28067	resonance	_
155-27	28068-28075	imaging	_
155-28	28076-28079	PCC	_
155-29	28080-28084	post	_
155-30	28085-28094	cingulate	_
155-31	28095-28101	cortex	_
155-32	28102-28106	CIAS	_
155-33	28107-28111	Chen	_
155-34	28111-28112	’	_
155-35	28112-28113	s	_
155-36	28114-28122	internet	_
155-37	28123-28132	addiction	_
155-38	28133-28138	score	_
155-39	28139-28141	AD	_
155-40	28142-28149	alcohol	_
155-41	28150-28160	dependence	_
155-42	28161-28164	SUD	_
155-43	28165-28182	substance-related	_
155-44	28183-28192	disorders	_
155-45	28193-28196	SAS	_
155-46	28197-28208	self-rating	_
155-47	28209-28216	anxiety	_
155-48	28217-28222	scale	_
155-49	28223-28226	SDS	_
155-50	28227-28238	self-rating	_
155-51	28239-28249	depression	_
155-52	28250-28255	scale	_
155-53	28256-28259	BIS	_
155-54	28259-28260	-	_
155-55	28260-28262	11	_
155-56	28263-28270	Barratt	_
155-57	28271-28284	impulsiveness	_
155-58	28285-28290	scale	_
155-59	28290-28291	-	_
155-60	28291-28293	11	_
155-61	28294-28298	FTND	_
155-62	28299-28309	Fagerstrom	_
155-63	28310-28314	test	_
155-64	28315-28317	of	_
155-65	28318-28326	nicotine	_
155-66	28327-28337	dependence	_
155-67	28338-28340	TR	_
155-68	28341-28351	repetition	_
155-69	28352-28356	time	_
155-70	28357-28359	TE	_
155-71	28360-28364	echo	_
155-72	28365-28369	time	_
155-73	28370-28373	FOV	_
155-74	28374-28379	field	_
155-75	28380-28382	of	_
155-76	28383-28387	view	_
155-77	28388-28390	FD	_
155-78	28391-28400	framewise	_
155-79	28401-28413	displacement	_
155-80	28414-28417	ROI	_
155-81	28418-28424	region	_
155-82	28425-28427	of	_
155-83	28428-28436	interest	_
155-84	28437-28441	AFNI	_
155-85	28442-28450	Analysis	_
155-86	28451-28453	of	_
155-87	28454-28464	Functional	_
155-88	28465-28476	Neuroimages	_
155-89	28477-28482	dmPFC	_
155-90	28483-28494	dorsomedial	_
155-91	28495-28505	prefrontal	_
155-92	28506-28512	cortex	_
155-93	28513-28516	Xin	_
155-94	28517-28519	Ge	_
155-95	28520-28523	and	_
155-96	28524-28529	Yawen	_
155-97	28530-28533	Sun	_
155-98	28534-28538	have	_
155-99	28539-28550	contributed	_
155-100	28551-28558	equally	_
155-101	28559-28561	to	_
155-102	28562-28566	this	_
155-103	28567-28571	work	_
155-104	28572-28582	References	_
155-105	28583-28586	The	_
155-106	28587-28597	prefrontal	_
155-107	28598-28609	dysfunction	_
155-108	28610-28612	in	_
155-109	28613-28624	individuals	_
155-110	28625-28629	with	_
155-111	28630-28638	internet	_
155-112	28639-28645	gaming	_
155-113	28646-28654	disorder	_
155-114	28654-28655	:	_
155-115	28656-28657	a	_
155-116	28658-28671	meta-analysis	_
155-117	28672-28674	of	_
155-118	28675-28685	functional	_
155-119	28686-28694	magnetic	_
155-120	28695-28704	resonance	_
155-121	28705-28712	imaging	_
155-122	28713-28720	studies	_
155-123	28721-28727	Reward	_
155-124	28727-28728	/	_
155-125	28728-28738	punishment	_
155-126	28739-28752	sensitivities	_
155-127	28753-28758	among	_
155-128	28759-28767	internet	_
155-129	28768-28775	addicts	_
155-130	28775-28776	:	_
155-131	28777-28789	implications	_
155-132	28790-28793	for	_
155-133	28794-28799	their	_
155-134	28800-28809	addictive	_
155-135	28810-28819	behaviors	_
155-136	28820-28831	Perspective	_
155-137	28831-28832	:	_
155-138	28833-28844	behavioural	_
155-139	28845-28855	addictions	_
155-140	28856-28862	matter	_
155-141	28863-28873	Psychology	_
155-142	28874-28876	of	_
155-143	28877-28885	computer	_
155-144	28886-28889	use	_
155-145	28889-28890	:	_
155-146	28891-28893	XL	_
155-147	28893-28894	.	_

#Text=Addictive use of the internet: a case that breaks the stereotype
#Text=A case of problematic internet use successfully treated with an SSRI-antipsychotic combination
#Text=Problematic internet use: proposed classification and diagnostic criteria
#Text=The brain activations for both cue-induced gaming urge and smoking craving among subjects comorbid with internet gaming addiction and nicotine dependence
#Text=Differences in functional connectivity between alcohol dependence and internet gaming disorder
#Text=Different resting-state functional connectivity alterations in smokers and nonsmokers with internet gaming addiction
#Text=Substance abuse precedes internet addiction
#Text=More than a just a game: video game and internet use during emerging adulthood
#Text=D VDM: the (co-)occurrence of problematic video gaming, substance use, and psychosocial problems in adolescents
#Text=Brain activities associated with gaming urge of online gaming addiction
#Text=Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task
#Text=Associations between the risk of internet addiction and problem behaviors among Korean Adolescents
#Text=Alterations of resting state functional network connectivity in the brain of nicotine and alcohol users
#Text=Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues
#Text=Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies
#Text=Modification in the proposed diagnostic criteria for internet addiction
#Text=
#Text=Development of Chinese Internet Addiction Scale and its psychometric study
#Text=A rating instrument for anxiety disorders
#Text=A self-rating depression scale
#Text=Factor structure of the Barratt impulsiveness scale
#Text=The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire
#Text=Screening for internet addiction: an empirical study on cut-off points for the Chen Internet Addiction Scale
#Text=DPABI: data processing & analysis for (resting-state) brain imaging
#Text=Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion
#Text=Functional connectivity in the resting brain: a network analysis of the default mode hypothesis
#Text=Functional connectivity in the motor cortex of resting human brain using echo-planar MRI
#Text=Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations
#Text=The cognitive psychology of lottery gambling: a theoretical review
#Text=AFNI: software for analysis and visualization of functional magnetic resonance neuroimages
#Text=Reframing video gaming and internet use addiction: empirical cross-national comparison of heavy use over time and addiction scales among young users
#Text=Neural correlates of substance abuse: reduced functional connectivity between areas underlying reward and cognitive control
#Text=Individual differences in prefrontal cortex function and the transition from drug use to drug dependence
#Text=New developments in brain research of internet and gaming disorder
#Text=A cognitive-behavioral model of internet gaming disorder: theoretical underpinnings and clinical implications
#Text=Du X, Yang Y, Gao P, Qi X, Du G, Zhang Y, Li X, Zhang Q.
156-1	28895-28904	Addictive	_
156-2	28905-28908	use	_
156-3	28909-28911	of	_
156-4	28912-28915	the	_
156-5	28916-28924	internet	_
156-6	28924-28925	:	_
156-7	28926-28927	a	_
156-8	28928-28932	case	_
156-9	28933-28937	that	_
156-10	28938-28944	breaks	_
156-11	28945-28948	the	_
156-12	28949-28959	stereotype	_
156-13	28960-28961	A	_
156-14	28962-28966	case	_
156-15	28967-28969	of	_
156-16	28970-28981	problematic	_
156-17	28982-28990	internet	_
156-18	28991-28994	use	_
156-19	28995-29007	successfully	_
156-20	29008-29015	treated	_
156-21	29016-29020	with	_
156-22	29021-29023	an	_
156-23	29024-29042	SSRI-antipsychotic	_
156-24	29043-29054	combination	_
156-25	29055-29066	Problematic	_
156-26	29067-29075	internet	_
156-27	29076-29079	use	_
156-28	29079-29080	:	_
156-29	29081-29089	proposed	_
156-30	29090-29104	classification	_
156-31	29105-29108	and	_
156-32	29109-29119	diagnostic	_
156-33	29120-29128	criteria	_
156-34	29129-29132	The	_
156-35	29133-29138	brain	_
156-36	29139-29150	activations	_
156-37	29151-29154	for	_
156-38	29155-29159	both	_
156-39	29160-29171	cue-induced	_
156-40	29172-29178	gaming	_
156-41	29179-29183	urge	_
156-42	29184-29187	and	_
156-43	29188-29195	smoking	_
156-44	29196-29203	craving	_
156-45	29204-29209	among	_
156-46	29210-29218	subjects	_
156-47	29219-29227	comorbid	_
156-48	29228-29232	with	_
156-49	29233-29241	internet	_
156-50	29242-29248	gaming	_
156-51	29249-29258	addiction	_
156-52	29259-29262	and	_
156-53	29263-29271	nicotine	_
156-54	29272-29282	dependence	_
156-55	29283-29294	Differences	_
156-56	29295-29297	in	_
156-57	29298-29308	functional	_
156-58	29309-29321	connectivity	_
156-59	29322-29329	between	_
156-60	29330-29337	alcohol	_
156-61	29338-29348	dependence	_
156-62	29349-29352	and	_
156-63	29353-29361	internet	_
156-64	29362-29368	gaming	_
156-65	29369-29377	disorder	_
156-66	29378-29387	Different	_
156-67	29388-29401	resting-state	_
156-68	29402-29412	functional	_
156-69	29413-29425	connectivity	_
156-70	29426-29437	alterations	_
156-71	29438-29440	in	_
156-72	29441-29448	smokers	_
156-73	29449-29452	and	_
156-74	29453-29463	nonsmokers	_
156-75	29464-29468	with	_
156-76	29469-29477	internet	_
156-77	29478-29484	gaming	_
156-78	29485-29494	addiction	_
156-79	29495-29504	Substance	_
156-80	29505-29510	abuse	_
156-81	29511-29519	precedes	_
156-82	29520-29528	internet	_
156-83	29529-29538	addiction	_
156-84	29539-29543	More	_
156-85	29544-29548	than	_
156-86	29549-29550	a	_
156-87	29551-29555	just	_
156-88	29556-29557	a	_
156-89	29558-29562	game	_
156-90	29562-29563	:	_
156-91	29564-29569	video	_
156-92	29570-29574	game	_
156-93	29575-29578	and	_
156-94	29579-29587	internet	_
156-95	29588-29591	use	_
156-96	29592-29598	during	_
156-97	29599-29607	emerging	_
156-98	29608-29617	adulthood	_
156-99	29618-29619	D	_
156-100	29620-29623	VDM	_
156-101	29623-29624	:	_
156-102	29625-29628	the	_
156-103	29629-29630	(	_
156-104	29630-29632	co	_
156-105	29632-29633	-	_
156-106	29633-29634	)	_
156-107	29634-29644	occurrence	_
156-108	29645-29647	of	_
156-109	29648-29659	problematic	_
156-110	29660-29665	video	_
156-111	29666-29672	gaming	_
156-112	29672-29673	,	_
156-113	29674-29683	substance	_
156-114	29684-29687	use	_
156-115	29687-29688	,	_
156-116	29689-29692	and	_
156-117	29693-29705	psychosocial	_
156-118	29706-29714	problems	_
156-119	29715-29717	in	_
156-120	29718-29729	adolescents	_
156-121	29730-29735	Brain	_
156-122	29736-29746	activities	_
156-123	29747-29757	associated	_
156-124	29758-29762	with	_
156-125	29763-29769	gaming	_
156-126	29770-29774	urge	_
156-127	29775-29777	of	_
156-128	29778-29784	online	_
156-129	29785-29791	gaming	_
156-130	29792-29801	addiction	_
156-131	29802-29809	Similar	_
156-132	29810-29828	hyporesponsiveness	_
156-133	29829-29831	of	_
156-134	29832-29835	the	_
156-135	29836-29847	dorsomedial	_
156-136	29848-29858	prefrontal	_
156-137	29859-29865	cortex	_
156-138	29866-29868	in	_
156-139	29869-29876	problem	_
156-140	29877-29885	gamblers	_
156-141	29886-29889	and	_
156-142	29890-29895	heavy	_
156-143	29896-29903	smokers	_
156-144	29904-29910	during	_
156-145	29911-29913	an	_
156-146	29914-29924	inhibitory	_
156-147	29925-29932	control	_
156-148	29933-29937	task	_
156-149	29938-29950	Associations	_
156-150	29951-29958	between	_
156-151	29959-29962	the	_
156-152	29963-29967	risk	_
156-153	29968-29970	of	_
156-154	29971-29979	internet	_
156-155	29980-29989	addiction	_
156-156	29990-29993	and	_
156-157	29994-30001	problem	_
156-158	30002-30011	behaviors	_
156-159	30012-30017	among	_
156-160	30018-30024	Korean	_
156-161	30025-30036	Adolescents	_
156-162	30037-30048	Alterations	_
156-163	30049-30051	of	_
156-164	30052-30059	resting	_
156-165	30060-30065	state	_
156-166	30066-30076	functional	_
156-167	30077-30084	network	_
156-168	30085-30097	connectivity	_
156-169	30098-30100	in	_
156-170	30101-30104	the	_
156-171	30105-30110	brain	_
156-172	30111-30113	of	_
156-173	30114-30122	nicotine	_
156-174	30123-30126	and	_
156-175	30127-30134	alcohol	_
156-176	30135-30140	users	_
156-177	30141-30151	Activation	_
156-178	30152-30154	of	_
156-179	30155-30165	prefrontal	_
156-180	30166-30172	cortex	_
156-181	30173-30176	and	_
156-182	30177-30185	anterior	_
156-183	30186-30194	thalamus	_
156-184	30195-30197	in	_
156-185	30198-30207	alcoholic	_
156-186	30208-30216	subjects	_
156-187	30217-30219	on	_
156-188	30220-30228	exposure	_
156-189	30229-30231	to	_
156-190	30232-30248	alcohol-specific	_
156-191	30249-30253	cues	_
156-192	30254-30261	Factors	_
156-193	30262-30272	modulating	_
156-194	30273-30279	neural	_
156-195	30280-30290	reactivity	_
156-196	30291-30293	to	_
156-197	30294-30298	drug	_
156-198	30299-30303	cues	_
156-199	30304-30306	in	_
156-200	30307-30316	addiction	_
156-201	30316-30317	:	_
156-202	30318-30319	a	_
156-203	30320-30326	survey	_
156-204	30327-30329	of	_
156-205	30330-30335	human	_
156-206	30336-30348	neuroimaging	_
156-207	30349-30356	studies	_
156-208	30357-30369	Modification	_
156-209	30370-30372	in	_
156-210	30373-30376	the	_
156-211	30377-30385	proposed	_
156-212	30386-30396	diagnostic	_
156-213	30397-30405	criteria	_
156-214	30406-30409	for	_
156-215	30410-30418	internet	_
156-216	30419-30428	addiction	_
156-217	30430-30441	Development	_
156-218	30442-30444	of	_
156-219	30445-30452	Chinese	_
156-220	30453-30461	Internet	_
156-221	30462-30471	Addiction	_
156-222	30472-30477	Scale	_
156-223	30478-30481	and	_
156-224	30482-30485	its	_
156-225	30486-30498	psychometric	_
156-226	30499-30504	study	_
156-227	30505-30506	A	_
156-228	30507-30513	rating	_
156-229	30514-30524	instrument	_
156-230	30525-30528	for	_
156-231	30529-30536	anxiety	_
156-232	30537-30546	disorders	_
156-233	30547-30548	A	_
156-234	30549-30560	self-rating	_
156-235	30561-30571	depression	_
156-236	30572-30577	scale	_
156-237	30578-30584	Factor	_
156-238	30585-30594	structure	_
156-239	30595-30597	of	_
156-240	30598-30601	the	_
156-241	30602-30609	Barratt	_
156-242	30610-30623	impulsiveness	_
156-243	30624-30629	scale	_
156-244	30630-30633	The	_
156-245	30634-30644	Fagerstrom	_
156-246	30645-30649	test	_
156-247	30650-30653	for	_
156-248	30654-30662	nicotine	_
156-249	30663-30673	dependence	_
156-250	30673-30674	:	_
156-251	30675-30676	a	_
156-252	30677-30685	revision	_
156-253	30686-30688	of	_
156-254	30689-30692	the	_
156-255	30693-30703	Fagerstrom	_
156-256	30704-30713	Tolerance	_
156-257	30714-30727	Questionnaire	_
156-258	30728-30737	Screening	_
156-259	30738-30741	for	_
156-260	30742-30750	internet	_
156-261	30751-30760	addiction	_
156-262	30760-30761	:	_
156-263	30762-30764	an	_
156-264	30765-30774	empirical	_
156-265	30775-30780	study	_
156-266	30781-30783	on	_
156-267	30784-30791	cut-off	_
156-268	30792-30798	points	_
156-269	30799-30802	for	_
156-270	30803-30806	the	_
156-271	30807-30811	Chen	_
156-272	30812-30820	Internet	_
156-273	30821-30830	Addiction	_
156-274	30831-30836	Scale	_
156-275	30837-30842	DPABI	_
156-276	30842-30843	:	_
156-277	30844-30848	data	_
156-278	30849-30859	processing	_
156-279	30860-30861	&	_
156-280	30862-30870	analysis	_
156-281	30871-30874	for	_
156-282	30875-30876	(	_
156-283	30876-30889	resting-state	_
156-284	30889-30890	)	_
156-285	30891-30896	brain	_
156-286	30897-30904	imaging	_
156-287	30905-30913	Spurious	_
156-288	30914-30917	but	_
156-289	30918-30928	systematic	_
156-290	30929-30941	correlations	_
156-291	30942-30944	in	_
156-292	30945-30955	functional	_
156-293	30956-30968	connectivity	_
156-294	30969-30972	MRI	_
156-295	30973-30981	networks	_
156-296	30982-30987	arise	_
156-297	30988-30992	from	_
156-298	30993-31000	subject	_
156-299	31001-31007	motion	_
156-300	31008-31018	Functional	_
156-301	31019-31031	connectivity	_
156-302	31032-31034	in	_
156-303	31035-31038	the	_
156-304	31039-31046	resting	_
156-305	31047-31052	brain	_
156-306	31052-31053	:	_
156-307	31054-31055	a	_
156-308	31056-31063	network	_
156-309	31064-31072	analysis	_
156-310	31073-31075	of	_
156-311	31076-31079	the	_
156-312	31080-31087	default	_
156-313	31088-31092	mode	_
156-314	31093-31103	hypothesis	_
156-315	31104-31114	Functional	_
156-316	31115-31127	connectivity	_
156-317	31128-31130	in	_
156-318	31131-31134	the	_
156-319	31135-31140	motor	_
156-320	31141-31147	cortex	_
156-321	31148-31150	of	_
156-322	31151-31158	resting	_
156-323	31159-31164	human	_
156-324	31165-31170	brain	_
156-325	31171-31176	using	_
156-326	31177-31188	echo-planar	_
156-327	31189-31192	MRI	_
156-328	31193-31203	Functional	_
156-329	31204-31216	connectivity	_
156-330	31217-31219	in	_
156-331	31220-31226	single	_
156-332	31227-31230	and	_
156-333	31231-31241	multislice	_
156-334	31242-31252	echoplanar	_
156-335	31253-31260	imaging	_
156-336	31261-31266	using	_
156-337	31267-31280	resting-state	_
156-338	31281-31293	fluctuations	_
156-339	31294-31297	The	_
156-340	31298-31307	cognitive	_
156-341	31308-31318	psychology	_
156-342	31319-31321	of	_
156-343	31322-31329	lottery	_
156-344	31330-31338	gambling	_
156-345	31338-31339	:	_
156-346	31340-31341	a	_
156-347	31342-31353	theoretical	_
156-348	31354-31360	review	_
156-349	31361-31365	AFNI	_
156-350	31365-31366	:	_
156-351	31367-31375	software	_
156-352	31376-31379	for	_
156-353	31380-31388	analysis	_
156-354	31389-31392	and	_
156-355	31393-31406	visualization	_
156-356	31407-31409	of	_
156-357	31410-31420	functional	_
156-358	31421-31429	magnetic	_
156-359	31430-31439	resonance	_
156-360	31440-31451	neuroimages	_
156-361	31452-31461	Reframing	_
156-362	31462-31467	video	_
156-363	31468-31474	gaming	_
156-364	31475-31478	and	_
156-365	31479-31487	internet	_
156-366	31488-31491	use	_
156-367	31492-31501	addiction	_
156-368	31501-31502	:	_
156-369	31503-31512	empirical	_
156-370	31513-31527	cross-national	_
156-371	31528-31538	comparison	_
156-372	31539-31541	of	_
156-373	31542-31547	heavy	_
156-374	31548-31551	use	_
156-375	31552-31556	over	_
156-376	31557-31561	time	_
156-377	31562-31565	and	_
156-378	31566-31575	addiction	_
156-379	31576-31582	scales	_
156-380	31583-31588	among	_
156-381	31589-31594	young	_
156-382	31595-31600	users	_
156-383	31601-31607	Neural	_
156-384	31608-31618	correlates	_
156-385	31619-31621	of	_
156-386	31622-31631	substance	_
156-387	31632-31637	abuse	_
156-388	31637-31638	:	_
156-389	31639-31646	reduced	_
156-390	31647-31657	functional	_
156-391	31658-31670	connectivity	_
156-392	31671-31678	between	_
156-393	31679-31684	areas	_
156-394	31685-31695	underlying	_
156-395	31696-31702	reward	_
156-396	31703-31706	and	_
156-397	31707-31716	cognitive	_
156-398	31717-31724	control	_
156-399	31725-31735	Individual	_
156-400	31736-31747	differences	_
156-401	31748-31750	in	_
156-402	31751-31761	prefrontal	_
156-403	31762-31768	cortex	_
156-404	31769-31777	function	_
156-405	31778-31781	and	_
156-406	31782-31785	the	_
156-407	31786-31796	transition	_
156-408	31797-31801	from	_
156-409	31802-31806	drug	_
156-410	31807-31810	use	_
156-411	31811-31813	to	_
156-412	31814-31818	drug	_
156-413	31819-31829	dependence	_
156-414	31830-31833	New	_
156-415	31834-31846	developments	_
156-416	31847-31849	in	_
156-417	31850-31855	brain	_
156-418	31856-31864	research	_
156-419	31865-31867	of	_
156-420	31868-31876	internet	_
156-421	31877-31880	and	_
156-422	31881-31887	gaming	_
156-423	31888-31896	disorder	_
156-424	31897-31898	A	_
156-425	31899-31919	cognitive-behavioral	_
156-426	31920-31925	model	_
156-427	31926-31928	of	_
156-428	31929-31937	internet	_
156-429	31938-31944	gaming	_
156-430	31945-31953	disorder	_
156-431	31953-31954	:	_
156-432	31955-31966	theoretical	_
156-433	31967-31980	underpinnings	_
156-434	31981-31984	and	_
156-435	31985-31993	clinical	_
156-436	31994-32006	implications	_
156-437	32007-32009	Du	_
156-438	32010-32011	X	_
156-439	32011-32012	,	_
156-440	32013-32017	Yang	_
156-441	32018-32019	Y	_
156-442	32019-32020	,	_
156-443	32021-32024	Gao	_
156-444	32025-32026	P	_
156-445	32026-32027	,	_
156-446	32028-32030	Qi	_
156-447	32031-32032	X	_
156-448	32032-32033	,	_
156-449	32034-32036	Du	_
156-450	32037-32038	G	_
156-451	32038-32039	,	_
156-452	32040-32045	Zhang	_
156-453	32046-32047	Y	_
156-454	32047-32048	,	_
156-455	32049-32051	Li	_
156-456	32052-32053	X	_
156-457	32053-32054	,	_
156-458	32055-32060	Zhang	_
156-459	32061-32062	Q	_
156-460	32062-32063	.	_

#Text=Compensatory increase of functional connectivity density in adolescents with internet gaming disorder.
157-1	32064-32076	Compensatory	_
157-2	32077-32085	increase	_
157-3	32086-32088	of	_
157-4	32089-32099	functional	_
157-5	32100-32112	connectivity	_
157-6	32113-32120	density	_
157-7	32121-32123	in	_
157-8	32124-32135	adolescents	_
157-9	32136-32140	with	_
157-10	32141-32149	internet	_
157-11	32150-32156	gaming	_
157-12	32157-32165	disorder	_
157-13	32165-32166	.	_

#Text=Brain Imaging Behav. 2016. doi:10.1007/s11682-016-9655-x.
158-1	32167-32172	Brain	_
158-2	32173-32180	Imaging	_
158-3	32181-32186	Behav	_
158-4	32186-32187	.	_
158-5	32188-32192	2016	_
158-6	32192-32193	.	_
158-7	32194-32197	doi	_
158-8	32197-32198	:	_
158-9	32198-32205	10.1007	_
158-10	32205-32206	/	_
158-11	32206-32212	s11682	_
158-12	32212-32213	-	_
158-13	32213-32216	016	_
158-14	32216-32217	-	_
158-15	32217-32221	9655	_
158-16	32221-32222	-	_
158-17	32222-32223	x	_
158-18	32223-32224	.	_

#Text=Microstructure abnormalities in adolescents with internet addiction disorder
#Text=Common fronto-parietal activity in attention, memory, and consciousness: shared demands on integration?
159-1	32225-32239	Microstructure	_
159-2	32240-32253	abnormalities	_
159-3	32254-32256	in	_
159-4	32257-32268	adolescents	_
159-5	32269-32273	with	_
159-6	32274-32282	internet	_
159-7	32283-32292	addiction	_
159-8	32293-32301	disorder	_
159-9	32302-32308	Common	_
159-10	32309-32324	fronto-parietal	_
159-11	32325-32333	activity	_
159-12	32334-32336	in	_
159-13	32337-32346	attention	_
159-14	32346-32347	,	_
159-15	32348-32354	memory	_
159-16	32354-32355	,	_
159-17	32356-32359	and	_
159-18	32360-32373	consciousness	_
159-19	32373-32374	:	_
159-20	32375-32381	shared	_
159-21	32382-32389	demands	_
159-22	32390-32392	on	_
159-23	32393-32404	integration	_
159-24	32404-32405	?	_

#Text=Brain basis of developmental change in visuospatial working memory
#Text=The role of dorsolateral prefrontal cortex in inhibition mechanism: a study on cognitive reflection test and similar tasks through neuromodulation
#Text=Mnemonic function of the dorsolateral prefrontal cortex in conflict-induced behavioral adjustment
#Text=Behavioral and neural mechanisms of compulsive drug seeking
#Text=Neural systems and cue-induced cocaine craving
#Text=Right anterior insula connectivity is important for cue-induced craving in nicotine-dependent smokers
#Text=Current smoking and reduced gray matter volume—a voxel-based morphometry study
#Text=Brain grey matter deficits in smokers: focus on the cerebellum
#Text=The effects of chronic cigarette smoking on gray matter volume: influence of sex
#Text=Functional characteristics of the brain in college students with internet gaming disorder
#Text=Opiate addicts lack error-dependent activation of rostral anterior cingulate
#Text=The role of the right inferior frontal gyrus: inhibition and attentional control
#Text=Dorsal medial prefrontal cortex plays a necessary role in rapid error prediction in humans
#Text=Alterations in regional homogeneity of resting-state brain activity in internet gaming addicts
#Text=Environmental and genetic factors in age-related hearing impairment
#Text=Increased cortical thickness in professional on-line gamers
#Text=Comparison of brain activation in response to two dimensional and three dimensional on-line games
160-1	32406-32411	Brain	_
160-2	32412-32417	basis	_
160-3	32418-32420	of	_
160-4	32421-32434	developmental	_
160-5	32435-32441	change	_
160-6	32442-32444	in	_
160-7	32445-32457	visuospatial	_
160-8	32458-32465	working	_
160-9	32466-32472	memory	_
160-10	32473-32476	The	_
160-11	32477-32481	role	_
160-12	32482-32484	of	_
160-13	32485-32497	dorsolateral	_
160-14	32498-32508	prefrontal	_
160-15	32509-32515	cortex	_
160-16	32516-32518	in	_
160-17	32519-32529	inhibition	_
160-18	32530-32539	mechanism	_
160-19	32539-32540	:	_
160-20	32541-32542	a	_
160-21	32543-32548	study	_
160-22	32549-32551	on	_
160-23	32552-32561	cognitive	_
160-24	32562-32572	reflection	_
160-25	32573-32577	test	_
160-26	32578-32581	and	_
160-27	32582-32589	similar	_
160-28	32590-32595	tasks	_
160-29	32596-32603	through	_
160-30	32604-32619	neuromodulation	_
160-31	32620-32628	Mnemonic	_
160-32	32629-32637	function	_
160-33	32638-32640	of	_
160-34	32641-32644	the	_
160-35	32645-32657	dorsolateral	_
160-36	32658-32668	prefrontal	_
160-37	32669-32675	cortex	_
160-38	32676-32678	in	_
160-39	32679-32695	conflict-induced	_
160-40	32696-32706	behavioral	_
160-41	32707-32717	adjustment	_
160-42	32718-32728	Behavioral	_
160-43	32729-32732	and	_
160-44	32733-32739	neural	_
160-45	32740-32750	mechanisms	_
160-46	32751-32753	of	_
160-47	32754-32764	compulsive	_
160-48	32765-32769	drug	_
160-49	32770-32777	seeking	_
160-50	32778-32784	Neural	_
160-51	32785-32792	systems	_
160-52	32793-32796	and	_
160-53	32797-32808	cue-induced	_
160-54	32809-32816	cocaine	_
160-55	32817-32824	craving	_
160-56	32825-32830	Right	_
160-57	32831-32839	anterior	_
160-58	32840-32846	insula	_
160-59	32847-32859	connectivity	_
160-60	32860-32862	is	_
160-61	32863-32872	important	_
160-62	32873-32876	for	_
160-63	32877-32888	cue-induced	_
160-64	32889-32896	craving	_
160-65	32897-32899	in	_
160-66	32900-32918	nicotine-dependent	_
160-67	32919-32926	smokers	_
160-68	32927-32934	Current	_
160-69	32935-32942	smoking	_
160-70	32943-32946	and	_
160-71	32947-32954	reduced	_
160-72	32955-32959	gray	_
160-73	32960-32966	matter	_
160-74	32967-32975	volume—a	_
160-75	32976-32987	voxel-based	_
160-76	32988-32999	morphometry	_
160-77	33000-33005	study	_
160-78	33006-33011	Brain	_
160-79	33012-33016	grey	_
160-80	33017-33023	matter	_
160-81	33024-33032	deficits	_
160-82	33033-33035	in	_
160-83	33036-33043	smokers	_
160-84	33043-33044	:	_
160-85	33045-33050	focus	_
160-86	33051-33053	on	_
160-87	33054-33057	the	_
160-88	33058-33068	cerebellum	_
160-89	33069-33072	The	_
160-90	33073-33080	effects	_
160-91	33081-33083	of	_
160-92	33084-33091	chronic	_
160-93	33092-33101	cigarette	_
160-94	33102-33109	smoking	_
160-95	33110-33112	on	_
160-96	33113-33117	gray	_
160-97	33118-33124	matter	_
160-98	33125-33131	volume	_
160-99	33131-33132	:	_
160-100	33133-33142	influence	_
160-101	33143-33145	of	_
160-102	33146-33149	sex	_
160-103	33150-33160	Functional	_
160-104	33161-33176	characteristics	_
160-105	33177-33179	of	_
160-106	33180-33183	the	_
160-107	33184-33189	brain	_
160-108	33190-33192	in	_
160-109	33193-33200	college	_
160-110	33201-33209	students	_
160-111	33210-33214	with	_
160-112	33215-33223	internet	_
160-113	33224-33230	gaming	_
160-114	33231-33239	disorder	_
160-115	33240-33246	Opiate	_
160-116	33247-33254	addicts	_
160-117	33255-33259	lack	_
160-118	33260-33275	error-dependent	_
160-119	33276-33286	activation	_
160-120	33287-33289	of	_
160-121	33290-33297	rostral	_
160-122	33298-33306	anterior	_
160-123	33307-33316	cingulate	_
160-124	33317-33320	The	_
160-125	33321-33325	role	_
160-126	33326-33328	of	_
160-127	33329-33332	the	_
160-128	33333-33338	right	_
160-129	33339-33347	inferior	_
160-130	33348-33355	frontal	_
160-131	33356-33361	gyrus	_
160-132	33361-33362	:	_
160-133	33363-33373	inhibition	_
160-134	33374-33377	and	_
160-135	33378-33389	attentional	_
160-136	33390-33397	control	_
160-137	33398-33404	Dorsal	_
160-138	33405-33411	medial	_
160-139	33412-33422	prefrontal	_
160-140	33423-33429	cortex	_
160-141	33430-33435	plays	_
160-142	33436-33437	a	_
160-143	33438-33447	necessary	_
160-144	33448-33452	role	_
160-145	33453-33455	in	_
160-146	33456-33461	rapid	_
160-147	33462-33467	error	_
160-148	33468-33478	prediction	_
160-149	33479-33481	in	_
160-150	33482-33488	humans	_
160-151	33489-33500	Alterations	_
160-152	33501-33503	in	_
160-153	33504-33512	regional	_
160-154	33513-33524	homogeneity	_
160-155	33525-33527	of	_
160-156	33528-33541	resting-state	_
160-157	33542-33547	brain	_
160-158	33548-33556	activity	_
160-159	33557-33559	in	_
160-160	33560-33568	internet	_
160-161	33569-33575	gaming	_
160-162	33576-33583	addicts	_
160-163	33584-33597	Environmental	_
160-164	33598-33601	and	_
160-165	33602-33609	genetic	_
160-166	33610-33617	factors	_
160-167	33618-33620	in	_
160-168	33621-33632	age-related	_
160-169	33633-33640	hearing	_
160-170	33641-33651	impairment	_
160-171	33652-33661	Increased	_
160-172	33662-33670	cortical	_
160-173	33671-33680	thickness	_
160-174	33681-33683	in	_
160-175	33684-33696	professional	_
160-176	33697-33704	on-line	_
160-177	33705-33711	gamers	_
160-178	33712-33722	Comparison	_
160-179	33723-33725	of	_
160-180	33726-33731	brain	_
160-181	33732-33742	activation	_
160-182	33743-33745	in	_
160-183	33746-33754	response	_
160-184	33755-33757	to	_
160-185	33758-33761	two	_
160-186	33762-33773	dimensional	_
160-187	33774-33777	and	_
160-188	33778-33783	three	_
160-189	33784-33795	dimensional	_
160-190	33796-33803	on-line	_
160-191	33804-33809	games	_
